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ABSTRACT 
CYTOTOXICITY AND CELLULAR RESPONSE TO a,~-UNSATURATED 
ALDEHYDES. ROLE OF ALDEHYDE DEHYDROGENASES 
Ngome Makia 
August 24, 2011 
The lipid aldehydes, 4-hydroxy-2-nonenal (4-HNE) and propene-2-al (acrolein) are 
reactive a,~-unsaturated aldehydes generated during the peroxidation of lipids and are 
implicated in the pathogenesis of several oxidative-stress mediated diseases, including 
steatohepatitis and cancer. We established that mouse liver aldehyde dehydrogenase 1 al 
(Aldhlal) efficiently metabolizes lipid aldehydes and protects a liver-derived cell line 
from the toxic effects of these aldehydes. Thus, mechanisms to induce the expression of 
Aldhlal might be a useful rationale for preventing oxidative stress-induced pathologies. 
We investigate whether well-known electrophiles, such as BHA or acrolein modulate the 
expression of Aldhlal and elucidate the signaling pathway involved. Microarray 
analyses were performed to examine whether acrolein or BHA up-regulate the expression 
of genes encoding enzymes involved in antioxidant or electrophile detoxification in mice 
liver. Mice were administered AIN76A (control) diet, diet containing 0.45% BHA or 5 
mg/kg acrolein by gavage for 7 days. The expression of genes encoding several 
electrophile detoxifying enzymes was specifically elevated, indicating a detoxification 
response. The elevation of Aldhlal was noticeable, with a 2- to 3-fold increase by both 
electrophiles. Quantitative real-time peR analysis also showed ;::::2.5-fold and ;::::3-
VI 
fold induction of Aldhlal gene expression by BRA and acrolein, respectively. Livers 
from BRA- and acrolein-treated mice also showed increased cytosolic Aldh activity 
compared to control. Acrolein and tert-butylhydroquinone (the metabolized products of 
BRA) are electrophiles that induce the expression of cytoprotective genes by direct 
activation of nuclear factor-E2-related factor-2 (Nrf2), activator protein 1 (AP-l) and 
nuclear factor kappa B (NF-KB) transcription factors or indirectly by activation of protein 
kinases, such as MAPKs. 
To decipher the signaling pathways involved in Aldhlal induction by 
electrophiles, we analyzed the mRNA levels of Aldhlal in the liver ofNrf2+I+ and Nrf2-
1- mice on C57BL6 background exposed to BRA. Mice exposed to BRA showed ::::;2-fold 
increase in mRNA levels of Aldhlal in both Nrf2+I+ and Nrf2-I-mice compared to 
control, indicating that electrophile-induced expression might be independent ofNrf2. 
However, the mRNA and protein levels of AP-l and the activity of c-Jun were 
significantly increased by BRA. We hypothesized that electrophile-induced expression of 
hepatic Aldhlal gene is mediated by activation of AP-l transcription factor. Transient 
transfection experiments were conducted in RepG2 cells with Aldhlal 5'-flanking 
luciferase reporter constructs. While co-transfection with Nrf2 expression plasmid alone 
or in the presence of tBRQ had no effect, over-expression of c-Junl AP-l resulted in ::::;4-
fold induction in Aldhlal transcriptional activity. Moreover, c-Jun transactivates 
Aldhlal promoter activity as a homodimer and not c-Junlc-fos heterodimer. We also 
established by promoter deletion and mutagenesis analysis that two AP-l sites at position 
-758 and -1069 relative to Aldhlal transcription start site are responsible for c-Jun-
mediated transactivation of Aldhlal luciferase activity. EMSA analysis using biotin-
Vll 
labeled probe and super shift with antibodies against c-Jun, c-fos and Nrf2 showed that c-
Jun binds to the proximal AP-1 site at -758 but not at -1069. The recruitment of c-Jun to 
this AP-1 site by BHA was confirmed by ChIP experiment, which showed ;:::;10-fold 
enrichment to the proximal AP-1 site with c-Jun. These results indicate that electrophiles 
promote the recruitment of c-Junl AP-1 to the Aldh1 a1 gene promoter, resulting in 
increased transcription of Aldh1al. 
Vlll 
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Lipid and Environmental Aldehydes 
Propene-2-al (acrolein) is a highly reactive a,~-unsaturated aldehyde ubiquitously 
present as an environmental pollutant in cigarette smoke, vehicle exhaust emission, 
drinking water and in effluents from industrial plants. It is produced by a variety of 
natural and synthetic processes that include the incomplete combustion of organic 
materials, such as fuels, plastic materials, wood, food, frying oils and tobacco (Stevens 
and Maier, 2008). The amount of acrolein in a single puff of cigarette smoke is estimated 
to range between 1.6 -22 f..lg/cigarette depending on the carbon filter of the cigarette 
(Thweatt et aI., 2007). Acrolein is found at a concentration of 0.04 to 0.08 ppm in 
ambient air (Beauchamp, Jr. et aI., 1985). However, acrolein levels can be as high as 90 
ppm in cigarette smoke. Inhalation studies demonstrate that the lethal dose of acrolein in 
mice is a 10 min exposure of 175 ppm (Beauchamp, Jr. et aI., 1985). The main 
endogenous sources of acrolein are the biotransformation of allyl alcohol, allylamine, 
spermine, spermidine and the widely used anticancer drug cyclophosphamide. Acrolein is 
a major end product formed from the peroxidation of the ro-6 polyunsaturated fatty acids, 
such as linoleic acid and arachidonic acid along with 4-hydroxynonenal (4-HNE), 
crotonaldehyde, malondialdehyde (MDA), hexanal and trans-2-hexenal 
1 
(Uchida K et al., 1998). Thus, humans are constantly exposed to acrolein and related 
aldehydes in the environment. It is estimated that the maximum daily human 
consumption of unsaturated aldehydes is ~5 mg/kg, while the total aldehyde consumption 
has been suggested to be ~ 7 mg/kg (Wang et al., 2008;Conklin et al., 2010). 
Mechanism of cytotoxicity of a,~-unsaturated aldehydes 
The a,~-unsaturated aldehydes, acrolein and HNE, are highly reactive 
electrophiles and can undergo Michael addition reaction with nucleophilic groups on 
proteins and DNA, forming stable covalent adducts (Esterbauer, 1993). These aldehydes 
form adducts with proteins by reacting with cysteine sulfhydryl group, histidine 
imidazole group and lysine £-amino group, resulting in alteration of several cellular 
processes. Enzymes containing amino and sulfhydryl groups in their active site can be 
inhibited by reactive aldehydes. For example, high levels of acrolein or HNE inhibit 
aldehyde dehydrogenases, cytochrome P450, GST mu and pi and the glycolytic enzymes, 
glyceraldehyde-3 phosphate and glucose-6 phosphate dehydrogenase (Berhane and 
Mannervik, 1990;Kuo et al., 1997;Silva and O'Brien, 1989;Szweda et al., 1993;Uchida 
and Stadtman, 1993). The conjugation of a,~-unsaturated aldehyde with reduced 
glutathione (GSH) can induce oxidative stress by depleting cells of their natural 
antioxidant, glutathione. HNE and acrolein are known to induce apoptotic and necrotic 
cell death by activation of death signaling pathways involving caspases and the 
mitochondrial permeability transition pore (mMTP) (Burcham and Fontaine, 2001). 
Reactive aldehydes are implicated in the pathogenesis of a number of 
inflammatory diseases in humans. The accumulation of reactive aldehydes in the liver 
2 
can promote the influx of inflammatory cells by stimulating the production of the 
pro inflammatory cytokines, TNFa, thereby amplifying inflammatory response 
(Browning and Horton, 2004;Esterbauer et ai., 1991). In addition, reactive aldehydes are 
also known to activate hepatic stellate cells leading to collagen deposition (Browning and 
Horton, 2004), suggesting that lipid aldehydes are implicated in the transition from fatty 
liver (steatosis) to steatohepatitis and other end stage liver diseases, such as liver fibrosis 
and non-alcoholic steatohepatitis (NASH). HNE and acrolein have also been linked to the 
pathogenesis of atherosclerosis (Uchida et ai., 1994). The low-density lipoprotein (LDL) 
becomes more atherogenic when modified by acrolein and HNE triggering the uptake of 
LDL by scavenger receptors located on vascular smooth muscle cells (Uchida et ai., 
1994;Uchida et ai., 1998;Uchida, 2000). Thus, high levels of 4HNE- and acrolein-
modified proteins have been detected in atherosclerotic lesions (Uchida et ai., 
1994;Uchida et ai., 1998). Cytotoxic aldehydes playa major role in the progression of 
myocardial ischemia reperfusion injury by activation of the mMTP (Eaton et ai., 1999). 
The opening of the mMTP is considered a primary event in necrotic cell death in 
myocardial ischemia-reperfusion injury. Thus, a small-molecule activator of ALDH2 
(Alda-1), when administered to rats before an ischemic event, reduced infarct size by 
60%, most likely through its inhibitory effect on the formation of protein adducts by 
electrophilic aldehydes (Chen et ai., 2008). Therefore, the metabolism of these toxic 
compounds to less reactive and excretable compounds is of great importance in 
ameliorating lipid aldehydes induced human diseases. 
The Aldehyde Dehydrogenase (ALDH) genes 
3 
Although the mechanism of reactive aldehydes-induced cytoxicity has been 
extensively studied, little is known about how cells respond to toxic insults by a,~­
unsaturated aldehydes. Cells have developed elaborate methods to resist cytotoxic 
aldehydes by the presence of cytoprotective genes encoding enzymes involved in 
aldehyde metabolism and detoxification. Multiple pathways are involved in the 
metabolism of acrolein and HNE including oxidation to carboxylic acid, reduction to an 
alcohol and the conjugation to GSH. The enzymes involved include glutathione S-
transferase (GST), ALDH, aldo-keto reductases (AKR), alcohol dehydrogenase (ADH) 
and cytochromes P450 (CYP) (Amunom et aI., 2007;Marchitti et aI., 2008;Srivastava et 
aI., 2001). The importance of these enzymes in acrolein and HNE detoxification is cell 
type- and species-dependent. Intravenous administration of acrolein into rats 
demonstrates that AKRs also playa major role in the metabolism of acrolein especially in 
the heart (Stevens and Maier, 2008). However, in vitro studies ofHNE metabolism 
performed with isolated hepatocytes and perfused mice livers suggest that both Aldhs and 
GST are the main enzymes involved in lipid aldehyde metabolism in hepatic tissues 
(Hartley et aI., 1995). 
ALDHs gene superfamily encodes enzymes that catalyze the irreversible 
oxidation of endogenous and exogenous aldehydes to their corresponding non-toxic 
carboxylic acids using either NAD+ or NADP+ as cofactor. These enzymes play critical 
roles in the cellular protection against oxidative damage induced by cytotoxic aldehydes 
by metabolizing these aldehydes to a form that is easily excreted. The active ALDH 
enzyme is composed of subunits that form either a homodimer or homotetramer protein. 
Each subunit is characterized by a Rossmann fold and contains an NAD(P)-binding 
4 
domain, a catalytic domain and an oligomerization domain (Marchitti et aI., 2008). A 
funnel-shaped opening at the interface of these domains leads to a putative catalytic 
pocket and is essential for substrate specificity. The ALDH Rossmann fold contains the 
structural motif, (GxxxxG; x represent any protein residue) which is necessary for 
cofactor binding. An invariant cysteine is found at the catalytic site of all ALDHs and is 
essential for the formation of the thiohemiacetal intermediate (Marchitti et aI., 2008). 
Members of the ALDH gene superfamily are composed of 555 genes in both 
eukaryotes and prokaryotes. To date, 172 ALDH genes have been identified in 
eukaryotes (Sophos and Vasiliou, 2003) with 19 functional ALDH genes in the human 
genome (Alnouti and Klaassen, 2008;Ellis, 2007;Marchitti et aI., 2008). Three isozymes, 
the cytosolic ALDH1A1 and ALDH3A1, and the mitochondrial ALDH2 are implicated 
in the detoxification of lipid-derived aldehydes. However, the role of Aldh isozymes in 
cellular protection against cytotoxic aldehydes especially in mice liver is still not 
completely understood. 
ALDH2 is a homo- or heterotetramer highly expressed in the liver and 
extrahepatic tissues. The human ALDH2 is encoded in the nucleus and imported to the 
mitochondrial matrix with the help of a 17 amino acid N-terminal mitochondrial 
localization sequence. ALDH2 enzyme plays a major role in the alcohol metabolism 
pathway based on its low Km «5 IlM) for acetaldehyde oxidation (Klyosov et aI., 1996). 
Asian individuals carrying a catalytically inactive form of the enzyme with a point 
mutation in ALDH2 (ALDH2*2) experience the facial flushing after alcohol ingestion, 
caused by elevated blood acetaldehyde (Goedde et aI., 1992). Emerging evidence 
indicates that ALDH2 plays a crucial role in cytoprotection against myocardial ischemia-
5 
reperfusion injury probably by detoxifying reactive aldehydes such as HNE (Chen et aI., 
2008). 
ALDH3Al is a homodimer that oxidizes medium chain aliphatic and aromatic 
aldehydes, and utilizes either NAD+ or NADP+ as cofactor. Aldh3al is poorly expressed 
in normal murine liver but is constitively expressed in the cornea where it protects the 
eye from UV -induced oxidative damage by scavenging hydroxyl radicals and 
detoxification of lipid peroxidation-derived aldehydes, such as HNE (Alnouti and 
Klaassen, 2008;Lassen et aI., 2007). ALDH3Al efficiently metabolizes cytotoxic lipid 
aldehydes and protects cells against HNE-induced apoptosis (Townsend et aI., 2001). 
ALDH3Al plays a major role in the metabolism of the anticancer drug 
cyclophosphamide and increased expression of ALDH3Al with ALDHIAI is 
responsible for the resistant phenotype exhibited by most cells to cyclophosphamide 
toxicity (Marchitti et aI., 2008). 
The cytosolic ALDHIAI enzyme is a homotetramer protein highly expressed in 
the liver, lung and retina. ALDHIAI plays an important role in retinoic acid (RA) 
biosynthesis by efficiently catalyzing the oxidation of both all-trans- and 9-cis-retinal 
(Marchitti et aI., 2008;Vasiliou et aI., 2004). Thus, ALDHIAI regulates normal growth, 
differentiation and development of adult epithelia by synthesizing RA, a ligand for the 
nuclear RA receptor (RAR) and retinoid X receptor (RXR). Aldhlal gene is expressed at 
higher levels in human hematopoietic stem cells (HSCs), and is critical for stem cell 
differentiation and function (Chute et aI., 2006). The human ALDHIAI utilizes either 
NAD+ or NADP+ as cofactor, but prefers NAD+ over NADP+ (Xiao et aI., 2009). 
Previous studies revealed that the human ALDHIAI provides only moderate protection 
6 
against trans-2-nonenal and not against other lipid aldehydes, such as HNE, acrolein and 
trans-2-hexenal (Townsend et aI., 2001). However, there is compelling evidence to 
suggest that ALDHIAI plays a prominent role in the cellular defense against oxidative 
damage induced by cytotoxic aldehydes. Studies with Aldhlal-I- mice indicate that 
Aldhlal protects the eye lens and cornea from cataract formation due to ageing- or UV 
radiation-induced oxidative stress by detoxifying cytotoxic lipid aldehydes (Choudhary et 
aI., 2005;Lassen et aI., 2007). The human lens ALDHIAI efficiently oxidizes lipid-
derived aldehydes, including HNE (Km 4.8 11M), trans-2-heptenal (Km 177 11M) and 
MDA (Km 3.5 11M) (Marchitti et aI., 2008;Xiao et aI., 2009). 
In addition to its role in detoxification of lipid aldehydes, Aldhlal plays an 
important role in drug and xenobiotic metabolism. Over-expression of Aldhlal causes 
resistance to the anticancer drug, cyclophosphamide (CP) by detoxifying its major active 
aldehyde metabolite, acrolein (Moreb et aI., 2007). Aldhlal is one of the major enzymes 
involved in the metabolism of toxic ethanol metabolite, acetaldehyde (Km 50-180 11M) 
(Browning and Horton, 2004;Marchitti et aI., 2008). ALDHIAI also possesses a p-
nitrophenyl acetate esterase activity and is involved in the bioactivation of the antianginal 
drug, nitroglycerin (Beretta et aI., 2008). Furthermore, recent studies indicate that 
ALDHIAI is a major enzyme responsible for detoxification of3-deoxyglucosone, which 
is produced by the process of glycoxidation, and 3-deoxyglucosone is implicated in the 
pathogenesis of diabetes (Collard et aI., 2007). We hypothesized that Aldhlal is the 
major enzyme involved in acrolein and other lipid aldehyde detoxification in mouse liver. 
Thus, an understanding of the molecular mechanism regulating Aldhl al gene expression 
is of importance in potentially attenuating the toxic action of carbonyl compounds. 
7 
The Aldehyde dehydrogenase 1a1 gene regulation 
Even though Aldhlal is constitutively expressed in various tissues especially the 
liver, the expression of Aldhlal gene is known to be altered by a wide variety of 
endogenous and exogenous stimuli. The levels of Aldhlal mRNA were markedly lower 
in mice with elevated levels of hepatic RA, suggesting that elevated hepatic RA down-
regulates Aldhlal expression in a feedback pathway to control RA biosynthesis 
(Andreola et aI., 1997). Aldhlal is a major enzyme involved in RA biosynthesis. 
Transient transfection studies revealed that RARa and the CCAAT/enhancer-binding 
protein ~ (C/EBP~) transactivate the Aldhl gene. The activation of Aldhlal gene 
expression by RAR was further supported by the fact the RXRa-l - mice display decreased 
liver Aldhlal levels (Gyamfi et aI., 2006). The molecular mechanism ofRA-induced 
down-regulation of Aldhlal was attributed to RA-mediated decrease in the mRNA 
expression of C/EBP~ (Elizondo et aI., 2000;Elizondo et aI., 2009). 
Aldhlal was previously shown to be induced by phenobarbital (PB) treatment in 
rat (Pappas et aI., 2001). Alnouti and Klaassen also reported induction of Aldhlal gene 
in mouse liver by constitutive androstane receptor (CAR) activators, presumably 
operating through a CAR binding site in the 5 '-flanking region of Aldhlal gene (Alnouti 
and Klaassen, 2008). The 5' -flanking region of the mouse Aldh 1 al gene was previously 
characterized and is highly conserved to that of the rat and human ALDHI (Hsu et aI., 
1999;Hsu et aI., 2000). It contains putative cis-acting regulatory elements such as GAT A, 
AP-l, Nrf2, SP-l NF-K B, AhR-Arnt, CAR and Stat5 binding sites. There is also the 
presence of an Oct 1 and a CCAA T binding sites which are highly conserved in the rat 
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and human gene, and are essential for basal promoter activity (Guimond et aI., 2002;Hsu 
et aI., 1999). 
Aldh1a1 expression is reported to be enhanced by chemicals which are known to 
activate redox-sensitive transcription factors, such as Nuclear Factor-E2-related factor-2 
(Nrf2). For example, oxidative and electrophilic stress were shown to modulate the 
expression of Aldh1a1 and other cytoprotective genes by activation ofNrf2 (Hu et aI., 
2006;Lamle et aI., 2008;Leonard et aI., 2006;Reisman et aI., 2009;Thimmulappa et aI., 
2002). We also showed by micro array profiling in mice liver that Aldh1a1 gene 
expression was induced by electrophiles, such as BHA and acrolein (Amunom, Makia 
and Prough, unpublished report). However, the signaling pathway involved in 
electrophile-induced expression of Aldh1a1 gene is not completely understood. 
Electrophiles and oxidants modulate the expression of cytoprotective genes by activation 
of redox-sensitive transcription factors, such as Nrf2, AP-1 and NF-KB. 
The Nuclear Factor-E2-related factor-2 (Nrf2) transcription factor 
The transcription factor Nrf2 belongs to the cap-n-collar (CNC) family of basic 
leucine zipper (bZIP) proteins. In addition to oxidants, Nrf2 is activated by chemical 
compounds that undergo redox cycling or be metabolized to reactive or electrophilic 
intermediate (Rushmore et aI., 1990;Rushmore and Pickett, 1991). A wide variety of 
natural and synthetic compounds are known activators ofNrf2, such as BHA and its 
metabolite tert-butylhydroquinone (t-BHQ), sulforaphane (SFN), 1,2 dithiole-3-thione 
(D3T), phenethylisothiocyanate (PEITC) and reactive aldehydes. The mechanism of 
activation ofNrf2 by aldehydes and other electrophiles is not completely understood. 
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However, the activation ofNrf2 by oxidative stress and electrophiles is proposed to occur 
by one of two mechanisms (Nguyen et aI., 2003;Nguyen et aI., 2004;Nguyen et aI., 
2009). In the absence of oxidative and electrophilic stress, Nrf2 is localized in the 
cytoplasm in a complex with Kelch-like ECH-associated protein 1 (Keap-l) that 
facilitates the degradation ofNrf2 via the proteosomal system. Thus, under basal 
conditions the levels ofNrf2 is kept relatively low. Oxidative and electrophilic stress 
causes modification of cysteine residues within the hinge region of Keap-l, disrupting its 
association with Nrf2 and leading to nuclear translocation ofNrf2. 
Electrophiles, such as reactive aldehydes and BHA can also activate Nrf2 
indirectly by activation of protein kinase signaling pathways (Huang et aI., 2002;Huang 
et aI., 2000). The depletion of GSH by reactive aldehydes and other electrophiles causes 
oxidative stress that activates stress-signaling pathways involving kinases. Electrophiles 
have been shown to directly activate Rafl (a MAPK kinase kinase), which then 
phosphorylates and activates MEK (a MAPK kinase) (Yu et aI., 1997). The involvement 
of mitogen-activated protein kinase (MAPK), such as p38, c-Jun N-terminal kinase 
(JNK) and extracellular signal-regulated kinases 1 and 2 (ERKl/2) in the activation of 
Nrf2 is well established (Wu et aI., 2006;Yu et aI., 1997;Yuan et aI., 2006). Furthermore, 
acrolein-mediated activation ofNrf2 was dependent on the phosphatidylinositol-3-kinase 
(PI-3K) and protein kinase C (PKC) signal pathways (Zhang and Forman, 2008). The 
phosphorylation ofNrf2 at Ser 40 by PKC has been demonstrated to activate Nrf2 
(Huang et aI., 2002;Huang et aI., 2000). 
The activated Nrf2 heterodimerizes with small Maf (MafF, MafG and MafK) 
proteins and coordinates expression of antioxidant and electrophile detoxification genes 
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by binding to the antioxidant/electrophile response element (ARE/EpRE) commonly 
found in the promoter or enhancer region of these genes (Rushmore et aI., 1991). Gene 
expression profiling in the liver of Nrj2+I+ and Nrj2-I- mice exposed to prooxidants 
revealed that Nrf2 regulates hundreds of genes, including several antioxidant and 
electrophile detoxification enzymes (Hu et aI., 2006). The most notable of these genes are 
the glutathione S-transferases (GSTA2, GSTP, Gsta1 and Gstml), y-glutamyl synthetase 
(y-GCS), NADPH: quinone oxidoreductases (NQO-1), heme oxygenase (HO-l), 
glutathione peroxidases (GPx) and glutathione reductases (GR). We and others have 
shown that the Nrf2 activators, BHA and acrolein, increased mRNA expression of 
Aldhl al. The signaling pathways involved in the transcriptional regulation of Aldhl al 
gene by BHA and acrolein have not been previously studied. Moreover, it is not yet 
known whether Aldhl al is a direct target ofNrf2. However, aside from Nrf2, BHA and 
reactive aldehydes are also known to induce the transcriptional activity of the AP-l and 
NF-KB transcription factors (Choi and Moore, 1993;Iles and Liu, 2005). 
The Activator Protein 1 (AP-l) transcription factor 
The AP-l transcription factors are basic leucine zipper (bZIP) proteins that include 
members oftheJos (c-fos, Fos-B, Fra-l and Fra-2),jun (c-lun, lun B and lUll D) and the 
activating transcription factors (ATFI-5 and B-ATF). Members ofthejun family are 
known to regulate gene expression as either homodimers or as heterodimers with 
members oftheJos family. The dimeric AP-1 binds to cis-acting 12-0-
tetradecanoylphorbol 13-acetate (TPA)-responsive element (TRE) in the promoter of 
target genes (Eferl and Wagner, 2003) (Figure 1) CEferl and Wagner, 2003). The TRE 
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was originally described in the human collagenase gene promoter and has the sequence, 
5' -ATGAC/GTCA-3'. C-Jun is also known to form heterodimer protein complexes with 
Nrf2 and ATF2. The heterodimers of c-Jun with ATF-2 and Nrf2 are known to bind to 
the cyclic AMP response element (CRE) and ARE, respectively (Figure 1). The c-Jun 
protein has a b-ZIP DNA-binding domain and a transactivation domain containing 
phosphorylation sites for stress-activated protein kinases (SAPKs) such as JNK, p38 and 
ERK1I2. In response to oxidative and electrophilic stress, the SAPKs phosphorylate c-
Jun and enhance its trans activating capacity. In addition, reactive aldehydes can enhance 
the transcriptional activity of AP-1 by induction of AP-1 gene expression (Pugazhenthi et 
ai., 2006;Ranganna et ai., 2002;Tirumalai et ai., 2002;Wu et ai., 2006;Zhang and Forman, 
2008). 
AP-1 proteins have been implicated in several signal transduction pathways 
associated with cellular growth, differentiation and cellular stress (Eferl and Wagner, 
2003). AP-1 can either promote or antagonize cell survival in a tissue- and stress-
dependent manner. The mechanism that accounts for the dual role of AP-1 in apoptosis 
and survival signaling has not been established. Previous studies showed that c-Jun acts 
downstream of JNK to induce apoptosis in TNFa-stimulated thymocytes (Hasselblatt et 
ai., 2007). However, c-jun null mice die at midgestation and display increased apoptosis 
of fetal liver cells (Eferl and Wagner, 2003). A more recent study indicates that oxidative 
stress-mediated induction of c-Junl AP-1 promotes hepatocyte survival during acute 
hepatitis by transcriptional regulation of inducible nitric oxide synthase (Nos 2) gene 
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Figure 1. The basic leucine zipper (bZIP) family proteins and their binding partners. The 
jun family members can form either homodimer or heterodimers with members of the fos 
family. The dimeric AP-I binds to cis-acting 12-0- tetradecanoylphorbol I3-acetate 
(TP A)-responsive elements (TRE) in the promoter of target genes (Eferl and Wagner, 
2003). c-Jun also form heterodimers with ATF-2 and Nrf2 which binds to the cyclic 
AMP response element (eRE) and antioxidant response element (ARE), respectively. 
13 
especially against oxidative stress (Eferl and Wagner, 2003;Hasselblatt et aI., 
2007;Marden et aI., 2008;Tsuji, 200S). We propose that increased transcriptional 
activation of the aldehyde-metabolizing gene, Aldhlal, by reactive aldehydes is mediated 
by activation of c-JunJ AP-l proteins. 
The nuclear factor kappa B (NF -KB) 
Nuclear Factor kappa B (NF-KB) proteins are redox-sensitive transcription 
factors, which play key roles in immune and inflammatory responses. There are five NF-
KB proteins in mammals: RelA (p6S), RelB (P68), c-Rel (p7S), pSO and pS2 (Karin, 
1999). They modulate gene expression by forming a variety ofheterodimers and 
homodimers with each other. In most tissues, the predominant NF-KB dimer is a pSO/p6S 
heterodimer. NF-KB proteins are also known to modulate gene expression by forming 
active heterodimers with AP-l proteins (Rahmani et aI., 2001). NF-KB proteins are held 
in an inactive state in the cytoplasm by inhibitory proteins known as IKB. Following 
exposure to oxidative stimuli and electrophiles, IKB undergoes phosphorylation, 
ubiquitination and subsequent degradation of IKB (Karin, 1999). The degradation of IKB 
leads to the release of the pSO/p6S complexes, resulting in nuclear translocation and 
transcriptional activation of specific target genes. These target genes are involved in 
inflammatory responses to infection and stess. 
We hypothesize that mouse liver displays a protective response to toxic aldehydes 
by enhanced metabolic inactivation of these toxic species, mediated by induction of 
Aldhlal enzymes. Moreover, electrophile-induced expression of Aldhlal gene is 
mediated by c-JunJAP-1.The goal of these studies is two-fold. 1. To examine whether 
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lipid aldehydes and their GSH conjugates are substrates for Aldhlal. 2. To decipher the 
signaling pathways involved in electrophile-mediated induction of Aldhlal gene 
expression in mouse liver. 
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CHAPTER II 
MURINE HEPATIC ALDEHYDE DEHYDROGENASE IAI (Aldhlal) IS A 
MAJOR CONTRIBUTOR TO OXIDATION OF ALDEHYDES FORMED 
BY LIPID PEROXIDATION 
INTRODUCTION 
The liver, as the major site for metabolism and biotransformation of drugs and 
foreign compounds, is constantly exposed to reactive oxygen species (ROS), resulting in 
oxidative stress. During oxidative stress, these ROS, which include hydrogen peroxide 
(H20 2), superoxide radicals (Oi-) and hydroxyl radicals (OH.), can covalently modify 
proteins, lipids and DNA. The peroxidation of polyunsaturated fatty acids in membrane 
lipid by ROS produces unstable lipid hydroperoxides that decompose into aldehydes such 
as malondialdehyde (MDA), hexanal, trans-2-hexenal, propen-2 al (acrolein) and 4-
hydroxy-2-nonenal (HNE) (Esterbauer et aI., 1991 ;Esterbauer, 1993). Among these 
aldehydes, HNE and acrolein are highly electrophilic a,~-unsaturated aldehyde that can 
undergo Schiff base and Michael addition reactions with nucleophilic groups on proteins 
and DNA (Esterbauer, 1993). There is increasing evidence that the pathophysiological 
effects of ROS in cells is mediated by these cytotoxic aldehydes because they are more 
chemically stable than ROS and thus, can diffuse to distant sites from where they are 
formed (Ellis, 2007;Uchida et aI., 1994). 
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In addition, humans are exposed to these aldehydes as environmental pollutants 
and by endogenous processes generating reactive aldehydes in the liver. For example, 
chronic alcohol consumption, high fat diet or exposure to foreign compounds such as 
carbon tetrachloride (CCI4), allyl alcohol and the widely used anticancer drug, 
cyclophosphamide, markedly elevate the intracellular concentrations of cytotoxic 
aldehydes (Dwivedi et al., 2006;Nanji et al., 1994;Sampey et al., 2007;Stevens and 
Maier, 2008). Reactive a,~-unsaturated aldehydes, such as acrolein and crotonaldehyde 
are also present in cigarette smoke, vehicle exhaust emission, overheated foods and oil, 
drinking water and in effluents from industrial plants (Feron et al., 1991;Stevens and 
Maier, 2008). The maximum daily human consumption of unsaturated aldehydes is 
estimated at ~5 mg/kg whereas the total aldehyde (saturated and unsaturated) 
consumption is estimated at ~7 mg/kg (Wang et al., 2008;Conklin et al., 2010). 
The levels of reactive lipid aldehydes are elevated in various oxidative stress-
mediated diseases, including steatohepatitis (Chen et al., 1997), atherosclerosis (Uchida 
et al., 1994), Alzheimer's disease (Sayre et al., 1997), cataractogenesis (Srivastata et al., 
1996), diabetes (Toyokuni et aI., 2000) and cancer (Hammer et al., 1997). In fact, 
accumulation of reactive aldehydes is associated with the pathogenesis of these diseases. 
The toxicity of a,~-unsaturated aldehyde lies in their ability to form Michael adducts with 
thiol and amino groups of proteins resulting in alteration of several cellular processes. For 
example, enzymes such as glyceraldehyde-3-phosphate, glucose-6-phosphate 
dehydrogenases and cytochrome c oxidase containing lysine and cysteine residues in 
their active sites are readily inactivated by conjugation with these reactive aldehydes 
(Chen et al., 2001;Szweda et al., 1993;Uchida and Stadtman, 1993). In addition, a,~-
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unsaturated aldehydes can induce oxidative stress in cells by depleting cellular reduced 
glutathione, thereby altering signal transduction pathways in cells. At low 
concentrations, acrolein is known to trigger apoptotic cell death by mechanisms that 
involve activation of mitochondrial death pathways and caspases (Burcham and Fontaine, 
2001 ; Stevens and Maier, 2008;Tanel and Averill-Bates, 2007). Caspases, particularly 
caspase 3, which can cleave substrates, such as poly(ADP-ribose) polymerase (PARP), 
actin and laminin, are widely used as markers for apoptosis in different cell types. 
However, at high concentrations acrolein causes necrotic cell death. This phenomenon 
has also been observed with HNE (Cheng et aI., 2001;Thomberry and Lazebnik, 
1998;Zhang et aI., 2010). 
Despite their toxicity, many cytotoxic lipid-derived aldehydes can be successfully 
metabolized to less toxic compounds by the action of oxidative, reductive and 
conjugative enzymes. These enzymes include glutathione S-transferases (GST), aldehyde 
dehydrogenases (ALDH), aldo-keto reductases (AKR), alcohol dehydrogenases (ADH) 
and cytochrome P450 (CYP) (Amunom et aI., 2007;Conklin et aI., 2007;Marchitti et aI., 
2008;Srivastava et aI., 1998;Srivastava et aI., 2001). The relative importance of these 
enzymes in reactive aldehyde metabolism is cell type- and species-dependent. It is now 
known that the conjugation of acrolein with glutathione may not be a true detoxification 
process because acrolein-glutathione conjugates can undergo renal processing to form 
reactive species (Ramu et aI., 1995). In addition, the conjugation process is compromised 
when GSH concentrations are depleted during oxidative stress. ALDH oxidizes a range 
of toxic aldehydes to their corresponding non-toxic carboxylic acids using either NAD+ 
or NADP+ as cofactors. ALDHs playa critical role in the cellular protection against these 
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toxic species. There are 19 ALDH genes in the human genome (Marchitti et aI., 2008). 
To date, three isozymes, the cytosolic ALDHIAI and ALDH3Al, and the mitochondrial 
ALDH2 are suggested to be the main lipid aldehyde-oxidizing enzymes expressed in the 
mouse liver. 
The role of these enzymes in the cellular defense against oxidative damage 
induced by cytotoxic aldehydes is controversial. Previous studies by Townsend et al 
revealed that ALDHIAI over-expression provides only moderate protection against 
trans-2-nonenal and not against other lipid aldehydes (Townsend et aI., 2001). However, 
ALDH3Al could protect RAW 264.7 murine macrophage cell line against HNE-induced 
apoptosis, consistent with the prevention ofHNE-protein adduct formation (Townsend et 
aI., 2001). Mouse Aldh3al is poorly expressed in normal liver and highly expressed in 
cancerous cells (Alnouti and Klaassen, 2008). It is also abundantly expressed in the 
cornea and protects the cornea against cytotoxic lipid peroxidation-derived aldehydes 
(Lassen et aI., 2007). However, recent experiments with Aldhlal-I- mice indicate that 
Aldhlal also protects the eye from cataract formation induced by oxidative stress by 
detoxifying cytotoxic lipid aldehydes (Choudhary et aI., 2003;Choudhary et aI., 2005). 
Moreover, the human lens ALDH1A1 efficiently oxidizes lipid-derived aldehydes, 
including HNE (Km 4.8 J-lM), trans-2-heptenal (Km 177 J-lM) and MDA (Km 3.5 J-lM) 
(Xiao et aI., 2009). In addition, over-expression of ALDHI in neuroblastoma cells 
reduces both production ofprotein-HNE adducts and activation of caspase-3 (Zhang et 
aI., 2010). Aldh1a1 is known to decrease the effectiveness ofthe anticancer drugs 
cyclophosphamide by detoxifying its major active metabolites acrolein (Moreb et aI., 
2007). These results indicate that Aldh1a1 has the potential to protect against aldehydes 
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produced as a result of lipid peroxidation. However, it is unknown whether Aldhlal can 
protect against acrolein-induced toxicity in mouse liver. We hypothesized that Aldhlal is 
the major enzyme involved in acrolein and other lipid-derived aldehyde metabolism and 
detoxification in mouse liver. 
Although considerable characterization of the rat ALDHs in cytosol and 
mitochondria has been published, the relative contribution of different Aldh isozymes in 
metabolism and detoxification of reactive aldehydes in mouse liver is unknown. 
Moreover, the kinetic properties of murine Aldh orthologs in oxidation of reactive lipid 
aldehydes especially acrolein, have not been biochemically measured. Mouse is a more 
common laboratory model for research in medicine because of the availability of 
transgenic and until recently, the only source for gene-targeted and knockout mice. In the 
present study, we examined the role of murine hepatic Aldh isozymes in metabolism and 
detoxification of lipid-derived aldehydes, including acrolein and HNE, by enzyme kinetic 
and gene expression studies. In this chapter, we show by substrate preferences, gene 
expression patterns and in vitro knockdown experiments in Hepa-lclc7 that murine 
Aldhlal is the major cytosolic Aldh in mouse liver involved in cellular defense against 
reactive aldehydes-induced toxicity. 
MATERIALS AND METHODS 
Chemicals and Reagents 
Propionaldehyde, benzaldehyde, trans-2-hexenal, acetaldehyde, dithiothreitol 
(DTT), 3-( 4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), isopropyl 
~-D-l-thiogalactopyranoside (IPTG), N-ethylmaleimide (NEM), propen-2-al (acrolein) 
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and malonaldehyde bis-( dimethyl acetal, MDA) were purchased from Sigma-Aldrich 
Company, Inc. (St Louis, MO). 4-hydroxy-2-nonenal (HNE) was obtained from Cayman 
Chemical Co (Ann Arbor, MI). Oxidized ~-NAD+ and ~-NADP+ were purchased from 
Codexis (Redwood City, CA). Anti-glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) antibody (clone 6C5, MAB374) was purchased from Millipore (Temecula, 
CA). Rabbit polyclonal antibody against caspase 3 (H-277; sc-7148) was purchased from 
Santa Cruz Biotechnology, Inc (Santa Cruz, CA). Cleaved caspase 3 (AspI75) 
antibodies (#9661), and cytochrome c treated and untreated Jurkat cell extracts (#9663) 
were from Cell Signaling Technology (Danvers, MA). ALDHI antibody against purified 
rat ALDHI was produced in rabbits (Tweedie et aI., 1991). Rabbit polyclonal antibody 
against acrolein-protein adducts was provided by Aruni Bhatnagar, Department of 
Medicine/Cardiovascular Medicine, University of Louisville. Stealth ™ RNAi was 
synthesized by Invitrogen (Carlsbad, CA). 
Cloning, Expression and Purification of Recombinant Aldhlal, Aldh2 and Aldh3al 
The pCMV6-Aldhlal plasmid (MC202273) and pCMV6-Aldh2 (MR208315) 
containing the full length of mouse Aldhlal cDNA (NM_013467) and Myc-DDK-tagged 
mouse Aldh2 (NM_009656.2) Open Reading Frame (ORF), respectively, were purchased 
from OriGene (Rockville, MD). The ORF of Aldhlal was amplified by PCR using the 
following primers (forward: 5'-CATATGTCTTCGCCTGCACAACCTGCA-3'; reverse: 
5'-GGTACCGGAGTTCTTCTGAGATATCTTCA-3'). On the other hand, the ORF for 
Aldh2 was obtained using the following primers (forward: 5'-
CATATGTCCGCCGCCGCCACCAGCGC-3'; reverse: 5'-
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GGTACCCGAGTTCTTCTGTGGCACTTTGA-3 '). The forward primer for 
amplification of Aldh2 was designed to remove the mitochondrial signal sequence by 
PCR. Both forward primers contain an Nde1 site for cloning into the start codon (ATG) 
ofpET30b vector (Novagen, Inc., Madison, WI) to ensure correct initiation of translation 
in E coli. The reverse primer was designed to contain a Kpn1 site with deletion of the 
stop codon (TAA) to express a full length Aldh1a1 with a C-terminal his-tag. The 1.5 kb 
PCR product was then cloned into pCR2.1 vector using a T A cloning vector kit 
(Invitrogen, Carlsbad, CA). The sequence of the mouse Aldh1a1 and Aldh2 ORF was 
confirmed by sequence analysis at the University of Louisville, Center for Genetics and 
Molecular Medicine Nucleic Acid Core Facility. The PCR product was then digested 
with Nde1 and Kpn1, and subcloned into the pET30b expression plasmid (Novagen, Inc., 
Madison, WI). To generate the full length of mouse Aldh3a1 cDNA (NM_007436), total 
RNA was isolated from mouse primary hepatocytes treated with 50 ""M 1 ,2-
benzanthracene (BA) for 24 h. Total RNA was reverse transcribed to cDNA with Oligo-
dT primers using Advantage RT-for-PCR kit (Clontech, BD Bioscience, Palo Alto, CA). 
The ORF of Aldh3a1 was generated by PCR using as forward primer, 5'-
GGTACCAGCAATATCAGTAGCATCG-3' and as reverse primer, 5'-
CTCGAGTGAAGTAGCCCTCTCAATGC-3' . 
The sequence of the mouse Aldh3a1 ORF PCR product was confirmed by 
sequence analysis. The 1.5 kb PCR product was ligated into pCR2.1 vector and 
subsequently digested with Kpn1 and Xho1, and subcloned into pET30a (Novagen) 
expression vector allowing synthesis of a full-length Aldh3a1 with an N-terminal his-tag. 
One Shot® BL21 (DE3)pLysS competent E. coli (Invitrogen, Carlsbad, CA) were 
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subsequently transformed with pET30b-Aldh1a1 or pET30a-Aldh3a1 plasmid and were 
grown until the OD6oo ~ 0.6. The recombinant protein expression was induced by 
addition of 0.5 mM IPTG overnight. Cells were lysed with Bugbuster® Protein 
extraction reagent (Novagen, Inc., Madison, WI) containing 2 mM DTT and 10% 
glycerol, and purified using nickel-nitrilotriacetic acid (Ni-NTA) column (Qiagen, 
Valencia, CA). Proteins were eluted with 400 mM imidazole and concentration was 
determined by Pierce® BCA Protein Assay (Pierce, Rockford, IL). The purity of the 
recombinant protein was determined by SDS-PAGE electrophoresis stained with 
coomassie blue (Figure 2). We noted a single protein band at ~ 55 and 50 KDa in the 
eluate fractions of the pET30b-Aldh1a1 and pET30-Aldh3a1 transformed E. coli, 
respectively (Figure 2). To further confirm the identity of Aldh1a1, extracts from 
BL21 (DE3)pLysS cells transformed with pET30b-Aldh1a1, and purified rat ALDH1 
(Tweedie et aI., 1991) were resolved on SDS-PAGE gel, transferred onto nitrocellulose 
membrane and probed with antibody against purified rat ALDH1Al. 
Aldehyde Dehydrogenase Enzymatic Assay 
The enzymatic activities of Aldhs were measured spectrophotometric ally using 
recombinant his-tag proteins by monitoring the reduction ofNAD+ or NADP+ at 340 nm 
as previously described by Lindahl and Petersen (Lindahl and Petersen, 1991) using the 
molar absorptivity value of 6,220 M-1cm-1. Enzyme activity was assayed at 25°C in 50 
mM sodium phosphate buffer (pH 7.4), containing 1 mM EDTA and 0.01 % BME with 
either 1 mM NAD+ or NADP+ as cofactor. The reaction was initiated by addition of 
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Figure 2. SDS-PAGE analyses of purified recombinant mouse Aldh. (AJ Cell extracts 
(CE) from pET30a, pET30b-Aldh1a1 or pET30a-Aldh3a1 transformed BL21 (DE3)pLysS 
E coli and eluate fractions purified using Ni-NTA resin were resolved on 4-12% SDS-
PAGE and stained with coomassie blue. Lane 1: Prestained Marker; Lane 2: CE from 
pET30a transformed E coli; Lane 3: eluate fractions from pET30a vector transformed E 
coli; Lane 4: Lysates from pET30b-Aldh1a1 transformed E coli; Lane 5: eluate fractions 
from pET30b-Aldh1a1 transformed E coli; Lane 6: CE from pET30a-Aldh3a1 
transformed E coli; Lane 7: eluate fractions from pET30b-Aldh1a1 transformed E coli. 
(B) Western blot analysis of recombinant Aldh1 a1. Extracts from BL21 (DE3)pLysS 
transformed with pET30b-Aldh1a1 and purified rat liver ALDH1A1 immunoblotted with 
antibody against rat ALDHl. Due to the presence of his-tag the migration of the 
recombinant mouse Aldh1a1 is slower than that of purified rat Aldh1. Lane 1: Eluate 
fractions from BL21(DE3)pLysS transformed with pET30b-Aldh1a1 plasmid; Lane 2: 
ALDHIA1 purified from rat liver. 
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(Km, Vmax and Vmax/Km) of recombinant mouse Aldh1a1 and Aldh3a1 for oxidative 
metabolism of various aldehydes were examined. All reactions were performed 
in triplicate. Malondialdehyde (MDA) was prepared by acid hydrolysis of malonaldehyde 
bis-(dimethyl acetal) (Sigma-Aldrich Co, St. Louis, MO) by adding 17 !lL to 900 !lL of 
0.1 N HCl and incubating the solution at room temperature for 2 h (vortexing every 30 
min). The pH was neutralized with 1 N NaOH prior to use to achieve a 100 mM 
concentration. The cofactor preference of recombinant mouse ALDH was measured 
using varying concentrations of either NAD+ or NADP+. The Km of Aldh1a1 for NAD+ 
and NADP+ was defined using 1 mM propionaldehyde while the cofactor preference of 
Aldh3al was assessed by measuring its Km for either NAD+ or NADP+ using 2.5 mM 
benzaldehyde as substrate. 
Stealth ™ siRNA knockdown of mouse Aldhlal 
Stealth™ RNA oligonucleotides are 25 bp double-stranded RNA oligonucleotides 
and were designed using BLOCK-iTTM RNAi Designer (Invitrogen, Carlsbad, CA). The 
Stealth siRNA designed to target mouse Aldh1a1 (NM_013467) was synthesized by 
Invitrogen (sense strand, 5'-UAAAGAUGCCAGGUGAAGAGCCGUG-3'; antisense 
strand, 5'-CACGGCUCUUCACCUGGCAUCUUUA-3'). The sequences of the Stealth 
siRNA control are: sense strand, 5'-CACUCUCCUCAUCGGACCUUGGUUA-3'; 
antisense strand, 5' -UAACCAAGGUCCGAUGAGGAGAGUG-3 '). Before transfection, 
mouse hepatoma (Hepa-1clc7) cells (American Type Culture Collection, Rockville, MD) 
were maintained in Dulbellco Modified Eagle's Media (DMEM) supplemented with 10% 
fetal bovine serum and 1 % Antibiotic-Antimycotic (Invitrogen; Carlsbad CA). Cells were 
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transfected with either 150 pmol (50 nM) Stealth ™ siRNA control (siControl) or 
Stealth™ siRNA specific to Aldhlal (siAldhlal) using Lipofectamine™ RNAiMAX 
(Invitrogen) according to maimfacturer's instructions. To test the effect of stealth siRNA 
on Aldhlal gene expression, the mRNA levels and protein levels were analyzed 48 h 
after transfections by qRT-PCR and Western blot, respectively. 
Measurement of Cell Viability by MTT assay 
Hepa-lclc7 cell viability was evaluated using an MTT assay according to 
manufacturer's instruction. Hepa-lc1c7 cells (5,000 cellsllOO I.d) were plated in a 96-
well plate. Cells were treated with increasing concentrations of acrolein (0 to 100 flM) in 
serum free media for 24 h. Cells were then incubated with MTT (0.2 mg/ml) for 2 hand 
cell viability was assessed by measuring the absorbance at 570 nm. 
RNA Isolation and Quantitative Real Time PCR (QRT -PCR). 
RNA was isolated from Hepa-lc1c7 cells or mouse liver using TRI reagent 
(Molecular Research Center, Inc., Cincinnati, OH). The mRNA levels of Aldhlal, 
Aldhlbl, Aldh2 and Aldh3al were assessed by qRT-PCR. Total RNA isolated from cells 
was reverse transcribed to cDNA with random hexamer primers using the Advantage RT-
for-PCR kit (Clontech, BD Bioscience, Palo Alto, CA). RNase H was then used to 
degrade any residual RNA in the cDNA mix. QRT-PCR was performed using the ABI 
7900HT Sequence Detector System (Applied Biosystems, Foster City, CA) with gene 
specific F AM-labeled LUX primers synthesized by Invitrogen (Carlsbad, CA). A plot of 
the CT versus quantity of RNA was generated to verify linearity of amplification. All 
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qRT-PCR experiments were performed in triplicate using cDNA sample from 
independent RNA set and analyzed by the absolute quantitation standard curve method. 
The gene expression levels were normalized to 18S rRNA as endogenous control and 
data were expressed as the mean ± SD. Samples were analyzed by Student's t test and 
values of p < 0.05 were considered to be statistically significant. 
Western Immunoblotting. 
Whole cell extracts were prepared from Hepa-lclc7 cells using IX RIPA buffer 
(20 mM Tris-HCI,pH 7.5; 150mMNaCI, 1 mMNa2EDTA, 1 mMEGTA, 1% NP-40, 
1 % sodium deoxycholate, 2.5 mM sodium pyrophosphate, 1 mM p-glycerophosphate, 1 
mM Na3 V04, 1 Ilg/mlleupeptin; Cell Signaling Technology, Beverly, MA) containing 
protease inhibitors (Protease Inhibitor Cocktail Set III, EDTA free; Calbiochem, La Jolla, 
CA). For determination of acrolein-protein adducts in cells, a modified IX RIP A Lysis 
buffer containing 50 mM NEM was used. Protein concentration was measured using 
Pierce® BCA Protein Assay (Pierce, Rockford, IL). Lysates were resolved on 4-12% 
NuPAGE® Novex® Bis-Tris mini gels and transferred onto Amersham Hybond™-ECL 
nitrocellulose membranes (GE Amersham Pharmacia Biotech, Piscataway, NJ). 
Membranes were probed with antibodies against rat ALDHI (1 :2000), Caspase 3 
(1: 1000) or GAPDH (1: 10000) at room temperature for 2 h or acrolein-protein adducts 
(1 :2000) and cleaved Caspase 3 (1: 1000) at 4°C overnight. The membrane was incubated 
with horseradish peroxidase-conjugated goat anti-rabbit (Sc-2004, Santa Cruz 
Biotechnology) or goat anti-mouse (Sc-2005, Santa Cruz Biotechnology, Santa Cruz, 
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CA) secondary antibody and the transferred proteins were visualized with Amersham 
ECL Plus western blotting detection system. 
RESULTS 
Expression, Purification and Biochemical Characterization of Recombinant 
Aldhlal, Aldh2 and Aldh3al 
We examined the kinetic parameters (Km, V max and V max/Km) of recombinant 
mouse Aldhlal, Aldh2 and Aldh3al (Table 1) for oxidative metabolism ofa wide range 
of aldehyde substrates and the OS conjugates of HNE using either NAD+ or NADP+ as 
pyridine nucleotide cofactor. The cofactor preference of recombinant mouse ALDH was 
also assessed using varying concentrations of either NAD+ or NADP+. Kinetic 
parameters indicate that mouse Aldhlal exhibited high affinity for short chain aldehydes, 
such as propionaldehyde (Km = 141 flM) and acetaldehyde (Km = 202 flM) and the lipid 
aldehydes; acrolein (Km = 23.2 flM), trans-2-hexenal (Km = 31.2 flM), HNE (Km = 2.4 
flM) and MDA (Km = 7.5 flM) as shown in Table 1. The catalytic efficiency for Aldhlal 
was highest for HNE (V max/Km = 218) and lowest for benzaldehyde (Vmax/Km = 0.3). 
Mouse Aldhlal had an apparent Km of752 flM for benzaldehyde, indicating that the 
aromatic aldehydes, benzaldehyde is a poor substrate for Aldhla1. Aldhlal preferred 
NAD+ (Km = 50.2 flM) as cofactor, and displayed no catalytic activity with NADP+. The 
order of the catalytic efficiency of mouse Aldhlal for aldehyde substrates, as reflected by 
V max/Km was HNE > MDA > acrolein> trans-2-hexenal > propionaldehyde > 
acetaldehyde> benzaldehyde. The catalytic efficiency for Aldh2 was highest for 
acetaldehyde (V max/Km = 22) followed by propionaldehyde (V max/Km = 13). This result is 
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consistent with the human ALDH2. In Table 1, we observed that benzaldehyde is also a 
poor substrate for Aldh2. The affinity of Aldh2 for lipid aldehydes was considerably 
lower than that of Aldhlal, acrolein (Km = 72.5 flM) and HNE (Km = 161 flM). The rate 
of metabolism ofGSH conjugate ofHNE (GS-HNE) by Aldhlal and Aldh2 were lower 
compared with free HNE. Again, Aldhlal showed higher catalytic efficiencies (;::::;3.6 
fold) for metabolism of GS-HNE compared with Aldh2. 
Due to the extremely high V max of Aldh3al (flmol/min/mg) for most aldehyde 
substrates compared with that of Aldhlal and Aldh2 (nmol/min/mg), the catalytic 
efficiency of Aldh3al was higher for most aldehyde substrates except for the lipid 
aldehydes. In contrast to Aldhlal, mouse Aldh3al exhibited high affinity for aromatic 
aldehyde, such as benzaldehyde (Km = 37 flM) followed by the lipid aldehydes and 
showed poor affinity for short chain aldehydes, such as propionaldehyde (Km = 3380 flM) 
and acetaldehyde (Km = 1000 flM). Aldh3al was capable of metabolizing lipid 
aldehydes, such as acrolein, HNE and MDA with low affinity for substrate binding (Km 
>300 flM) compared with Aldhlal. In addition, both Aldh2 and Aldh3al used NAD+ and 
NADP+ as cofactor for oxidative metabolism of aldehydes, but preferred NAD+ 
(Aldh3al, Vmax/Km = 484; Aldh2, Vmax/Km = 14) overNADP+ (Aldh3al, Vmax/Km = 87; 
Aldh2, V max/Km = 0.6). The catalytic efficiencies for metabolism of acrolein were 
comparable between Aldhlal and Aldh3al (Vmax/Km = 23). However, Aldhlal exhibited 
far higher relative affinity for acrolein (Km = 23.2 flM) compared with Aldh3al (Km = 
464 flM). Furthermore, the Aldhlal displayed high catalytic efficiency for HNE 
compared Aldh3al, suggesting that reactive lipid-derived aldehydes were preferred 
substrates for Aldhlal. 
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Table 1. Kinetic properties of recombinant mouse Aldhs. 
Aldh enzyme activity was determined by monitoring the formation ofNADH at 340 nm 
as previously described by Lindahl and coworkers (Lindahl and Petersen, 1991). Enzyme 
activities were measured spectrophotometrically at 25°C in a reaction mixture containing 
1 mM NAD+ at pH 7.4. The kinetic parameters were determined using non-linear 
regression software Kineti77. The values represent the means ± SD from 3-4 assays. The 
kinetic parameters for NAD+ and NADP+ were determined using 1 mM propionaldehyde 
(Aldhla1 and Aldh2) or 2.5 mM benzaldehyde (Aldh3al) as the substrate. 
a Unit is nmol/minlmg; 
b Unit is flM; 
C Unit is ml/minlmg; and, 
d Unit is flmol/minlmg. 
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Table 1 
A}(lhlal Aldh2 AMh3~11 
Substrate V a max Kmb Vmaxikmc V a max Kmb Vmax/kmc Vmaxd Kb m Vmaxil{mC 
Propionaldehyde 799 ± 21 141 ± 30 5,6 619 ± 129 49 .... ± 13 13 2-1.7 ± 1.2 3380 ± 3& ., 
Acet<llclehyde 910 ± 36 202 ± P 4,5 751 ± 116 35." ± 14 22 32 .... ± 1.0 1000 ± 20 32 
B e1lZ<lldehyde 256 ± 14 752 ± 90 0.3 120 ± 24 1911 ± 33 0,1 28.6 ± 1.6 J7 ± 6 7"'3 
w 
Trans-2-hexenal 390 ± 37 31.2 ± 4,1 12,) ND ND ND 28.1 ± 1.1 236 ± 40 119 
HNE 522 ± 26 2 .... ± 0.9 21& 489 ± 58 161 ± 41 3 29.5 ± 3.7 425 ± 94 69 
Acrolein 5li ± 22 23.2 ± 4.3 13 543 ± 36 71.5±15 7.4 10.3 ± 1.1 464 ± 85 23 
11<110 ndiald ehyde 408 ± 15 7.5 ± 1.2 54 ND ND ND 83 ± 0.7 302 ± 52 )":' .. / 
NAD+ 751 ± 7 50.2 ± 4 L'i 764 ± 49 56 ± 6.& L,(6 26.9 ± 5.9 55.5 ± 2.3 484 
NADP ND ND ND 177 ± 16 181 ± 37 0.6 28 ± ;,.5 320 ± 18 37 
GS-HNE 112±3 32.5 ± 4.4 3.6 161 ± 26 18-t±13 1.0 ND ND ND 
Expression of Aldehyde dehydrogenases in mouse liver and mouse hepatoma cell 
lines 
To assess which Aldh isoform plays a prominent role in oxidative metabolism and 
detoxification of reactive lipid aldehydes in mouse liver, we assessed the mRNA levels of 
the major Aldhs expressed in mouse liver and Hepa-IcIc7 cells by qRT-PCR. The 
Aldhi al gene was highly expressed in mouse liver and Hepa-I c1 c7 cells compared with 
Aldh2, Aldhi bI and Aldh3aI (Figure 3). The mRNA levels of Aldh2 were expressed at 
comparable levels in both mice liver and Hepa-Ic1c7 cells. However, Aldhi bi mRNA 
expression was higher in Hepa-I c I c7 compared with mouse liver (;::;2-fold). As 
previously demonstrated, Aldh3aI mRNA expression was extremely low in mouse liver, 
but was moderately expressed in Hepa-Ic1c7 cells compared with AldhIal. Aldhial 
mRNA levels were 34-fold and 73-fold higher than the Aldh2 mRNA levels in mouse 
liver and Hepa-Ic1c7 cells, respectively. The order ofmRNA expression of the major 
Aldhs involved in lipid aldehyde metabolism in mice liver and Hepa-Ic1c7 was Aldhial 
> Aldh2 > Aldhibi > Aldh3al. We concluded from enzyme kinetics and gene expression 
data that Aldhial most likely plays a prominent role in the cellular defense against 
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Figure 3. Endogenous levels of aldehyde dehydrogenase gene expression in mouse liver 
and mouse hepatoma cells. Total RNA extracted from the liver of C57BLl6 mice (n=5) or 
Hepa-lclc7 cells was reverse transcribed to eDNA with random hexamer primers using 
Advantage RT-for-PCR kit. The eDNA was used for analysis of gene expression of 
Aldhlal , Aldh2, Aldhi bi and Aldh3aI by qRT-PCR. The qRT-PCR experiments were 
performed in triplicate using eDNA from 5 separate murine liver sample sets. The gene 
expression levels were normalized to 18S rRNA as endogenous control and data were 
expressed as the mean ± SD. 
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Knockdown of Aldhlal gene expression sensitized liver-derived cell lines to 
acrolein-induced cell death 
To specifically examine the role of AldhlaJ in cellular protection against reactive 
lipid-derived aldehydes such as acrolein, we assessed whether knockdown of Aldhlal 
gene expression sensitized Hepa-lclc7 cells to acrolein-induced cell death. Hepa-lclc7 
cells were transfected with either Stealth control or Stealth Aldhlal-specific siRNA. The 
effect of knockdown of Aldhlal gene expression was assessed by qRT-PCR and Western 
blot. RNA was isolated from cells 48 h after transfection and was reverse transcribed to 
cDNA. The cDNA was then used to assess Aldhlal mRNA expression normalized to 
18S as endogenous control by qRT-PCR. In Figure 4A, we observed> 80% reduction in 
Aldhlal mRNA levels in stealth Aldhlal-specific siRNA transfected cells compared 
with untransfected control. 
Cell extracts (40 Ilg) prepared from Hepa-lclc7 cells transfected with Stealth 
control siRNA or Stealth Aldhlal-specific siRNA were separated on SDS-PAGE gels 
and transferred onto nitrocellulose membrane. The membranes were probed with 
antibodies against rat ALDHIAI and GAPDH as endogenous control (Figure 4B). 
Densitometry analysis of Aldhl al protein levels corrected for GAD PH showed :::0 85% 
reduction in Aldhla1 protein level in cells transfected with Stealth Aldhlal-specific 
siRNA compared with untransfected control (Figure 4C). Subsequently, we assessed 
whether Hepa-1c1c7 cells with knockdown of Aldh1a1 gene exhibit higher sensitivity to 
acrolein-induced cell death. Twenty four hours after transfection ofHepa-1c1c7 cells 
with either stealth control or Stealth Aldhla1 siRNA, cells were exposed to a range of 
acrolein concentrations (0-100 IlM) for 24 h and cell viability was examined by MTT 
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assay. Figure 3D showed that Hepa-lc1c7 cells exhibit higher sensitivity to acrolein, with 
25 IlM and higher concentrations producing concentration-dependent decrease in cell 
viability. We also observed a comparable dose-dependent decrease in viability between 
untransfected and control siRNA transfected cells. However, knockdown of Aldhlal 
gene expression resulted in marked decreased in cell viability compared with WT cells. 
The half maximal effective concentrations (ECso) of acrolein for cells with low 
expression of Aldhlal (ECso ~22 IlM) was significantly reduced compared with that of 
the untransfected and control siRNA transfected cells (ECso ~35 IlM). These results 
indicate that cells with low Aldhlal expression are highly vulnerable to acrolein-induced 
cell death, suggesting that Aldhlal protects cells from reactive aldehydes-induced cell 
death by enhanced metabolism of these reactive species. 
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Figure 4. Hepa-lclc7 cells with knockdown of Aldhlal gene expression by stealth 
specific siRNA are highly sensitive to acrolein-induced cell death compared with control 
cells. (A-C) Stealth specific siRNA mediated knockdown of Aldhlal gene in Hepa~lc1c7 
cells. Hepa-lc1c7 cells were transfected with either 150 pmol (50 nM) Stealth control 
(siControl) or Stealth Aldhlal-specific siRNA (siAldhlal) using Lipofectamine 
RNAiMAX. (A) qRT-PCR analysis of Aldhlal gene expression in various Hepa-lclc7 
cells. The mRNA expression of Aldhlal was examined by qRT-PCR and experiments 
were performed in triplicate using cDNA sample from independent RNA set. The gene 
expression levels were normalized to 18S rRNA as an endogenous control and data were 
expressed as fold over WT. (B) Western blot analysis of Aldhlal expression in Hepa-
lc1c7 cells. Cell extracts prepared from WT, siControl and siAldhlal cells were 
separated on 4-12% SDS-PAGE gel and transferred onto nitrocellulose membrane. 
Membranes were probed with antibodies against ALDHIA1. Membranes were stripped 
and then reprobed with antibodies against GAPDH. The Western blot experiment was 
performed in triplicate and the figure is a representative blot. (C) Densitometry analysis 
of Aldhlal protein levels normalized to GAPDH in WT, siControl and siAldhlal Hepa-
lc1c7 cells. (D) Knockdown of Aldhlal sensitizes Hepa-lc1c7 cells to acrolein 
treatment. Twenty four h after transfection with Stealth siRNA control or Stealth 
Aldhlal-specific siRNA, cells were treated with increasing concentrations of acrolein for 
24 h and cell viability assessed by MTT (0.2 mg/ml for 2 h) at 570 nm as described in 
Materials and Methods. The half maximal effective concentrations (ECso) were as 
follows: WT untransfected cells (35.61 ± 1.64 J.lM), Stealth control siRNA transfected 
cells (35.72 ± 1.62 J.lM) and Stealth Aldhlal-specific siRNA transfected cells (22.92 ± 
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0.32 11M). The values are expressed as the mean ± S.E. and the ECso for SiAldhlal 
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Increased acrolein-protein adducts in Hepa-lc1c7 cells with siRNA silencing of 
Aldhlal gene expression 
Acrolein and other highly reactive a,~-unsaturated aldehydes readily alkyl ate 
proteins forming Michael addition adducts with a free carbonyl group. It is now known 
that protein carbonylation by reactive aldehydes precedes the toxic process leading to cell 
death (Burcham and Fontaine, 2001). We examined whether acrolein-protein adducts are 
increased in cells with knockdown of Aldhlal after acrolein treatment. Hepa-lc1c7 cells 
were transfected with either stealth control siRNA (siControl) or Aldhlal specific stealth 
siRNA (siAldhlal). After transfection, cells were exposed to either 10 flM or 25 flM 
acrolein for 24 h. Lysates prepared from cells were separated on SDS-P AGE and 
transferred onto nitrocellulose membrane. The membrane was probed with antibodies 
against acrolein-protein adducts and GAPDH (Figure 5A). The level of acrolein-protein 
adducts of individual proteins was analyzed by densitometry corrected for GADPH using 
UN-SCAN-IT gel 6.1 software (Silk Scientific Inc., Orem, Utah). Three protein bands 
labeled PI, P2 and P3 were chosen for analysis of acrolein-protein adducts accumulation 
in the siControl and siAldhlal cells following exposure to acrolein (10 flM and 25 flM) 
(Figure SB). Densitometry analysis showed that acrolein-protein adducts content of PI 
and P3 continued to increase in both siControl and siAldhal-treated cells up to 25 flM 
acrolein. We also noticed accumulation of endogenous acrolein-protein adducts for 
protein PI, P2 and P3 in siAldhlal-treated cells compared with siControl cells. In protein 
1 and 3 (PI and P3), the level of acrolein-protein adducts were increased in Aldhlal-
specific Stealth siRNA transfected cells compared with control siRNA-transfected cells 
after treatment with 10 flM acrolein. 
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Figure 5. The levels of acrolein-protein adducts in response to acrolein treatment were 
increased in Hepa-lclc7 cells with knockdown of Aldhlal gene compared with control 
siRNA-transfected control cells (A) Western blot analysis of acrolein-protein adducts in 
Hepa-l c1 c7 cells transfected with either stealth control siRNA or Aldhl aI-specific 
siRNA and exposed to acrolein. Lanes 1-2: untreated cells, Lanes 3-4: cells were treated 
for 24 h with 10 flM acrolein. Lanes 5-6: cells exposed to 25 flM acrolein for 24 h. 
Western blot experiments were performed in triplicate and the figure is a representative 
blot. (B) Densitometry analysis of the levels of individual protein-acrolein adducts in 
siControl (Stealth control siRNA transfected cells) and siAldhlal (Stealth Aldhlal 
specific siRNA-transfected cells) in response to 10 flM and 25 flM acrolein. Samples 
were analyzed by 2-tailed t-test and values of p < 0.05 were considered to be statistically 
significant. *, significantly different from siControls; and #, indicates significantly 
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However, for PI, P2 and P3, we observed elevated levels of acrolein-protein adducts in 
siAldhlaI cells compared to siControl cells at 25 ~M acrolein treatment. These results 
indicate that when Aldhlal protein levels are low, the impaired acrolein metabolism and 
detoxification led to accumulation of acrolein-protein adducts. 
Increased acrolein-induced Caspase 3 activation and apoptosis in Hepalc1c7 cells 
after knockdown of Aldhlal gene expression 
In addition to protein-acrolein adducts accumulation and cell viability, we 
investigated whether knockdown of Aldhlal sensitized cells to acrolein-induced caspase 
3 activation, a marker of apoptosis. Reactive lipid aldehydes are known to induce 
oxidative stress by depletion of GSH (Ellis, 2007). Oxidative stress and acrolein-protein 
or HNE-protein adducts have been implicated in induction of apoptosis (Tanel and 
Averill-Bates, 2007;Xiao et aI., 2003). Previous studies demonstrated that HNE induces 
activation of caspase 3 in human lens epithelia cells (HLECs), human leukemia cells 
(HL-60) and neuroblastoma cell line (SH-SY5Y) (Cheng et aI., 2001 ;Choudhary et aI., 
2002;Zhang et aI., 2010). Inactive procaspase 3 (32 KDa) zymogen is activated by 
proteolytic cleavage adjacent to Asp 175 into activated 17- and 19-KDa fragments. Thus, 
the activation of caspase 3 is monitored by Western blot analysis of the cleaved 
fragments. To examine whether Aldhial can protect cells against acrolein-induced 
apoptosis, we transfected Hepa-l c 1 c7 cells with Stealth Aldh 1 aI-specific siRNA 
(siAldhlaI) or Stealth control siRNA (siControl) for 24 h and cells were subsequently 
exposed to 25 ~M acrolein for 24 h. Cell extracts separated by SDS-PAGE gels were 
transferred onto nitrocellulose membrane and probed for cleaved caspase 3 fragments, 
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Figure 6. Transient knockdown of Aldhlal gene expression sensitizes Hepa-lclc7 cells 
to acrolein-induced caspase 3 activation and apoptosis. (A) Western blot analysis of 
acrolein-induced caspase 3 activation. Hepa-lclc7 cells were transfected with Stealth 
Aldhlal-specific siRNA (siAldhlal) or Stealth control siRNA (siControl) for 24 hand 
cells were subsequently exposed to 25 11M acrolein for 24 h. Cell extracts prepared with 
IX RIPA buffer were separated on SDS-PAGE gel and transferred onto nitrocellulose 
membranes. The membranes were probed for cleaved caspase 3 with anti-cleaved caspase 
3 antibodies and caspase 3 with anti-caspase 3 antibodies. Anti-cleaved caspase 3 
(AspI75) antibody detects levels oflarge fragment (17/19 KDa) of activated caspase 3 
resulting from cleavage adjacent to Asp175. Western blot experiment was performed in 
triplicate and the figure is a representative blot. Densitometry was normalized to GAPDH 
ofprocaspase 3 (B) and cleaved caspase 3 (17 and 19 KDa fragments) (C) in WT, 
siControl- or siAldhlal-treated Hepa-Ic1c7 cells exposed to 25 11M acrolein. Positive (+) 
control for caspase 3 cleavage was extracts from cytochrome c-treated lurkat cells 
(#9663) and negative (-) control was extract from untreated lurkat cells. The results were 
analyzed by Student's - test and values ofp < 0.05 were considered to be statistically 
significant. *, significantly different from WT (p< 0.05; 2-tailed t-test). 
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caspase 3 and GADPH as endogenous control (Figure 6A). The levels ofprocaspase 3 
(Figure 6B) and cleaved caspase 3 (17 and 19 KDa fragments) (Figure 6C) in 
untransfected cell (WT), siControl- and siAldh1a1-treated Hepa1c1c7 cells exposed to 25 
11M acrolein were assessed by densitometry corrected for GADPH using UN-SCAN-IT 
gel 6.1 software. The levels of procaspase 3 were moderately increased in WT and 
siAldh1a1 cells after acrolein treatment. However, procaspase 3 protein levels were 
slightly decreased in siAldh1 a1 cells in the absence of acrolein treatment. As expected, 
the levels of the 17 and 19 KDa fragments of caspase 3 (active) were robustly increased 
(;:::: 40-fold) when cells were exposed to acrolein compared to untreated WT cells or 
control siRNA transfected cells. The 19 KDa fragment was moderately increased in 
siAldh1a1 cells compared with WT and siControl cells after acrolein (25 11M) exposure 
(Figure 6C). However, we observed elevated levels (;:::: 3-fold) of the 17 KDa fragment in 
siAldh1a1 cells compared with WT and siControl cells after acrolein (25 11M) treatment. 
These results indicate that Aldh1a1 knockdown cells exhibit high sensitivity to acrolein-
induced caspase 3 initiated apoptosis. We can conclude from these data that Aldh1a1 by 
enhanced detoxification and metabolism of acrolein protects cells against apoptosis 
induced by acrolein. 
DISCUSSION 
Comparison of Substrate Specificity for murine Aldhs 
The relative contribution of Aldh isozymes in protection against aldehyde toxicity 
is controversial. While earlier studies indicated that ALDH3A1 but not ALDH1A1 
protects against cytotoxic lipid derived-aldehydes, most recent studies in eye lens of 
44 
Aldh1a1-1- mice showed that ALDH1A1 can protect against these reactive aldehydes 
(Choudhary et aI., 2005;Townsend et aI., 2001). The contribution of the different 
isozymes of Aldh to oxidation of lipid derived-aldehydes has not been examined in the 
liver, even though the liver is the major site for metabolism and biotransformation of 
foreign compounds. In this study, we sought to clearly define which Aldh isoforms playa 
major role in oxidation and detoxification of cytototic lipid-derived aldehydes in mouse 
liver by enzyme kinetics and gene expression pattern. Having obtained purified 
recombinant murine Aldhs expressed in E. coli, we performed enzyme kinetic analysis to 
compare their relative capacity for clearance of various aldehydes. As seen in Table 1, 
the catalytic efficiencies can best be compared using the V max/Km parameters. Aldh3a1 
displays highest preference for aromatic aldehyde substrates and utilizes both NAD+ and 
NADP+ as oxidizing pyridine nucleotide co factors with preference for NAD+. Although 
Aldh3Al displays 20-112-fold higher V max values for most aldehyde substrates, the 
V max/Km parameters demonstrate that Aldh1a1 is a better catalyst than Aldh3al for 
oxidative clearance of a,~-unsaturated aldehydes. The human and murine Aldhla1 
proteins exhibit similar V max/Km parameters with some differences (Xiao et aI., 2009). 
The human ALDH2 (Marchitti et aI., 2008) and ALDH1BI (Stagos et aI., 2010) proteins 
displayed significantly lower V max/Km parameters for the lipid-derived aldehydes than 
Aldh1al. The substrate specificity of recombinant Aldhs for GS-conjugates ofHNE 
indicates that GS-HNE is a good substrate for Aldh1a1 and Aldh2. However, both 
enzymes display a Km value for GS-HNE that is much higher than the free HNE itself, 
suggesting that free HNE is a better substrate for these enzymes than its GSH conjugate. 
Aldhlal showed higher catalytic efficiencies (;::::3.6 fold) for metabolism of GS-HNE 
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compared with Aldh2. Kinetic studies also demonstrate that GS-HNE is not a substrate of 
Aldh3al. The conclusion taken from the data in this report and the literature is that the 
catalytic efficiency for lipid aldehyde oxidation by Aldhlal is the highest reported, 
suggesting its potential importance for metabolism of these toxic compounds. 
Aldhlal is highly expressed in mouse liver and Hepa-lc1c7 cells 
In Figure 3, we showed that Aldhlal is highly expressed in the livers of male 
C57BLl6 mice and in mouse hepatoma Hepa-lclc cells relative to other Aldh enzymes. 
The levels of Aldhlal mRNA were about 34-fold higher than that of the next more 
abundant mRNA, Aldh2. There was much less Aldhlbl and Aldh3Al mRNA expression 
in either liver or Hepa-l c 1 c cells. This observation is supported by the data in Chapter 
III, which demonstrate that acrolein caused a 3-fold induction of Aldhlal mRNA in male 
mouse livers, while other forms of Aldh were not induced by treatment with acrolein, 
providing a mechanism for the liver cell to respond to toxic aldehydes. In addition, it is 
known that hepatic Aldhlal is also induced in animals treated with butylated 
hydroxyanisole (Alnouti and Klaassen, 2008) or phenobarbital (Deitrich et aI., 1977). 
These compounds are known activators of transcription factors such as activator protein 1 
(API), nuclear factor-erythroid 2 related factor 2 (Nrf2), and constitutive androstane 
receptor (CAR). These observations clearly demonstrate that mouse Aldhlal and 
probably the human ortholog (ALDHlAl) are major protective enzymes against the 
products of lipid peroxidation and other toxic aldehydes in the environment. 
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Ablation of Aldhlal gene expression increases acrolein-induced cell death, acrolein 
protein adducts, and caspase cleavage 
As a method of assessing the role of specific gene products in toxicological 
processes, an in vitro method using gene ablation allows one to test the role of specific 
proteins in response to toxic agents. Because Hepa-Ic1c7 cells appeared to recapitulate 
the spectrum of Aldhs expressed in mouse liver, we chose this cell system to test whether 
ablation of Aldhlal protein and enzyme activity increases the sensitivity of these cells to 
acrolein (Figure 4). Using Stealth™ siRNA knockdown technology, we documented that 
transfection of Aldhlal-specific siRNA suppresses the levels of Aldhlal mRNA and 
protein in Hepalc1c cells (Figure 4A-C). We then challenged these cells with increasing 
concentrations of acrolein to assess the relative sensitivity to acrolein toxicity (Figure 
4D). While the control siRNA had no effect on acrolein toxicity curve as measured with 
MTT-dependent cell viability, transfection of Hepa-lc1c7 cells with Aldhlal-specific 
siRNA caused a shift to the left in the acrolein toxicity curve, clearly demonstrating that 
cells with Aldhlal ablation were statistically more sensitive to acrolein toxicity than 
control siRNA transfected or untransfected cells. These results provide evidence of an 
important protective role for Aldhlal against a,~-unsaturated aldehydes in mouse liver. 
Previous experiments demonstrate that treatment of cells with acrolein led to 
increased acrolein-protein adducts and enhanced caspase 3 activation resulting in 
proteolytic cleavage ofPARP (Burcham and Fontaine, 2001;Tanel and Averill-Bates, 
2007). We measured the levels of acrolein-protein adduct in cells transfected with 
Aldh I a I-specific siRNA and noted that the levels of acrolein-protein adducts (P I, P2, P3) 
were significantly increased relative to control siRNA transfected cells (Figures SA, B). 
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In addition to PI, P2, and P3, low concentration (10 /-lM) of acrolein resulted in a larger 
amount of lower molecular weight acrolein-linked proteins that was not seen at higher 
concentrations, most likely due to less extensive cross-linking present in PI, P2, and P3. 
This could be due to the use of non-reducing Western blot At higher acrolein 
concentrations, these lower molecular weight protein-adduct species decreased in 
amount, while the higher molecular weight forms increased significantly as a function of 
acrolein concentration. In addition, caspase 3 cleavage to a 17 KDa fragment was 
strikingly increased in siAldhlal transfected Hepa-lc1c7 cells exposed to 25 /-lM 
acrolein, relative to untransfected or siControl transfected cells (Figure 6). These results 
clearly demonstrate that the pro-apoptotic changes caused by acrolein and levels of 
acrolein-protein adducts are increased under conditions of Alclhlal depletion. 
In summary, we presented evidence that Aldhlal plays a major role in cellular 
defense against oxidative damage induced by reactive lipid aldehydes in mouse liver. 
Aldh 1 al exhibits far higher affinity for acrolein and HNE compared with Aldh2 or 
Aldh3al. The endogenous Aldhlal gene was highly expressed in mouse liver and liver-
derived cell lines compared with Aldh2 and Aldh3al. The knockdown of Aldhlal 
expression by siRNA caused Hepa-lc1c7 cells to be more sensitive to acrolein-induced 
cell death and resulted in increased accumulation of acrolein-protein adducts and caspase 
3 activation. Thus, mechanisms to induce Aldhlal gene expression may provide a useful 
rationale for therapeutic protection against oxidative stress-induced pathologies. 
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CHAPTER III 
MOLECULAR MECHANISMS UNDERLYING TRANSCRIPTIONAL 
REGULATION OF MOUSE HEPATIC ALDEHYDE DEHYDROGENASE IAI 
BY ELECTROPHILES 
INTRODUCTION 
The ALDH gene superfamily encodes enzymes that catalyze the NAD(P)+-
dependent oxidation of aldehydes generated from a wide variety of endogenous and 
exogenous processes to their corresponding carboxylic acids. There are 555 genes 
encoding ALDH proteins with 172 of these genes found in eukaryotes (Sophos and 
Vasiliou, 2003). At present, 19 functional ALDH genes have been identified in the 
human genome. Among the Aldh isoforms, the cytosolic mouse Aldhlal plays a critical 
role in oxidative metabolism of highly toxic lipid aldehydes and protects liver-derived 
cells from the toxic effects oflipid aldehydes (Makia et aI., 2011). Lipid peroxidation 
generates many aldehydes as by products, among which acrolein and HNE are 
presumably the most toxic and harmful. These aldehydes are implicated in the 
pathogenesis of oxidative stress-induced pathologies, such steatohepatitis, 
atherosclerosis, myocardial ischemia/reperfusion injury, cataract and cancer. 
Murine Aldhlal gene, previously known as Retinaldehyde dehydrogenase I 
(Raldhl or Ahd-2) is found on chromosome 19 and spans 45 kb in length (Hsu et ai., 
1999;Hsu et aI., 2000). It contains 13 exons and encodes a protein of;::;501 amino acids 
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with a molecular weight of;:::;5 5 KDa. Mouse Aldh 1 gene shares 96% and 87% of its 
amino acid sequence with rat ALDH1 and the human ALDHI respectively, indicating 
that it is the mouse homologue of the human ALDHI gene (Hsu et aI., 1999). The tissue 
distribution of mouse Aldhlal gene is similar to that ofhumanALDHI gene. It is highly 
expressed in the liver, lung, kidney, eye lens, gonads and retina (Marchitti et aI., 
2008;Vasiliou Vet aI., 2004). Increased expression of Aldh1al gene in the liver and lens 
has been postulated as a mechanism to protect these organs against cytotoxic aldehydes-
induced cellular damage. Thus, an understanding of the molecular regulation of Aldh1a1 
gene expression is of importance in ameliorating the toxic effects of carbonyl compounds 
and in preventing oxidative stress-induced pathologies. 
Although the human and mouse Aldhla1 gene have been cloned and the promoter 
region characterized, little is known about the molecular mechanisms that regulate the 
expression of this gene in mouse liver (Elizondo et aI., 2009;Hsu et aI., 1999). An 
understanding of the factors controlling Aldhla1 gene expression may assist efforts to 
control the progression of oxidative stress-mediated diseases. The expression of Aldh1a1 
gene is regulated by a wide variety of endogenous and exogenous stimuli. Aldhla1 
expression is reported to be enhanced by activators ofNrf2 (Hu et aI., 2006;Lee et aI., 
2003;Reddy et aI., 2007;Thimmulappa et aI., 2002). Recent studies indicate that oxidative 
stress-mediated activation ofNrf2 induces the expression of antioxidant and electrophiles 
detoxifying genes including Aldh1a1 in an in vivo mice model of renal 
ischemialreperfusion injury (Leonard et aI., 2006). Furthermore, the basal expression of 
Aldh1a1 gene was significantly reduced in Nrf2-I- mice compared with wild type (WT) 
mice (LamIe et aI., 2008), suggesting that the basal expression of Aldh1a1 may be 
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regulated by Nrf2. However, the signaling pathway involved in electrophile-induced 
expression of Aldhlal gene is not completely understood. It is not yet known whether 
Aldhlal gene is a direct target ofNrf2, since most activators ofNrf2 are also known 
inducers of the AP-I proteins. 
There is increasing evidence that acrolein and related aldehydes, such as HNE and 
crotonaldehyde at non-toxic concentrations, are important signaling molecules and can 
induce the expression of cytoprotective genes encoding antioxidant and electrophile 
detoxification enzymes (Liu et aI., 2010;Ranganna et aI., 2002;Tirumalai et aI., 2002). 
Interestingly, many of these cytoprotective genes are involved in metabolism and 
detoxification of reactive aldehydes. The signaling pathways involved in reactive 
aldehydes-induced expression of cytoprotective genes are not completely understood. 
However, reactive aldehydes are known activators of redox-responsive transcription 
factors, namely nuclear factor-erythroid 2 related factor 2 (Nrf2), nuclear factor kappa B 
(NF-KB) and members of the activator protein I (AP-I) family (Kwak et aI., 2003;Park et 
aI., 2005;Pugazhenthi et aI., 2006;Ranganna et aI., 2002;Tirumalai et aI., 2002;Wu et aI., 
2006;Zhang and Forman, 2008). 
Nrf2 and AP-I transcription factors are hepatoprotective against oxidative and 
electrophilic stress by transcriptional up-regulation of antioxidant and electrophile 
detoxifying genes. The activation ofNrf2 by electrophiles is known to disrupt its 
association with Keap-l leading to Nrf2 translocation and nuclear accumulation. In the 
nucleus, Nrf2 heterodimerizes with the small Maf proteins and binding to specific 
response elements termed ARE/EpRE coordinates expression ofhepatoprotective genes. 
AP-l proteins are also a binding partner for Nrf2. However, AP-l transcription factors 
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preferably modulate gene expression as either homodimers ofjun family or heterodimers 
with members oftheJos family. There is now compelling evidence to indicate that AP-l 
proteins are hepatoprotective especially against oxidative and electrophilic stress. AP-l 
proteins were shown to be cytoprotective against apoptosis induced by UV irradiation or 
TNFa exposure (Weitzman et aI., 2000;Lamb et aI., 2003). Moreover, JunD regulates the 
expression of human ferritin H genes which is protective against oxidative stress-
mediated cytotoxicity (Tsuji, 2005). Hasselblatt et ai. demonstrate that hepatocyte 
survival during acute hepatitis was dependent on c-Jun/ AP-1-induced expression of 
inducible nitric oxide synthase (nos2) gene (Hasselblatt et aI., 2007). However, there has 
been no report on the role of the redox-sensitive transcription factors, AP-l and Nrf2 in 
the regulation of Aldhs and detoxification of lipid peroxidation. 
The purpose of this study was to investigate whether well-known electrophiles 
modulate the expression of Aldh1a1 in mouse liver and to elucidate the signaling 
pathways involved. Gene expression profiles in the liver by acrolein and BHA were 
analyzed by microarray to examine whether acrolein or BHA exposure up-regulates the 
expression of genes encoding antioxidant or electrophile detoxification enzymes in mice 
liver (Amunom, Makia and Prough, unpublished). Mice were administered AIN76A 
(control) diet, diet containing 0.45% BHA or 5 mg/kg acrolein by gavage for 7 days. The 
expression of genes encoding several electrophile detoxifying enzymes such as Gstm 1, 
Gsta3, Gstp, Gstz 1, Akr 1 c13, Akr 1 c 19, Akr 1 c20 and Akr 1 a4 was specifically elevated 
C:::2-fold), indicating a detoxification and antioxidant response. The elevation of Aldhla1 
gene was noticeable with a 2- to 3-fold increase by both electrophiles. These results 
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support a model in which high acrolein levels in cells stimulate Aldhlal gene expression, 
thereby enhancing acrolein metabolism. 
In vivo, BHA is oxidatively demethylated by cytochrome P450 to tert-
butylhydroquinone (t-BHQ) with an oxidizable I, 4-diphenolic structure. The resultant t-
BHQ can undergo redox cycling by two-electron oxidation to tert-butylbenzoquinone 
(tBQ) generating semiquinone radicals and ROS (Abiko et aI., 2011;Nakamura et aI., 
2003;Pinkus et aI., 1996). Even though, BHA is a known activator ofNrf2, studies by 
Pinkus et al demonstrated that BHA-induced expression of GST -Ya gene is mediated by 
induction of AP-1 activity (Pinkus et aI., 1996). Compelling evidence was presented 
showing that the induction of AP-1 transcriptional activity by BHA or t-BHQ is due to 
quinone-mediated generation of oxygen radicals and oxidative stress. However, the 
metabolite of t-BHQ, similarly to acrolein, can act as an e1ectrophile and reacts with 
intracellular nucleophiles including protein thiol and GSH by Michael addition reactions, 
resulting in protein alkylation and GSH depletion. GSH-tBHQ conjugates have been 
detected in cells exposed to t-BHQ (Nakamura et aI., 2003). As an electrophile, t-BHQ 
can also cause dissociation of the Keapl-Nrf2 complex through covalent modifications of 
cysteine residues (C257, C273 , C288 and C297) on Keap-1, resulting in nuclear accumulation 
ofNrf2 (Nguyen et aI., 2004;Rushmore and Pickett, 1991). 
In this chapter, we focus on electrophile-mediated regulation of Aldhlal in mouse 
liver. The mRNA expression and activity of Aldhlal in liver from mice treated with 
BHA or acrolein were measured by qRT-PCR and Aldh activity assay, respectively. 
Second, we examined the signaling pathway involved in BHA- or acrolein-mediated 
induction of Aldhlal gene expression. Since the major function of Aldhla1 is to detoxify 
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highly toxic lipid aldehydes, the induction of Aldhlal gene in mice liver might be a 
mechanism to alleviate toxicity associated with lipid peroxidation and could represent a 
useful strategy for preventing oxidative stress-associated diseases. 
EXPERIMENT AL DESIGN and METHODS 
Chemicals 
Tert-butylhydroquinone (t-BHQ), propen-2-al (acrolein), TRIzol®, SP600125 
(JNK inhibitor), PD98059 (MEK inhibitor) and okadaic acid (phosphatase inhibitor) were 
purchased from Sigma-Aldrich Company, Inc. (St Louis, MO). AIN-76A diet and AIN-
76A diet containing butylated hydroxyanisole (BHA) were obtained from Purina 
Laboratories. Anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibody, 
clone 6C5 (MAB374) was purchased from Millipore (Temecula, CA). Rabbit polyclonal 
antibodies against c-Jun (N; sc-45), Jun D (329; sc-74), Nrf2 (C-20; sc-722), JNK (FL; 
sc-572) and pJNK (G-7; sc-6254), horseradish peroxidase-conjugated goat anti-rabbit 
(Sc-2004) and goat anti-mouse (Sc-2005) were purchased from Santa Cruz 
Biotechnology, Inc (Santa Cruz, CA). Phospho c-Jun (Ser63 II) antibody (#9261) was 
obtained from Cell Signaling Technology (Danvers, MA). 
Animals Genotyping and Treatment 
Wild type (WT) and Nrf2 knockout (Nrf2-I-) male mice (C57BU6, 22 g to 27 g) 
were obtained from the Breeding Colony of Roberto Bolli, University of Louisville. In 
order to ensure pure genetic lines, genotypes were examined by PCR analysis of genomic 
DNA isolated from tails. Mice were maintained on AIN76A chow (Purina) diet or paired-
fed AIN-76 diet containing 0.45% BHA (Purina Test Laboratories) for 7 days. Acrolein 
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(5 mg/kg body weight) was administered by gavage for 7 consecutive days while on 
AIN-76A diet. Control mice were either fed AIN76A diet or chow diet with water 
administration by gavage for the BHA and acrolein experiments, respectively. The mice 
were sacrificed 24 h after the last treatment and the livers were harvested and stored at -
80°C until used. Procedures were performed in accordance with approval by UofL 
Institutional Animal Care and Use Committee (IACUC). 
RNA Isolation and Quantitative RT -peR. 
RNA was isolated from mice liver or Hepa-IcIc7 using TRI reagent (Molecular 
Research Center, Inc., Cincinnati, OH) following standard protocol. Briefly, :::::O.1g of 
frozen liver tissue was homogenized in I ml of TRI reagent (Invitrogen, Carlsbad, CA). 
The RNA was purified using silica membrane spin columns (RNeasy reagent; Qiagen, 
Valencia, CA). The RNA integrity was assessed by running a I % agarose gel and 
quantified using the Nano Drop spectrophotometer. The RNA was ali quoted and stored at 
-80°C until used. 
The mRNA levels of Aldhlal, AldhIa7, Aldhlbl, Aldh2, and the Nrfl regulated 
genes (Ho-I, Nqo-I and Gstml) were assessed by qRT-PCR according manufacturer's 
instructions for absolute quantitation standard curve method. Briefly, total RNA isolated 
from mice liver or Hepa-l c 1 c7 were reverse transcribed to cDNA using the Advantage 
RT-for-PCR kit (Clontech, BD Bioscience, Palo Alto, CA) with random hexamer 
primers. RNase H was then used to degrade any residual RNA in the eDNA mix. QRT-
PCR was performed using the ABI 7900HT Sequence Detector System (Applied 
Biosystems, Foster City, CA) using gene specific FAM-Iabeled LUX primers 
(Invitrogen). The primer specificity was determined by BLAST analysis of predicted 
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PCR products and the confirmation of a single PCR product by the melting curve 
analysis. A plot of the CT versus quantity of RNA was generated to verify linearity of 
amplification. All qRT-PCR experiments were performed in triplicate using cDNA 
sample from independent RNA sets and analyzed by the absolute quantitation standard 
curve method. All gene expression levels were normalized with 18S rRNA as 
endogenous control. QRT-PCR experiments were performed in triplicate using cDNA 
sample from independent RNA sets and data were expressed as the mean ± SD and 
analyzed by Student's t test. Values ofp < 0.05 were considered to be statistically 
significant. 
Cytosolic ALDH Activity 
The hepatic Aldh activity was examined in the cytosolic fractions isolated from 
the liver of male C57BL6 mice (Jackson Laboratories, Bar Harbor, MA) treated daily 
with acrolein (5 mg/kg by gavage) or sulforaphane (10 mg/kg by gavage) for 7 
consecutive days or placed on BHA diet (0.45% BHA in AIN76 diet) for 7 days and 
sacrificed 24 h after the last treatment. All procedures were performed following IACUC 
guidelines. The liver cytosolic fraction was isolated following protocol adapted in the 
Prough laboratory for preparation ofliver microsomes (Remmer et aI., 1966). Briefly, the 
livers were excised and cut into small pieces with scissors in a beaker of saline and 
homogenized in 0.25 M sucrose buffered with 50 mM potassium phosphate buffer (PH 
7.4). The homogenized liver was then centrifuged at 1000 rpm for 10 min. Further 
sedimentation at 12000 rpm for 20 min was then done in the same tube. The supernatant 
was then decanted leaving 5-10% of the supernatant with the pellet. The supernatant was 
sedimented at 108,000g for 1 h. To stabilize the enzymes, 20% glycerol was then added 
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to the supernatant or cytosolic fractions and stored at -80°C. The Aldh activity was 
measured spectrophotometrically as described in Chapter II using 1 mM propionaldehyde 
(substrate specific for Aldhl al) as substrate. 
Western blotting 
Hepa-l c1 c7 cells were treated with increasing doses of acrolein as described in the figure 
legends. Cells were harvested at different times and Western blot was essentially 
performed as described in the Method of Chapter II. HepG2 cells were also transfected 
with c-Jun or Nrf2 expression plasmids. Membranes were probed with antibodies against 
rat ALDHl (1 :2000) and GAPDH (1: lOOOO) at room temperature for 2 h or c-Jun 
(1 : lOOO), Jun D (1 : 1 000), Nrf2 (1: lOOO) and phospho c-Jun (1: lOOO), JNK (1: lOOO) and 
phospho JNK (1 : lOOO) at 4°C overnight. The membrane was incubated with horseradish 
peroxidase-conjugated goat anti-rabbit (1: 1 0000) or goat anti-mouse secondary (1: 1 0000) 
antibody and the transferred proteins were visualized with Amersham ECL Plus western 
blotting detection system. 
Transcription Factor Binding Sites Analysis 
The putative transcription factor binding sites of the murine Aldhlal 5'-flanking 
region (-80001+27 bp) was analyzed by Genomatrix MatInspector and Transfac software 
with emphasis on the binding sites for Nrf2 (A/GIGACNNNGC) and AP-I 
(AIGAC/GICA). Putative AREs and IRE were identified in the proximal promoter of 
Aldhlal, suggesting that electrophile-mediated transcription of Aldhlal may be 
regulated by either Nrf2 or AP-l. We cloned an :::::;2.0 kb fragment of mouse Aldhlal 
proximal promoter that contains these putative ARE and IRE, upstream of pGL3 basic 
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luciferase reporter vector using mouse genomic DNA (Promega, Madison, WI) as our 
template in PCR reaction. 
Plasmids and Cloning of Aldhlal Promoter Region 
Mouse genomic DNA was purchased from Promega (Madison, WI) and used in 
PCR experiment to generate 2,002 bp of mouse 5'-flanking sequence. This region 
contains -1963/+23 bp relative to the transcription start site (TSS) of mouse Aldh1a1 
gene. The upstream primer (5'-GGTACCAAATGGGCAGGCATGGTAAC-3') was 
designed to introduce a Kpn 1 site while the downstream primer (5' -
AGATCTTGGTTTGGCTCCTGGAACAC-3 ') introduced a HindIII site. The PCR 
product was recovered into a pCR2.1 vector (Invitrogen, Carlsbad CA). The identity of 
the sequences of the PCR products was confirmed by sequence analysis in the University 
of Louisville, Center for Genetics and Molecular Medicine Nucleic Acid core facility. 
Kpn1 and HindIII enzymes were used to subclone the 2002 bp Aldh1a1 promoter region 
into the pGL3-Basic vector to generate -1963/+27 Aldh1a1-Luc constructs. 
The expression plasmid for c-fos (pRSV-cfos) and c-jun (pRSV-cjun) were 
provided by Pickett C.B and Nguyen T (Schering-Plough Research Institute, Kenilworth, 
New Jersey). The expression plasmid for Jun D (pcDNA3.1-JunD), Jun B (pcDNA3.1-
JunB), Fra-1 (pcDNA3.1-Fra1) and Fra2 (pcDNA3.1-Fra2) were kind gifts from Sunita 
K. Agarwal (NIDDK, NIH). The Nrf2 expression plasmid (pCI-Nrf2neo) was donated by 
K.S. Ramos (University of Louisville). The Plasmid 0.1 64GSTYa-ARELuc (0.164Ya-
ARELuc) containing 164 bases of the rat GST -Ya minimal promoter with a consensus 
ARE cloned upstream ofthe luciferase reporter gene was used as a positive control for 
Nrf2-dependent regulation of gene expression (Falkner et aI., 1998). A construct 
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containing the human collagenase TRE (pCoITRELuc) was generated by Immaculate 
Amunom at the Prough laboratory. This plasmid was previously used as a positive 
control for AP-l transcription activity. 
Transfection of HepG2 Cells and Luciferase Reporter Assays 
The human hepatoma cell line HepG2 (HB8065, American Type Culture 
Collection, Rockville, MD) was maintained in Eagle's minimal essential media with 10% 
fetal bovine serum (HyClone, Logan UT), 1 % antibiotic-antimycotic solution (containing 
penicillin, streptomycin and fungizone; Invitrogen; Carlsbad CA) and non-essential 
amino acids (1X; Mediatech Inc. Herndon VA). Cells were plated at a density of 
approximately 150,000 cells/ml per well in 12-well plate. After plating, cells were 
transfected using 1 flg/2.5 flL of Lipofectamine L TX and 1 flL of Plus (Invitrogen, 
Carlsbad, CA) with 250 ng/well ofpGLO.5-1684Aldhla1, pGL1.5-1684Aldh1a1, -
1963/+27 Aldh1al, -1496/+27 Aldh1a1-Luc, -1005/+27 Aldhlal-Luc, -480/+27 Aldh1a1-
Luc, pO. 164GSTYa-ARELuc or pCoITRELuc. The cells were co-transfected with 
varying amounts ofpRSV-cfos (0-80 ng), pRSV-cjun (0-80ng) or pCI-Nrf2neo (0-100 
ng). After incubation at 37°C for 24 h, the transfection media was replaced with 1 ml 
media containing 10% FBS and then cells were treated when necessary with 0.1 % DMSO 
or t-BHQ. The cells were harvested after overnight incubation (~17-24 h) with 100)J.L of 
Luciferase ceUlysis buffer (Promega, Madison, WI). The ~-galactosidase and luciferase 
activities were determined as described by Falkner et al (1998). The data were expressed 
as luciferase activity relative to ~-galactosidase activity to normalize for transfection 
efficiency. All transient transfection experiments were performed in triplicate and 
experiments were repeated at least twice for confirmation. Statistical comparisons among 
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treatment groups were determined using a two-tailed t-test, with p<0.05 as a criterion for 
significance. 
RESULTS 
Induction of Aldhlal gene expression by acrolein and BHA in mouse liver 
Kinetic studies with recombinant Aldhlal enzyme showed that reactive lipid-
derived aldehydes, such as acrolein and HNE are good substrates of Aldhlal. These 
aldehydes are implicated in the pathogenesis of many oxidative stress-induced diseases. 
Thus mechanisms to induce the expression of Aldhlal might be beneficial against these 
pathologies. Previous studies demonstrate that the expression of Aldhlal gene is 
modulated by a wide variety of endogenous and exogenous stimuli (Alnouti and 
Klaassen, 2008;Leonard et aI., 2006). Microarray studies in the Prough laboratory 
indicated that acrolein feeding up-regulated Aldhlal (;::::; 2-fold) gene expression in mouse 
liver (Amunom, Makia and Prough, unpublished report). Hepatic Aldhlal mRNA levels 
were also induced (;::::;3-fold) by treatment of mice with other electrophiles, BHA. To 
confirm these microarray data, we 'examined whether acrolein or BHA can induce the 
expression of Aldhlal gene in mice liver. C57BLl6 mice on laboratory chow diet were 
treated with water (control) or 5 mg/kg acrolein by gavage daily for 7 days. The daily 
human consumption of unsaturated aldehydes is estimated to be ;::::; 5 mg/kg and no 
hepatocellular damage was observed in mice exposed to this dose of acrolein (Conklin et 
aI., 2010), showing that 5 mg/kg is a sublethal concentration of acrolein. However, 
significant damage to the liver was observed when mice were administered an acrolein 
dose of 10 mg/kg. Mice on AIN76 diet were also administered SFN (10 mg/kg) daily by 
gavage or fed AIN-76 diet containing 0.45% BHA for 7 days. Total RNA extracted from 
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the liver was used for qRT-PCR analysis of gene expression of AldhJ aJ, GstmJ, Nqo-J 
and Ho-J (Figure 7). Aldhlal mRNA levels were significantly increased in mice liver by 
acrolein (:::::; 3-fold) or BHA (2.5-fold) treatment compared with control. The mRNA 
expressions of Aldh1a1 were also significantly increased when Hepa-1clc7 cells were 
treated with 20 /lM acrolein for 6 h compared with control (Figure 8). As expected, 
acrolein treatment caused induction of antioxidant and electrophile detoxification genes, 
such as Gstml, Nqo-l and Ho-l gene in mice liver. The mRNA expression ofGstml, 
Nqo-l and Ho-l were also increased by BHA treatment in mice (Figure 7). 
Even though, Ho-l and Nqo-l genes were significantly induced by SFN in mice 
liver, no induction of Aldhlal and Gstml gene expression was observed with SFN 
(Figure 7). These results suggest that the mechanism of induction ofHo-l and Nqo-l 
gene expression by electrophiles differs from that of Aldhlal or Gstml. The 
isothiocyanate, SFN is a known activator ofNrf2 (Nguyen et aI., 2009), while BHA and 
acrolein are known to induce gene expression by activation of either Nrf2 or AP-l (Choi 
and Moore, 1993;Lee and Murray, 2010). We conclude from Figures 7 and 8 that the 
signaling pathway involved in electrophile-mediated induction of Aldhlal gene differs 
from that ofNqol and Ho-l. 
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Figure 7. QRT-PCR analysis of electrophile detoxification gene expression in the liver of 
mice treated with acrolein, BHA or SFN. For the acrolein experiment, C57BLl6 mice on 
laboratory chow diet were treated with water (control) or 5 mg/kg acrolein by gavage 
daily for 7 days . For BHA and SFN experiment, C57BLl6 mice on AIN-76 diet were 
placed on diet containing 0.45% BHA for 7 days or administered 10 mg/kg SFN daily for 
7 days by gavage (n= 4-5). Total RNA was extracted from the liver, reverse-transcribed 
to cDNA and qRT-PCR analysis of AId hI aI , Gstml , Nqo-I and Ho-I gene expression 
was performed as described in Materials and Methods. * is indicative of statistical 
































Figure 8. Acrolein induces the mRNA levels of cytoprotective genes encoding 
antioxidant and electrophile-detoxification enzymes in Hepa-I cl c7 cells. Cells were 
untreated (control) or treated for 6 h with 20 ~M acrolein. Total RNA was extracted from 
the cells, reverse-transcribed to eDNA and gene expression in relation to I8S was 
measured by qRT-PCR in triplicate using eDNA from independent sample sets. * 
indicates statistical difference compared with controls (p<0.05; 2-tailed t-test). 
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Hepatic cytosolic Aldh activity was induced in mice treated with acrolein (::::::4-
fold) or BRA (::::::4.5-fold) when 1 mM propionaldehyde and NAD+ was used as substrate 
and cofactor, respectively (Figure 9). However, the acrolein- or BRA-induced Aldh 
activity was nearly undetected when the assay was performed with NADP+ as pyridine 
nucleotide cofactor. The major cytosolic Aldh isozymes are Aldhlal and Aldh3al. From 
kinetic studies, we showed that propionaldehyde is a good substrate for Aldhlal and that 
Aldhlal utilized solely NAD+ as cofactor. Moreover, since the mRNA levels of 
endogenous Aldh3al gene in normal mice liver is negligible, the major isoform that 
contributes to acrolein- or BRA-induced Aldh activity in mice liver is likely Aldhlal. 
This is the first report to demonstrate induction of Aldh gene expression by acrolein in 
mouse liver. Consistent with the mRNA expression, cytosolic Aldh activity was not 
induced in liver of mice by SFN even at a dose of 10 mg/kg. These results validate our 
micro array data which demonstrate the induction of hepatic Aldhlal gene expression and 
other electrophile detoxification gene by BHA or acrolein. We postulate from the SFN 





Figure 9. Increased liver cytosolic ALDH activity by BHA or acrolein in mice. C57BLl6 
mice on normal chow diet were treated with water (control) or 5 mg/kg acrolein by 
gavage daily for 7 days. For BHA and SFN experiment, C57BLl6 mice on AIN-76 diet 
were placed on diet containing 0.45% BHA for 7 days or administered SFN (10 mg/kg) 
daily for 7 days by gavage (n= 4-5). The liver was extracted and the cytosol obtained by 
centrifugation at 108,000 x g for 1 h. Aldh activity was assessed by monitoring the 
formation ofNAD(P)H at 340 nm as previously described by Lindahl and coworkers 
(Lindahl and Petersen, 1991). The reactions rates were assayed spectrophotometrically at 
37°C in a reaction mixture containing 1 mM propionaldehyde with either 1 mM NAD+ or 
NADP+ as cofactor at pH 7.4. Specific activities (nmol/min/mg of protein) for cytosols 
were 2.22 ± 0.24 (NAD+) and 15.8 ± 0.51 (NADP+) for controls; 9.97 ± 2.28 (NAD+) and 
11.95 ± 0.88 (NADP+) for BHA-treated animals. * Significantly different from controls 
(p< 0.05 ; 2 tailed t test). 
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Induction of Aldhlal gene expression by BHA in C57BL6 WT and Nrf2-I- mouse 
liver 
The mechanism of BHA- or acrolein-induced transcription of Aldhlal is not 
completely understood. Previous studies have shown that the basal expression of Aldhlal 
was significantly reduced in Nrf2-I- mice compared with WT. However, the mRNA levels 
of Aldhlal gene were not up-regulated in mice with liver-specific knockout of the 
negative regulator Keap-l, which showed constitutive activation ofNrf2. Our previous 
results also indicated that Aldhlal gene expression was not induced by SFN, a known 
activator ofNrf2 (Figure 7 and 9). However, the induction of gene expression by acrolein 
and BHA is dependent on activation of redox-sensitive transcription factors, such as Nrf2 
and AP-l. Thus, in order to assess the role ofNrf2 in electrophile-induced transcription 
of Aldhlal, C57BLl6 WT and Nrf2-I- mice were exposed to 0.45% BHA for 7 days. 
RNA was isolated from the mouse liver and the mRNA levels of Aldhlal and known 
Nrf2 target genes, such as Gstml, Nqol and Ho-l, were examined by qRT-PCR. 
The exposure of mice to BHA resulted in :::::2-fold increase in mRNA levels of 
hepatic Aldhlal in both WT and Nrf2-I- mice compared with untreated control of the 
same genotype (Table 2). However, the basal expression of Aldhlal was significantly 
reduced in Nrf2-I- mice compared with WT control mice of the same genotype. The up-
regulation ofNqo-l, Gstml and Ho-l mRNA expression byBHA in WT mice was 
significantly reduced in Nrf2-I- mice, suggesting that BHA-induced expression of these 
genes is dependent on Nrf2. However, the induction of Aldhlal gene by BHA in WT 
mice was not significantly different in Nrf2-I- mice. These results indicate that BHA-
induced expression of Aldhlal is not mediated by Nrf2. 
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Table 2 
Effects ofNrf2 genotype on changes in mRNA levels of antioxidant and electrophile 
detoxification genes in response to dietary BHA 
Constitutive Levels Inducible Levels Fold Induction 
Gene Nrf2+I+ Nrf2-I- Nrf2+I+ Nrf2-I- Nrf2+I+ Nrf2-I-
Aldhlal 1.0 0.22 2.51 0.43 2.5* 2.0 
Aldhla7 1.0 0.38 2.07 0.66 2.1 * 2.2 
Aldh2 1.0 0.23 1.28 0.31 1.3 1.4 
Aldhlbl 1.0 0.53 1.06 1.29 1.1 2.4** 
Gstml 1.0 0.1 10.8 0.27 10.8* 2.6** 
Nqol 1.0 0.11 8.8 0.48 8.8* 4.6** 
Ho-I 1.0 0_77 2.84 1.09 2.6* 1.4** 
Values are the average fold change per genotype in the liver of WT and Nrf2-I- mice. 
QRT -PCR analysis of gene expression in the liver of C57BLl6 Nrf2+I+ and Nrf2-I- mice in 
response to dietary administration of the phenolic antioxidant, BHA. Mice were fed either 
AIN-76A diet (control, n=4) or diet supplemented with 0.45% BHA (treated, n=4) for 7 
days. The Nrf2-I- mice were fed chow diet only (control, n=3) or diet supplemented with 
0.45% BHA (treated, n=3). RNA extracted from the liver was reversed-transcribed to 
form cDNA. The mRNA levels of Aldhlal, Aldhla7, Aldh2, Aldhlbl , Ho-l , Nqo-l and 
Gstml genes were analyzed by qRT-PCR. The fold induction is shown. For each point, a 
single mRNA was analyzed in triplicate and the average is shown. * indicates 
significantly different from WT control (p<0.05; 2-tailed t test). ** indicates significantly 
different from BHA-treated WT (p<0.05 ; 2-tailed t test). 
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Induction of AP-l gene expression by acrolein or BHA in mouse liver 
In order to examine whether electrophile-induced expression of Aldhlal gene is 
dependent on AP-l, we assessed the mRNA levels of c-jun and c-fos in the liver of 
acrolein- and BHA-treated mice. We observed significant induction of c-jun and c-fos 
(::::2.0 fold) in WT mice after BHA treatment (Figure lOA). This induction was 
significantly decreased in Nrf2-I- mice, suggesting that c-Jun and c-fos genes expression 
are modulated by Nrf2. The expression of AP-l genes in WT and Nrf2-I- mice correlates 
with that of Aldhlal gene (Figure 1OA). Thus, the low basal expression of Aldhlal in 
Nrf2-I- mice might be due to low levels of AP-I genes in these mice. We also observed 
::::4.0-fold and 2.0-fold induction in the mRNA levels of c-jun and c-fos genes 
respectively in the liver of mice after acrolein treatment (Figure lIA). The induction of 
mRNA levels of c-Jun and c-fos gene by acrolein observed in Hepa-lc1c7 cells was 
consistent with that observed in mouse liver (Figure llA). We hypothesized that 
electrophile-induced expression of Aldhlal gene is mediated by AP-l proteins. To 
further test our hypothesis, we assessed the protein levels and transcriptional activity of c-
Jun in cellular extracts from WT mice exposed to BHA. Western blotting with antibodies 
against c-Jun and phospho-c-Jun was performed in extracts from the liver of WT mice 
exposed to control diet or diet containing BHA (Figure lOB). We observed significant 
increases in both protein levels and phosphorylation status of c-Jun in BHA-treated mice 
liver compare with control. To further test our hypothesis in Hepa-lc1c7, cells were 
exposed to increasing concentrations of acrolein for 4 h and the expression and activity of 
c-Jun were analyzed by immunoblotting (Figure lIB). Furthermore, Hepa-lc1c7 cells 
were treated with acrolein (20 f-LM) at various time intervals and the activities of JNK and 
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Figure 10. Effect ofBHA on c-jun and c-fos gene expression in mouse liver. (A) Nrf2+I+ 
or Nrf2- I- mice on C57BLl6 background were placed on AIN-76A diet (control, n=4) or 
diet supplemented with 0.45% BHA (treated, n=4) for 7 days. QRT-PCR was used to 
examine mRNA levels of c-jun and c-fos. (B) C57BLl6 mice were fed either AIN-76A 
diet (control, n=4) or diet supplemented with 0.45% BHA (treated, n=4) for 7 days. Cell 
extracts were separated on SDS-PAGE gel and transferred onto nitrocellulose 
membranes. The membranes were incubated with antibodies against c-Jun (1 : 1000) and 
phospho-c-Jun (1 : 1 000; Ser 63) overnight at 4°C. (C) Densitometry analysis of c-Jun and 
c-Jun activation in response to BHA. Western blot was repeated three times and the 
figure is a representative blot. * and # indicate statistical significant difference compared 
with Nrf2+I+ and Nrf2-I- controls, respectively (p<0.05 ; 2-tailed t-test). 
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Figure 11 . Effect of acrolein on c-jun and c-fos transcriptional activity in mouse liver and 
Hepa-Ic1c7 cells_ A. C57BLl6 mice were treated with water (control, n=5) or 5 mg/kg 
acrolein (treated, n=5) by gavage daily for 7 days _ HepaIcIc7 cells were exposed to 20 
/lM acrolein for 6 h. The mRNA levels of c-jun and c-fos were assessed by qRT-PCR. 
B-C. Concentration- and time-dependent activation of c-Jun by acrolein. (B) Western blot 
of c-Jun protein level and activity. Hepa-Ic1c7 cells were treated with varying doses of 
acrolein for 4 h_ (C) Cells were treated with 20 /lM acrolein at various time intervals. 
Membranes were incubated with antibodies against c-Jun phospho Ser63 , c-Jun, JNKI /2 
and p-JNKl /2. Western blot experiment was repeated three times and the figures shown 
are representative blot. Densitometry analysis is indicated by number below each blot. * 
Statistical difference compared to control (p<0_05 ; 2-tailed t test). 
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c-Jun were analyzed by Western blot with antibodies against phospho-c-Jun and 
phospho-JNK (Figure II C). Acrolein at a concentration of 2.5 !J.M induced the protein 
levels and phosphorylation of c-Jun compared with control (Figure liB). This induction 
was highest at an acrolein concentration of 20 11M. We also noticed increased 
phosphorylation of c-Jun, 2 h after treatment of cells with 20 11M acrolein (Figure II C). 
The kinetics of c-Jun phosphorylation is similar to that of JNK. Thus, the use of specific 
antibodies against phosphorylated JNK implicates the JNK signaling pathway in 
electrophile-induced expression of Aldhlal gene. 
Increased Aldhlal transcriptional activity by acrolein 
To further confirm that the mechanism of Aldhlal transcription by acrolein or BHA 
is mediated by AP-I, reporter gene assays using Aldhlal 5'-flanking sequence (-1963 to 
+27 relative to the transcription start site) of Aldhlal gene was examined. This promoter 
region of Aldhlal gene contains putative AP-l (-1516, -1069, -758 and -60) and Nrf2 (-
665, -1068 and -1753) binding sites, whose sequence closely resembles the canonical 
TRE (TGACTCA) and ARE (TGACNNNGCA), respectively. We transfected HepG2 
cells with Aldhlal luciferase construct (p2.0Aldhlal) that contains the proximal 
promoter of Aldhlal gene cloned upstream of the luciferase gene. Twenty four hrs after 
transfection, cells were treated with 20 !J.M acrolein for 6 hand luciferase activity was 
examined and normalized to p-galactosidase activity (Figure 12). As control for 
electrophile-induced transcription of ARE gene dependent on Nrf2, cells were transfected 
with pGSTYa-ARELuc construct that contains the ARE of the GST-Ya gene cloned 
upstream of a luciferase gene. We observed significant induction of Aldhlal promoter 
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activity when cells were treated with acrolein (~1.8 fold) compared with untreated 
control (Figure 12). However, the induction seen with the luciferase assay was modest 
compared with the endogenous Aldh1a1 gene expression (~4-fold) in Hepa-1c1c7 cells 
observed by qRT-PCR (Figure 8). This might be due to the fact that acrolein treatment in 
the luciferase experiment was done in media containing low serum compared to serum 
free media in the qRT-PCR experiment. Furthermore, luciferase experiments were 
performed in HepG2 which might express higher endogenous levels of AP-1 compared to 
Hepa-1c1c7. HepG2 cells were chosen for the transient transfection and luciferase 
experiment due to high transfection efficiencies. However, as expected acrolein treatment 












p2.0Aldh1 a1 Luc pGSTYa-ARELuc 
Figure 12. The Aldh1a1 transcriptional activity is significantly increased by acrolein. 
HepG2 cells were transfected with -1963/+27Aldh1a1 (p2.0Aldh1a1Luc) or GSTYa-
ARE (positive control) luciferase plasmids for 24 h. After transfection, cells were treated 
with either DMSO or 20 11M acrolein for 6 h and luciferase activity was examined. Data 
are means ± SD from at least three independent experiments. *Significant induction 
compared to vector transfected cells (p< 0.05; 2 tailed t test). 
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Aldhlal transcriptional activity is not induced by Nrf2 
To examine whether the acrolein-mediated induction III Aldh1a1 promoter 
activity is dependent on Nrf2 transcription factor, we co-transfected cells with either 
p2.0Aldh1a1Luc or GSTYa-ARELuc constructs and increasing concentration of Nrf2 
expression plasmids (Figure 14). We confirmed over-expression of c-lun, lunD and Nrf2 
in HepG2 cells by Western blot (Figure 13). We noticed a concentration-dependent 
increase in ARE-driven transcriptional activity with Nrf2 over-expression compared with 
vector control (Figure 14). However, the over-expression of Nrf2 failed to stimulate the 
promoter activity of Aldh1al. The apparent lack of Nrf2-mediated Aldh1a1 
transcriptional activity might be due to the absence of an electrophile or antioxidant 
responsive element in the cloned region of Aldh1a1 proximal promoter. Thus, we 
generated an Aldh1a1 luciferase construct containing 4.6 kb fragment of Aldh1a1 
promoter. However, there was still no significant difference in the Nrf2-mediated 
Aldh1a1 promoter luciferase activity compared to vector control when cells were 
transfected with p4.6Aldh1a1 construct (Figure 14). Thus, transient transfection 
experiments in HepG2 cells with Aldh1a1 5'-flanking luciferase reporter constructs 
showed that co-transfection with Nrf2 expression plasmid alone or in the presence of t-
BHQ had no effect (data not shown) of Aldh1a1 transcriptional activity. In addition to 
experiments with Nrf2-I- mice and SFN treatment in WT mice, this result further 






Figure 13. Western blots indicating over-expression of c-Jun, JunD and Nrf2 in HepG2 
cells. HepG2 cells in 6 well plates were transfected with 2 ~g ofpcDNA3, c-Jun, JunD or 
Nrf2 expression plasmid for 48 h. After transfection, cell extracts were separated on 
SDS-PAGE gel and transferred onto nitrocellulose membranes. The membranes were 
probed with antibodies against c-Jun (1 : 1000; sc-45) and JunD (1 : 1 000; sc-74) and Nrf2 
(1: 1000; C20, sc-722). Western blot experiment was performed in triplicate and the 
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Figure 14. The Aldhlal promoter luciferase activity is not activated by Nrf2. HepG2 
cells were transiently co-transfected with pO. 164GSTYa-ARELuc (ARE control), 
p4.6AldhlalLuc or p2.OAldhlal-Luc luciferase construct and increasing concentrations 
ofNrf2 expression plasmid. Luciferase activity was normalized to ~-galactosidase 
activity and corrected for the activities in cells that had been co-tranfected with empty 
plasmids. Data are means ± SD from at least three independent experiments. * Significant 
induction compared to control vector-transfected cells (p< 0.05; 2 tailed t test). 
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Increased Aldhlal transcriptional activity by AP-l 
We assessed the effect of AP-l on Aldhlal transcriptional activity by transient 
transfection experiments in HepG2 cells with Aldhlal 5'-flanking luciferase reporter 
construct. Cells were co-transfected with either p2.0Aldhlal or pColTRE and with c-Jun, 
c-fos or both c-Jun and c-fos expression plasmids. The pColTRE construct contains the 
TRE sequence from human collagenase gene upstream of a luciferase gene and has been 
used previously as a positive control for AP-l-dependent gene transcription. Over-
expression of c-Jun resulted in :::::A-fold induction in Aldhlal transcriptional activity 
(Figure 15). C-Jun over-expression was verified by Western blot (Figure 13). However, 
we noticed that the regulation of Aldhlal promoter activity by c-Jun and c-fos was 
different to that of the prototypic AP-l responsive gene, the human collagenase gene. As 
shown in Figure 15, both c-Jun and c-fos are required for induction of collagenase TRE 
luciferase activity. This synergism between c-Jun and c-fos for induction of collagenase 
TRE activity was absent in Aldhlal gene, suggesting that c-JunlAP-l might induce 
Aldhlal promoter activity as a homodimer and not as c-Junlc-Fos heterodimer. 
To further test the hypothesis that electrophile-mediated transcription of Aldhlal is 
dependent on AP-l and not the Nrf2 transcription factor, we assessed the role of c-Jun 
dominant negative protein (TAM67) on acrolein-mediated Aldhlal transcription (Figure 
16). HepG2 cells were co-transfected with p2.0Aldhlal and with c-Jun, TAM67 or both 
c-JunlT AM67 expression plasmids. Twenty four hrs after transfection, cells were treated 
for 6 h with 20 I-lM acrolein. Acrolein-mediated increase in Aldhlal promoter activity 
was enhanced by over-expression of c-Jun. However, acrolein or c-Jun-induced 
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Figure 15. The Aldhlal promoter activity is transactivated by c-Jun and c-Fos. HepG2 
cells were transiently co-transfected with -1963/+27AldhlalLuc (p2.0AldhlalLuc), 
pGL3 Basic or pColTRELuc luciferase construct with either c-Jun or c-Fos expression 
plasmid. Luciferase activity was normalized to p-galactosidase activity. Data are means ± 
SD from at least three independent experiments. * Significant induction compared to 
































Figure 16. Inhibition of c-Jun mediated transactivation of Aldhl al-Iuciferase activity by 
c-Jun dominant negative (TAM67) protein. HepG2 cells were transiently co-transfected 
with -1963 /+27AldhlaILuc (p2.0AldhlaILuc) luciferase construct with c-Jun or TAM67 
expression plasmid. 24 h after transfection, cells were treated for 6 h with DMSO or 20 
/lM acrolein. Luciferase activity was normalized to ~-galactosidase activity. Data are 
means ± SD from at least three independent experiments. *, significant difference 
compared to vector-transfected cells (p< 0.05; 2 tailed t-test). &, significant difference 
compared to acrolein-treated cells (p< 0.05; 2 tailed t test) # indicates significantly 
different from c-Jun transfected and acrolein treated cells. 
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transcription of Aldhlal was abrogated by over-expression of TAM67, supporting the 
dependence on c-JunJ AP-l. 
The role of AP-l family proteins on Aldhlal transcriptional activity 
We next examined the role of other AP-l family members on Aldhlal gene 
transcription. Previous studies indicate that the jun family members (c-Jun, Jun D and lun 
B) can induce the expression of genes as either homodimers or heterodimers with 
members of the fos (c-fos, Fos B, Fra-l and Fra-2) family. We tested the effect of 
increasing concentrations of c-lun, Jun D, lun B or Fra-l on Aldhlal transcriptional 
activity in HepG2 cells. As shown in Figure 17, c-lun (;::,;3 fold), Jun D (;::,;2.5 fold) or lun 
B (;::,;4.5 fold) at 80 ng concentration significantly transactivate Aldhlal promoter 
luciferase activity compared to control. However, at lower concentrations (20 ng), only c-
lun showed significant induction of Aldhlalluciferase activity, suggesting increased 
potency of the c-Jun transcription factor compared with the other Jun family members. 
We next transfected Hepa-lclc7 cells with either pcDNA3.1 (control) or jun family (c-
lun, lunD or JunB) expression plasmids to assess whether over-expression of these 
transcription factors can induce the protein levels of endogenous Aldhlal gene (Figure 
18). Western blot analysis shows that over-expression of c-lun, JunD or JunB in Hepa-
lc1c7 cells increased Aldhlal protein compared to vector control transfected cells. 
These results further confirm that electrophile-mediated induction of Aldhlal is 
dependent on AP-l genes. 
We then assessed the role of the fos family (c-fos, Fra-l and Fra-2) on Aldhlal 
transcriptional activity. The fos family are known to induce gene expression as 
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Figure 17. Effect of lun family proteins on transactivation of Aldhlal -luciferase activity. 
HepG2 cells were transiently co-transfected with -1963/+27AldhlaILuc 
(p2.0AldhlaILuc) luciferase construct with increasing concentration (0, 20, 40 and 80 
ng) of c-lun, lun D, lun B or Fra-l expression plasmid. Luciferase activity was 
normalized to p-galactosidase activity. Data are means ± SD from at least three 
independent experiments. * Significant induction compared to vector transfected cells 















Figure 18. Over-expression of Jun family proteins in Hepa-l c1 c7 increases the 
endogenous protein levels of Aldh 1 al. Hepa-l c1 c7 cells were transfected with 1 ).lg of 
vector control (pcDNA3.1), c-Jun, JunB and JunD expression plasmid. 48 h after 
transfection, cell extracts were prepared with IX RIPA buffer, separated on SDS-PAGE 
gel and transferred onto nitrocellulose membranes. The membranes were probed with 
antibodies against c-Jun (1:1000; sc-45) and Jun-D (1:1000; sc-74) and ALDHI (1:1000) . 
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Figure 19. The effect ofheterodimerization between c-jun and fos family proteins (c-fos, 
Fra-1 and Fra-2) on Aldh1a1 transcriptional activity. HepG2 cells were transiently co-
transfected with -1963/+27Aldh1a1Luc (p2.0Aldh1a1Luc) luciferase construct with c-Jun 
and Fra1, Fra2 or c-fos expression plasmid. Luciferase activity was normalized to ~ -
galactosidase activity. The results are presented as fold induction compared to vector 
control co-transfected cells. Data are means ± SD from at least three independent 
experiments. * Significant induction compared to vector transfected cells (p< 0.05; 2 
tailed t test). ** Significantly different compared to c-Jun transfected cells (p< 0.05; 2 
tailed t test). 
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heterodimer with Jun family. While over-expression of Fra-1 or Fra-2 had no effect on 
Aldh1a1 transcription either alone or with c-Jun, over-expression of c-fos inhibits c-Jun-
mediated transactivation of Aldh1a1 promoter activity (Figure 19). 
To further test the effect of c-fos on Aldh1a1 promoter activity, we transiently co-
transfected HepG2 cells with either p2.0Aldh1a1 or pColTRELuc and with constant 
amount of c-Jun or increasing concentrations of c-fos. While increasing concentrations of 
c-fos resulted in a concentration-dependent increase in the transcriptional activity of 
collagenase TRE, increasing concentrations of c-fos caused a concentration-dependent 
decrease in Aldh1a1 promoter activity, which is suggestive of a dominant negative effect 
of c-Fos on c-Jun-mediated transactivation of Aldh1a1 promoter activity (Figure 20). 
These results indicated that transcriptional activation of Aldh1a1 promoter was mediated 
by c-Jun homodimer and not by c-Junlc-Fos heterodimer. The preferred complex that 
binds to Aldh1a1 promoter during acrolein-dependent transactivation of Aldh1a1 gene 
appears to be c-Jun homodimer. Thus, over-expression of c-fos resulted in the formation 
c-Junlc-fos heterodimer, thereby depleting the promoter of the active c-Jun homodimers. 
Previous studies showed that Nrf2 can induce the expression of cytoprotective 
genes by forming heterodimer with AP-1 proteins especially c-Jun (Lee and Murray, 
2010). We examined whether there is cross-talk between c-Jun and Nrf2 in Aldh1a1 
transcriptional activation. Cells were transfected with p2.0Aldh1a1 luciferase plasmids 
with varying concentrations of c-Jun and Nrf2 (Figure 21). Luciferase activity 
normalized to f3-galactosidase activity was assessed in these cells 48 h after transfection. 
We observed that over-expression ofNrf2 had no effect on c-Jun-mediated 
transactivation of Aldh1a1 promoter luciferase activity (Figure 21). 
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Figure 20. Induction of Aldhlal transcription is mediated by c-Jun homodimer and not 
by c-Jun/c-Fos heterodimer. HepG2 cells were transiently co-transfected with either 
pColTRE-Luc (TRE control) or -1963/+27Aldhlalluciferase construct and increasing 
concentration of c-jun and c-fos expression plasmid. Luciferase activity was normalized 
to p-galactosidase activity. The results are presented as fold induction compared to vector 
control co-transfected cells. Data are means ± SD from at least three independent 
experiments. * Significant induction compared to vector transfected cells (p< 0.05; 2 
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Figure 21. Lack of cross-talk between c-Jun and Nrf2 in transactivation of Aldhlal 
promoter activity. HepG2 cells were transiently co-transfected with -1963/+27Aldhlal 
luciferase construct with increasing concentrations of c-Jun and Nrf2 expression plasmid. 
Luciferase activity was normalized to p-galactosidase activity and corrected for the 
activities in cells co-tranfected with empty plasmids. Data are means ± SD from at least 
three independent experiments. * Significant induction compared to vector transfected 
cells (p< 0.05; 2 tailed t test). 
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Aldhlal transcription is not induced by NF-KB activation in HepG2 
Previous studies indicate that electrophile-mediated transcription of 
cytoprotective genes is also dependent on NF-KB activation (Karin, 1999;Lamb et aI., 
2003;Yang et aI., 2005). The NF-KB signaling pathway is highly sensitive to oxidative 
and electrophilic stress. Electrophiles can induce the phosphorylation and degradation of 
IKB, resulting in nuclear accumulation ofNF-KB. Moreover, the proximal promoter of 
Aldhlal (-1963 to +27 relative to transcription start site) contains putative NF-KB 
binding sites at positions -638 and -1139 relative to the transcription start site. We 
assessed the effect of activation ofNF-KB by TNFa on Aldhlal transcriptional activity. 
HepG2 cells were transfected with either p2.0Aldhlal or pNF-KB luciferase constructs 
for 24 h. After transfection, cells'were treated with either 0.5ng/f.!1 or 1.0 ng/f.!l TNFa for 
4 h (Figure 22a). As expected, we observed a concentration-dependent increase in NF-KB 
responsive luciferase activity by TNFa. However, Aldhlal promoter activity was not 
responsive to TNFa even at a concentration (1 ng/f.!l) known to activate NF-KB. This 
indicates that the regulation of Aldhl al transcription by electrophiles is not directly 
mediated by NF-KB. NF-KB proteins are also known to modulate gene expression by 
forming active heterodimers with AP-l proteins (Rahmani et aI., 2001). We further 
assessed whether there is cross-talk between the NF-KB signaling pathway and c-JunlAP-
1 on regulation of Aldhlal gene transcription. Cells were co-transfected with Aldhlal 
luciferase plasmid and c-Jun expression plasmids. Cells were then treated with TNFa (1 
ng/f.!l) for 4 h. The c-Jun mediated induction of Aldhlal promoter activity was 
significantly reduced when cells were treated with TNFa. These results suggest that NF-
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Figure 22. Aldhlal promoter activity is not responsive to activation ofNF-KB signaling 
pathway by TNFa. HepG2 cells were transfected with either 250 ng p2.0AldhlalLuc or 
pNF-KBLuc in a 12 well plate. After overnight incubation cells were treated with 
increasing concentrations ofTNFa as indicated for 4 h (A) or with 1 ng/ I-.tl TNFa for 4 h 
(B). Data are means ± SD from at least three independent experiments. * Significant 
induction compared to vector transfected cells (p< 0.05; 2 tailed t test). # indicates 
significantly different from c-jun transfected cells (p< 0.05; 2 tailed t test). 
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Aldh1a1 promoter activity, but it apparently alters AP-1-dependent Aldh1a1 
transcriptional activity in a yet to be defined manner. 
Role of MAPKs in electrophile-mediated transcription of Aldhlal 
The activities of AP-1 proteins are regulated by MAPK, such as p38, ERKl/2 and JNK. 
The activation of JNK by oxidative stress or electrophile is known to phosphorylate its 
downstream target c-Jun, resulting in increased transcriptional activity of c-Jun. We 
examined the role ofMAPK in electrophile-mediated transcription of Aldhla1 gene. 
HepG2 cells were co-transfected with -1963/+27Aldh1alluciferase construct and a cjun 
expression plasmid. Cells were pre-treated with 0.4% DMSO, 25 f.lM SP600125 (JNK 
inhibitor), 50 f.lM PD98059 (MEK inhibitor) or 40 nM OA (protein phosphatase 2a 
inhibitor) for 17 h. Cells were then treated with either 0.4% DMSO or 20 f.lM for 6 h 
(Figure 23). Acrolein-mediated increases in Aldhlal transcriptional activity were 
diminished when cells were pretreated with JNK (SP600125) or MEK (PD98059) 
inhibitors. The inhibition of the JNK signaling pathway also abrogated the c-Jun-
mediated transactivation of Aldh1al promoter activity. However, pretreatment of cells 
with the phosphatase 2A inhibitor, OA had a small but insignificant effect on acrolein- or 
c-Jun-mediated transcriptional activation of Aldh1a1 gene. These results indicate that 
JNK signaling pathway playa critical role in electrophile-mediated transcriptional 
activation of Aldh1al gene. 
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Figure 23. The role ofMAPKs in electrophile-mediated transactivation of Aldh1a1 
promoter activity. Aldh1a1 transcriptional activity is significantly reduced by inhibition 
of JNK (SP600125) and MEK (PD98059) kinase and increased by inhibition of protein 
phosphatase 2A (Okadaic acid) activity in HepG2 cells. HepG2 cells were co-transfected 
with p2.0Aldh1 a1 (-1963 /+27 Aldh1a1) luciferase construct and a c-jun expression 
plasmid. Cells were treated with 0.4% DMSO, 50 /lM SP600125, 50 /lM PD98059 or 40 
nM OA for 17 h. Data are means ± SD from at least three independent experiments. * 
Significant induction compared to vector transfected cells (p< 0.05; 2 tailed t test). # 
indicates significantly different from c-jun transfected cells (p< 0.05; 2 tailed t test). 
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DISCUSSION 
The regulation of Aldhlal gene expression by BHA and acrolein 
Reactive oxygen species are readily generated in the liver during normal 
metabolism of foreign compounds and fatty acids, and even higher levels are produced in 
pathological conditions, such as steatosis. The ROS-mediated destruction of membrane 
lipids and free fatty acids results in the formation of lipid aldehydes by a chain AND 
autocatalytic reaction known as lipid peroxidation. The reactive lipid-derived aldehydes 
are most likely responsible for the pathophysiological effects ofROS and are implicated 
in the pathogenesis of several oxidative stress-associated pathologies, such as 
steatohepatitis, liver fibrosis, cancer and aging. Cells have developed elaborate systems to 
cope with these toxic electrophiles, thereby preventing aldehyde-induced oxidative 
damage. Our previous study to evaluate the sensitivity of cells with low expression of 
Aldhlal indicate that lipid aldehydes, such as acrolein and HNE are readily detoxified by 
Aldhlal (Makia et aI., 2011). Moreover, high levels of Al dhla 1 gene expression in the 
liver and lens, two organs noted for generation of ROS and cytotoxic lipid aldehydes 
suggest the importance of Aldhlal in cellular protection against oxidative stress-induced 
damage. Thus, mechanisms to induce the expression of Aldhl al gene in mouse liver may 
be a useful strategy to prevent oxidative stress-induced diseases, such as the progression 
of hepatic steatosis to steatohepatitis. 
Previous studies indicate that Aldhl al gene expression is induced by a variety of 
microsomal enzyme inducers, such as phenobarbital (PB) and BHA (Alnouti and 
Klaassen, 2008). Moreover, the expression of several genes encoding antioxidant and 
electrophile detoxification enzymes, including Aldhlal was specifically elevated in 
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mouse liver by electrophiles such as BHA and acrolein (Amunom, Makia and Prough, 
unpublished report). The induction of Aldhlal and other electrophile detoxification 
genes, such as Nqo-l, Ho-l and Gstml in mice liver by acrolein or BHA was confirmed 
by qRT-PCR (Figure 7). Consistent with the mRNA levels, the cytosolic Aldh activity 
was significantly induced in BHA or acrolein treated-mice liver, when 1 mM 
propionaldehyde and NAD+ was used as substrate and cofactor, respectively (Figure 9), 
to measure Aldhlal-specific enzyme activation. Enzyme kinetic studies with 
recombinant mouse Aldhs (Table 1) indicate that propionaldehyde is a good substrate for 
Aldhlal and that Aldhlal solely uses NAD+ as cofactor. Furthermore, the expression of 
cytosolic Aldh3al is negligible, while Aldhlal is highly expressed in normal mice liver, 
suggesting that the predominant cytosolic isoform of Aldh induced in mice liver by BHA 
or acrolein is Aldhlal. Thus, cytosolic Aldhlal activity is induced in mice liver by 
acrolein or BHA compared to control mice. 
h. The role of Nrf2 in electrophile-mediated activation of Aldhlal gene expression 
The signaling pathway involved in electrophile-mediated transactivation of 
Aldhl al gene in mice liver is not clearly understood. However, BHA and acrolein are 
known to stimulate the expression of cytoprotective genes by direct activation of redox-
responsive transcription factors or by indirect activation of protein kinase signaling 
pathway, such as MAPK. To assess the role ofNrf2 in electrophile-mediated 
transcription of Aldhl al gene, we fed C57BL6 WT or Nrf2-I- mice diet containing BHA 
for 7 days and analyzed the mRNA expression of Aldhlal and Nrf2-target genes, Nqol, 
Ho-l and Gstml by qRT-PCR (Table 2). BHA-induced expression ofNqol, Ho-l and 
Gstml genes in WT mice were significantly reduced in Nrf2-I- mice, implicating Nrf2 in 
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BHA-induced expression of these genes. However, the fold-induction of Aldhlal mRNA 
expression by BHA in WT mice was not significantly different from Nrf2-I- mice, 
indicating that BHA-mediated transcription of Aldhlal gene is not dependent on Nrf2. 
Furthermore, we demonstrated that the prototypic Nrf2 activator, SFN did not induce 
Aldhlal gene expression in mouse liver (Figures 7 and 9). These results were consistent 
with previous studies using keap I-knockdown (keap l-kd) mice with constitutively active 
Nrf2 in the liver (Reisman et aI., 2009). The mRNA levels ofNqol and Gstml genes 
were significantly increased in keap l-kd mice compared to WT control, suggesting that 
over-expression ofNrf2 transcriptionally activates these genes. However, Aldhla1 
mRNA expression in the livers ofkeapl-kd mice was comparable to that ofWT mice, 
supporting the hypothesis that the induction of Aldhlal gene expression by electrophiles 
is regulated by Nrf2-independent mechanism. 
The molecular mechanism underlying transcriptional regulation of Aldhlal gene 
by electrophiles was further examined by analysis of the 8.0 kb region of the 5' -flanking 
sequence ofthe mouse Aldh1a1 gene for AP-l-like (TRE) and Nrf2-like (ARE) binding 
sites using the Genomatrix MatInspector Professional consensus sequence identification 
program. The region between -1963 to +27 bp relative to the transcription start site 
containing AP-l-like (-1516, -1069, -758 and -60) and Nrf2-like (-665, -1068 and -1753) 
binding sites was cloned upstream of the luciferase reporter plasmid. Transient 
transfection experiments in HepG2 demonstrate that Aldhlal-luciferase reporter 
containing these cis-regulatory elements is responsive to acrolein (Figure 11). Acrolein 
induced an approximately 1.8-fold increase in Aldhlal-luciferase activity, demonstrating 
that -1963 to +27 region of Aldh1al promoter is responsive to electrophiles. 
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Electrophiles promote nuclear accumulation ofNrf2 by causing its dissociation from 
keap 1. Nrf2 then binds to an ARE in the promoter of target gene resulting in increased 
gene expression (Nguyen et aI., 2004;Nguyen et aI., 2009;Rushmore et aI., 1991). While 
there was a concentration-dependent activation of GSTYa-ARE-Iuciferase activity by 
Nrf2, increasing concentrations ofNrf2 failed to stimulate the activity of Aldhlal-
luciferase reporter (Figure 14). A possible explanation for the lack of responsiveness to 
Nrf2 of Aldhl al-Iuciferase reporter could be due to the absence of a functional ARE in 
the region (-1963 to +27 bp) of Aldhlal promoter used for our experiments. In addition, 
Aldhlal-luciferase construct containing 4.6 bp region of Aldhlal promoter was also 
unresponsive to Nrf2, which further lends support to our hypothesis that electrophile-
induced expression of Aldhlal gene is independent ofNrf2. 
The role of AP-l in BHA or acrolein-mediated activation of Aldhlal gene 
We hypothesized that electrophile-induced transcription of Aldhlal gene is 
mediated by activation of AP-l transcription factor. The induction of antioxidant and 
electrophile detoxification genes by electrophiles is known to be mediated by stimulation 
of the expression and activity of AP-l genes. For example, oxidative stress-induced 
expression of human ferritin H gene was dependent on activation of lunD (Tsuji, 2005). 
Expression c-jun and c-fos genes were significantly increased by BHA or acrolein in the 
liver of WT mice (Figure 10 and 11). While the mRNA expression of c-fos in the liver of 
WT mice by BHA or acrolein compared to control were similar (;:::2-fold), we observed a 
4-fold increase in c-jun mRNA expression by acrolein and a 2-fold increase by BHA. The 
mRNA levels of c-jun and c-fos gene were also significantly increased by acrolein in 
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Hepa-lc1c7 cells compared to untreated cells. The basal expression of c-jun or c-fos 
genes were significantly reduced in Nrf2-I- mice compared to WT control. Moreover, the 
induction of c-jun and c-fos gene by BHA in WT mice was reduced in Nrf2-I- mice, 
suggesting that the Nrf2 modulates the basal and BHA-induced expression of the AP-l 
genes. Previous studies in Nrf2-I- mouse embryonic fibroblast (MEF) also reported the 
regulation of AP-l gene expressions by Nrf2 (Yang et aI., 2005). Thus, the low basal 
expression of c-Jun and c-fos possibly explained the reduced expression of Aldhlal gene 
observed in the liver of Nrf2-I- mice not treated with BHA. The phenolic electrophilic 
compounds, such as BHA have been reported to augment the protein expression and 
activity of AP-l genes (Choi and Moore, 1993;Li et aI., 2005;Tsuji, 2005;Yang et aI., 
2002). The transactivation potential of c-Jun is enhanced by N-terminal phosphorylation 
through JNK (Eferl and Wagner, 2003). WT mice treated with BHA showed increased 
protein expression and phosphorylation of c-Jun compared to control (Figure 10). We 
also observed increased phosphorylation of c-Jun, 2 h after treatment ofHepalc1c7 cells 
with acrolein (20 11M) (Figure 11). The phosphorylation of c-Jun, 2 h after treatment 
correlates with the activation of its upstream kinase JNK. These results suggest that 
electrophile-induced transcription of Aldhlal gene is mediated by enhanced expression 
and activity of AP-l genes. 
Co-transfection of HepG2 cells with collagenase TRE-Iuciferase reporter 
constructs and c-Jun, c-fos or c-Jun/c-fos expression plasmids demonstrate that both c-
Jun and c-Fos were required to activate the collagenase TRE-Iuciferase activity (Figure 
15 and 20). However, c-Jun strongly activated (4-fold) Aldhlal-luciferase reporter, 
while co-transfection with plasmids encoding c-Fos abrogated reporter activity, 
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suggesting that c-Jun activates Aldhlal transcriptional activity as a homodimer and 
collagenase TRE as heterodimer with c-Fos. Transient transfection analysis with c-Jun 
dominant negative proteins (TAM67) further confirmed that activation of Aldhlal-
luciferase reporter activity by acrolein is dependent on c-Jun (Figure 16). 
Transient transfection experiments by co-transfection of Aldhlal 5'-flanking 
luciferase constructs and c-Jun, JunD or JunB expression plasmids in HepG2 
demonstrates that many members of the jun family proteins activate Aldhlal-luciferase 
activity, with c-Jun serving as a more effective transcription factor (Figure 17). We also 
noticed that while Fral and Fra2 had no significant effect on c-Jun-mediated 
transactivation of Aldhlal-luciferase activity, over-expression of c-Fos modestly 
inhibited activation of Aldhlal reporter activity by c-Jun (Figure 19). Abrogation of c-
Jun-dependent gene activation by c-Fos was previously reported by Marden et aI, who 
demonstrated that whereas c-Jun homodimers strongly activated CYP2J2 expression, 
heterodimers formed between c-Fos and c-Jun were not active (Marden et aI., 2003). 
Moreover, previous studies also demonstrated that the c-Jun-mediated activation of the 
human atrial natriuretic peptide (ANP) promoter was inhibited by overexpression of c-
Fos (Kovacic-Milivojevic and Gardner, 1992). 
The effects of increasing concentrations of c-Fos on the activation of Aldhl al- or 
human collagenase TRE-Iuciferase activity by c-Jun was used to further assess the role of 
c-Fos on c-Jun-mediated transactivation of Aldhlal gene (Figure 19). A concentration-
dependent activation and inhibition of collagenase TRE- and Aldhlal-luciferase activity, 
respectively, by c-Fos was noted, indicating that the predominant AP-l complex that 
causes enhanced Aldhlal promoter luciferase activity is c-Jun homodimer and not c-
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Jun/c-Fos heterodimer. Thus, the mouse Aldhl al and human CYP2J2 genes show similar 
pattern of regulation by AP-l. 
The role of NF -KB signaling pathways in BHA or acrolein-mediated activation of 
Aldhlal gene 
Previous studies demonstrate that c-Jun can enhance transcription of target gene 
by functional interaction with other transcription factors, such as Nrf2 and NF-KB. The 
up-regulation of human CYP2J2 gene by BHA was shown to be mediated by interaction 
ofc-Jun with Nrf2 (Lee and Murray, 2010). Thus, Nrf2 apparently acts as a binding 
partner for c-Jun transcriptional activation of CYP2J2 gene. However, transient 
transfection experiment establishes that over-expression ofNrf2 had no effect on c-Jun-
mediated activation of Aldh1a1-luciferase activity (Figure 21). Acrolein and other 
electrophiles have been reported to enhance the expression of cytoprotective genes by 
activation of nuclear factor KB (NF-KB) transcription factor (Pinkus et aI., 1996). 
Moreover, AP-1 interacts with NF-KB to activate gene transcription (Rahmani et aI., 
2001). TNFa is a pro-inflammatory cytokines activated by cytotoxic aldehydes and is a 
strong activator of the NF-KB signaling pathway. The concentration (1 ng/ul) ofTNFa 
that normally stimulate the NF -KB responsive luciferase activity could not activate 
Aldhlal-Iuciferase activity (Figure 22). However, TNFa inhibited c-Jun-mediated 
activation of Aldhlal-Iuciferase activity, suggesting that NF-KB activation abrogates c-
Jun induced activation Aldhlal activity. 
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Role of MAPKs in electrophile-mediated transcription of Aldhlal 
Lipid aldehydes were previously shown to induce the expression of electrophile 
detoxifying genes by activation ofMAPK such as JNK and ERK (Lamb et al., 2003;Wu 
et al., 2006). Hepalc1c7 cells treated with acrolein (20 MM) showed increase JNK 
phosphorylation 2 h after treatment compared to untreated control (Figure 10). 
Experiments using specific inhibitors of JNK, ERK or MEKI revealed the functional 
importance ofMAPK activation for Aldhlal gene expression. The treatment of HepG2 
with JNK (SP600125) or ERKlMEKl (PD98059) inhibitors blocks acrolein or c-Jun-
mediated transactivation of Aldhlal promoter activity (Figure 22). However, the 
phosphatase 2A inhibitor (okadaic acid) had no significant effect on acrolein or c-Jun-
mediated transactivation of Aldhlalluciferase activity. These results suggest that JNK 
plays a critical role in electrophile-induced transcription of Aldhlal and shows functional 
consequences of increased phosphorylation of c-Jun and JNK by acrolein. 
In summary, we have provided evidence that Aldhlal gene expression can be 
induced by electrophiles such as acrolein and BHA and that increased expression of 
Aldhlal gene by electrophiles is dependent on c-JuniAP-l and not Nrf2 or NF-KB. 
Aldhlal gene expression was modulated by a c-Jun homodimer, but not by c-Junlc-fos 
heterodimers. The MAPK especially JNK also plays a crucial role in electrophile-
mediated transactivation of Aldhlal gene. 
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CHAPTER IV 
CHARACTERIZATION OF CIS-RESPONSIVE DNA ELEMENT INVOLVED IN 
REDOX-PROTECTIVE TRANSCRIPTION OF ALDHIAI GENE 
INTRODUCTION 
The comparison of the sequences of the proximal promoter region of mouse 
Aldhlal (m-AHD-2) revealed similarities with the rat RALDHIAI and the human 
hALDHIAI (Guimond et aI., 2002;Hsu et aI., 1999). Analysis ofthe 5'-flanking region 
of the mouse Aldhlal for putative regulatory elements revealed an Oct 1 binding site at-
68 bp and a CCAAT box at -87 bp relative to the transcription start site, which are well 
conserved in the rat RALDHI and human ALDHI genes. Transient transfection studies 
using rat RALDHI promoter deletion luciferase reporter constructs demonstrated that 
CCAAT and Oct motifs were essential for basal promoter activity (Guimond et aI., 2002). 
The conservation of these motifs in the mouse Aldhlal and human ALDHIAI promoter 
suggests that these regulatory elements might also be critical for the basal promoter 
activity of mouse Aldhlal and human ALDHIAl. The analysis of nucleotide sequence 
of the mouse Aldhlal promoter region, starting from -1963 to +25 relative to the 
transcription start site revealed a number of potential regulatory elements, such as GAT A, 
E2F, AhR-Arnt, Stat5, Sox5, SPI and NF-KB binding sites. Previous studies identified a 
putative retinoic acid response element (RARE) located at -91/-75 bp adjacent to the 
CCAAT box of the hALDHI gene (Elizondo et aI., 2000;Elizondo et aI., 2009). The 
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RARE sequence was later identified at a similar position in mouse Aldhl promoter and 
was reported to mediate retinoic acid (RA) down-regulation ofhALDHl and mouse 
Aldhlal gene expression through interaction of the RAR and C/EBP~ in human (HepG2) 
and mouse (Hepal) hepatoma-derived cells (Elizondo et aI., 2009), respectively. The 
down-regulation of ALDHlAl by elevated hepatic RA is a feedback pathway to control 
RA biosynthesis since ALDHlAl is a major enzyme involved in the biosynthesis ofRA. 
Aldhlal is highly expressed in the liver and lens which are suggested to generate 
large amounts of ROS and cytotoxic lipid aldehydes, such as HNE and acrolein 
(Marchitti et aI., 2008;Vasiliou et aI., 2004). It is postulated that increased expression of 
Aldhlal in these organs is a mechanism to protect against aldehyde-induced oxidative 
damage and oxidative stress-induced pathologies. We also showed that Aldhlal 
efficiently metabolizes lipid-derived aldehydes and protects liver-derived cell lines from 
the toxic effect oflipid aldehydes. The induction of Aldhlal gene expression by high 
levels of acrolein might represent a mechanism to control the levels of acrolein in the 
body by enhanced metabolism and detoxification. Thus, an understanding of the factors 
controlling Aldhl al expression may assist efforts to control the progression of steatosis 
to steatohepatitis. 
We demonstrated that electrophiles, such as BHA and acrolein induce the 
expression of Aldhlal gene by activation of c-juniAP-l proteins. However, it is still not 
clear how AP-l modulate Aldhl al gene expression by electrophiles. The regulation of 
Aldhl al gene expression by AP-l is similar to that of Cyp2J2 gene but different from the 
human collagenase gene. The AP-l proteins are composed of either homodimers of fun 
family (c-Jun, JunD and JunB) or heterodimers with/os family (c-fos, Fos-B, Fral and 
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Fra2). One ofthe well-characterized AP-1 target genes is the human collagenase gene, 
which contains a consensus TRE (TGAC/GTCA). Tumor-promoting phorbol12-
myristate 13-acetate (TPA) was shown to activate the transcription of human collagenase 
gene by promoting the association of c-Jun/c-Fos heterodimer to its cognate TRE. The 
AP-1 (c-jun/c-fos) transcription factors are also known to recognize the half site 
(underlined) of the ARE (AlGTGACNNNGC) and are activated during oxidative stress 
and by electrophiles. Hasselblatt et al demonstrate that c-Jun binds to the nos2 promoter 
in vivo and is required for efficient expression of inducible nos gene during Con A- or 
LPS-mediated hepatitis (Hasselblatt et a1., 2007). Moreover, a previous study in HepG2 
cells demonstrates that the up-regulation of CYP 2J2 gene transcription by BHA was 
dependent on the binding of c-Jun and Nrf2 to an atypical AP-1-like element in the 
proximal promoter of CYP2J2 (Lee and Murray, 2010). Ethanol was shown to induce the 
expression of the TFIIIB components, Brfl and TATA-binding protein (TBP) by 
promoting a marked increase in the direct recruitment of c-Jun to TBP and Brfl (Zhong 
et a1., 2011). Therefore, we hypothesized that electrophiles induce the expression of 
Aldh1a1 gene by promoting the binding of c-Jun to its cognate cis-acting regulatory 
elements in the promoter of Aldh1a1 gene. 
Analysis of the 5'-flanking region of the mouse Aldh1a1 gene using the 
Genomatrix MatInspector Professional consensus sequence identification program 
indicates the presence of four AP-1-like elements at positions -1516 (GCTGAATCA), -
1069 (GCTCAGTCA), -758 (ATGATTCA) and -60 (ATGACCCT). Luciferase reporter 
constructs containing Aldh1a1 promoter region with these AP-1-like binding sites were 
shown to be responsive to c-Jun homodimers and not c-Jun/c-fos heterodimers. A 
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number of AP-l-responsive genes contain atypical AP-l-like elements that accommodate 
alternate combination of bZIP factors and this can explain the difference in the 
modulation of Aldhlal and collagenase gene expression by AP-l transcription factors. 
In this chapter, we characterized the cis-regulatory DNA element involved in 
redox-protective transcription of Aldhlal gene. Furthermore, we assessed in vivo whether 
BHA exposure promotes the binding of c-Junl AP-l to the putative AP-l-like binding 
sites in the proximal promoter of mouse Aldhl al gene. 
EXPERIMENTAL DESIGN AND METHODS 
Cloning of Aldhlal deletion plasmids. 
Mouse genomic DNA was purchased from Promega (Madison, WI) and used in 
PCR experiments to generate 2002 bp of mouse 5'-flanking sequence as described above 
in Chapter 3. This region contains -1963/+23 bp relative to the transcription start site 
(TSS) of mouse Aldhlal gene. We generated three (3) deletion constructs; 1534 bp (-
1496/+27), 1043 bp (-1005/+27) and 518 bp (-480/+27) fragments of the mouse Aldhlal 
promoter by PCR using the -1963/+23 bp as template. The downstream primer for 
synthesis of the three deletion constructs was similar to that of the 2002 bp fragment 
(Chapter 3). The following upstream primers, which introduced a Nhel site, were used to 








The PCR products were recovered into a pCR2.1 vector (Invitrogen, Carlsbad CA). The 
sequences of the PCR products were confirmed by sequence analysis in the University of 
Louisville, Center for Genetics and Molecular Medicine Nucleic Acid core facility. Nhel 
and HindIII were used to subclone the 1534bp, 1043bp, and 518bp Aldhlal promoter 
fragments into pGL3-Basic to generate -14961+27Aldhlal-Luc, -1 005/+27Aldhl al-Luc 
and -4801+27Aldhlal-Luc constructs, respectively. A far upstream region of the 
Aldhlal promoter (-4673/-3000 bp) that contains putative ARE/TRE site was also 
generated using the upstream primer; 5'-GGTACCACTCAAATGGCTGAGCCAATG-
3' and downstream primer, 5'-GCTAGCACTCTTCCCATGGCTGTCTTG-3'. This 1684 
bp PCR fragment was cloned upstream of the -1496/+27Aldhlal or -518/+27Aldhlal-
Luc to generate the heterologous mouse Aldhlal constructs pGL1.5-1684Aldhlal and 
pGLO.5-1684Aldhl aI, respectively. 
HepG2 cells were transfected using 1 Ilg/2.5 ilL of Lipofectamine L TX and 1 ilL 
of Plus (Invitrogen, Carlsbad, CA) with 250 ng/well ofpGLO.5-1684Aldhlal, pGL1.5-
1684Aldhlal, -1963/+27Aldhlal, -14961+27Aldhlal-Luc, -1005/+27Aldhlal-Luc and-
4801+27 Aldh 1 al-Luc. The cells were co-transfected with or without pRSV -cjun (50 ng). 
After overnight incubation at 37°C, the transfection media was replaced with 1 ml media 
containing 10% FBS. The cells were harvested after overnight incubation (;::::17-24 h) with 
100 ilL of Luciferase cell lysis buffer (Promega, Madison, WI). The p-galactosidase and 
luciferase activities were determined as described by Falkner et al (1998). The data were 
expressed as luciferase activity relative to p-galactosidase activity to normalize for 
transfection efficiency. All transient transfection experiments were performed in triplicate 
and experiments were repeated at least twice for confirmation. Statistical comparisons 
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among treatment groups were determined using a two-tailed t test, with p<0.05 as a 
criterion for significance. 
Site-Directed Mutagenesis 
Mutagenesis of the two putative AP-1 sites located at -1069 and -757 bp of 
Aldh1a1 was carried out using GeneTailorTm Site-Directed Mutagenesis systems 
(Invitrogen, Carlsbad, CA) following standard protocol. Briefly, the -1496/+27Aldh1a1 
construct was methylated using DNA methylase at 37°C for 1 h. The template strand is 
methylated so that it is marked for degradation by the host McrBC endonuclease. The 
methylated plasmid was then amplified by PCR with two overlapping primers, one of 
which contains the target mutation using Platinum Taq Polymerase High fidelity. The 
PCR conditions were as follows: 94°C for 2 min; 20 cycles of 94°C for 30s; 55°C for 
30s; 68°C for 7 min (;:::; 6.5 kb plasmid); and 68°C for 10 min. The primers for 
mutagenesis of AP-1 sites located at -1069 and -758 bp are shown below. 
-758 bp: Sense, 5'-TCGACACTGCTTAGAGTAATaATaaACAAGTGCACGC-3' 
Antisense, 5' ATTACTCTAAGCAGTGTCGAAGGAAAGAAT -3' 
-1069 bp: Sense, 5'-TATTTACAAATTGAGAAGCTaAaTaAAGGCAAAAAGA-3' 
Antisense, 5'-AGCTTCTCAATTTGTAAATACAGAGAGGAA-3' 
The PCR product, linear and double-stranded was analyzed by a 1 % agarose gel stained 
with ethidium bromide. The mutagenesis mixture was then transformed into One-ShotR 
MAX Efficiency DH5a ™ -Tl R E. coli. The host E. coli circularized the linear mutated 
DNA and McrBC endonuclease in the host cell then digested the methylated template 
DNA, leaving only the unmethylated and mutated product. The sequences of the 
recovered PCR products were analyzed for mutagenesis by sequence analysis in the 
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University of Louisville, Center for Genetics and Molecular Medicine Nucleic Acid core 
facility. 
Preparation of Nuclear Extracts 
Nuclear extracts were prepared from mouse liver and HepG2 cells transfected 
with either pcDNA3.1 (vector control; 2 Ilg/well) or pcDNA3.1-c-Jun (c-Jun expression 
plasmid; 2 Ilg/well) for 48 h using NE-PER nuclear and cytoplasmic extraction reagents 
(Pierce, Rockford, IL) according to standard protocol. Briefly, HepG2 cells (1 x 106) in 
35 mm dishes were washed twice with ice-cold PBS and then scraped from the dishes 
with 1 ml of PBS and transferred to micro centrifuge tubes. Cells were then centrifuged at 
1500g for 5 min. The supernatant was discarded and the cell pellet was allowed to swell 
after addition of ice-cold CERI with vigorous vortexing of the tube to suspend the cell 
pellet. After 10 min of incubation at 4°C, ice-cold CERII was added and the tube was 
again vigorously vortexed and incubated for 1 min. The tube was then centrifuged at 
16000 x g for 5 min and the cytoplasmic fraction was transferred to a clean tube. The 
insoluble nuclear pellet was suspended in ice-cold NER. The tube was then incubated in 
ice for 40 min with 15s vortexing every 10 min. The tube was then centrifuged at 16000 g 
for 10 min and the nuclear extract was aliquoted and stored at -80°C until used for 
EMSA. Protein concentration was determined by Pierce® BCA Protein Assay (Pierce, 
Rockford, IL) using bovine serum albumin as standards. 
Electrophoretic Mobility Shift Assay (EMSA) 
A non-radioactive LightShift Chemiluminescent EMSA kit (Pierce, Rockford, IL) 
was used to examine whether c-Jun binds to the putative AP-l binding sites on Aldhlal 
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proximal promoter. The oligonucleotides used as probes or competitors in gel shift assays 
were end-labeled at their 5' with biotin and the sequences are shown below: 
AP-l Consensus: Sense, 5'-CTAGTGATGAGTCAGCCGGATC-3' 
Antisense, 5' -GATCGA TCCGGCTGACTCATCA-3' 
AP-l Site B: Sense, 5:- TGCTTAGAGTAATGATTCACAAGTGCACG-3' 
Antisense, 5' -CGTGCACTTGTGAATCA TT ACTCT AAGCA-3' 
AP-l Site B Mut: Sense, 5'-TGCTTAGAGTAATaATaaACAAGTGCACG-3' 
Antisense, 5'-CGTGCACTTGTttATtATTACTCTAAGCA-3' 
AP-l Site C: Sense, 5' - AATTGAGAAGCTCAGTCAAGGCAAAAAGA-3' 
Antisense, 5'-TCTTTTTGCCTTGACTGAGCTTCTCAA TT -3' 
AP-l Site C Mut: Sense, 5' -AATTGAGAAGCTaAaTaAAGGCAAAAAGA-3' 
Antisense, 5'-TCTTTTTGCCTTtAtTtAGCTTCTCAATT -3' 
The complementary oligonucleotides were annealed using a thermocycler (Applied 
Biosystems, GeneAmp PCR system 2400) program for annealing complementary 
oligonucleotides. EMSA reactions containing 20 fmoles of biotin-end labeled double-
stranded probes and 5 Ilg nuclear proteins (NP) were incubated for 20 min at room 
temperature in a lOX binding buffer with 5 mM MgCh, 2.5 % glycerol, 1 % NP-40 and 
50 ng/1l1 poly (dI-dC). The specificity of binding was analyzed by excess of unlabeled 
double stranded probes included in the binding reactions. In the competition experiments, 
25- to lOO-fold excess of unlabeled double stranded EMSA probes was included in the 
binding reactions. To further confirm specificity of binding, a 100-fold excess of 
unlabeled double stranded probe with mutations at the AP-l binding site was included in 
the binding reactions. For super shift analysis, nuclear extracts were incubated with 
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rabbit polyclonal c-Jun (sc-44 X, Santa Cruz Biotechnology, CA), c-fos (sc-52 X) or Nrf2 
(sc-722) antibodies for 30 min at 4°C before addition of the labeled probe. Loading 
buffer was added to the reactions and the protein-DNA complexes were resolved by 
electrophoresis on 6% precast DNA retardation gel (Invitrogen) in 0.5% TBE buffer (90 
mM Tris-HCI, 90 mM boric acid, 2.5 mM EDTA) at 100 V for 1 h at 4°C. Following 
electrophoresis, the binding reactions was then electrophoretically transferred onto a 
nylon membrane (Amersham Hybond-N+, GE Healthcare) with 0.5% TBE for 1 hat 
100V. At the end of transfer, the transferred DNA-protein complexes were then cross-
linked onto membrane using a UV cross-linker that was set at 120 mJ/cm2 for an 
exposure time of2 min. The biotin-labeled DNA was then detected using the 
Chemiluminescent Nucleic acid detection module (Pierce) following standard procedure 
for detection of immobilized nucleic acids. 
Chromatin Immnnoprecipitation Assay (ChIP). 
C57BLl6 mice were placed on AIN76 diet (control) or diet containing 0.45% 
BHA for 7 days. Animals were sacrificed and intact nuclei from the livers of control or 
BHA-treated mice were purified by sucrose density gradient without disrupting the 
internal macromolecular interactions. The ChIP assay was performed using the MAGnify 
chromatin-immunoprecipitation system (Invitrogen, CA) according to manufacturer's 
protocol with minor modifications. The pure nuclei were suspended in PBS and fixed in 
1 % formaldehyde in PBS at room temperature to cross-link the DNA binding proteins to 
cognate cis-acting elements. The nuclei were harvested after 30 min, washed with PBS 
and solubilized in Buffer A containing 50 mM Tris-CI, pH 8.0, 1 % SDS, 5 mM EDTA, 5 
mM EGTA, 0.5 mM PMSF and complete protease inhibitor mix (Roche Molecular 
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Biochemicals). The homogenate was sonicated 6-7 times on ice at 40% setting (Branson 
sonicator) to shear the chromosomal DNA into fragments of ~200 to 500 bp in size. The 
insoluble material was removed by centrifugation at 20,000 x g at 4°C for 5 min and the 
soluble chromatin supernatant (chromatin extract) was stored at -80°C until use. Before 
use, the chromatin extract was diluted 5-fold with dilution buffer containing 20 mM Tris-
CI, pH 8.0, 1 % Triton X-IOO, 1.2 mM EDTA and 150 mM NaCl. The cross-linked 
protein-DNA fragments were immunoprecipitated by overnight incubation of diluted 
chromatin with antibodies against IgG (control), c-Jun (sc-44 X; 1 Ilg/Ill) or c-fos (sc-447 
X; 1 Ilg/Ill) conjugated to Dynabeads protein A/G. The immune complexes were washed 
sequentially with IP buffer 1 and 2, and the protein-DNA cross-links were reversed by 
heat treatment in reverse cross-linking buffer containing proteinase K. The uncrosslinked 
DNA pulled down by the different antibodies was purified using the DNA purification 
magnetic beads. The purified DNA was analyzed by real-time PCR (ABI 7900HT 
Sequence Detector System, Applied Biosystems, Foster City, CA) with primers spanning 
the putative AP-l sites Band C in the proximal promoter of Aldhial gene. The 
sequences of the ChIP primers are shown below: 
AP-I Site B: Forward, 
Reverse, 
AP-I Site C: Forward 
Reverse 
5'-GTT CCT TCC ATA TCT TGT GCT GGG-3' 
5'-GAG GTG CGT GCA CTT GTG AAT CAT-3' 
5'-TCC TTC AAG GTC TGT GAC CAA AGC-3' 
5'-AAC AGG GAC CTG AGG AGT GTG TTT-3' 
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RESULTS 
Identification of AP-l-like elements that mediate electrophile response in the 
proximal promoter of Ald"l al gene by deletion analysis 
The analysis of the proximal promoter of Aldhlal by the Genomatrix 
Matlnspector Professional software revealed four putative AP-l-like elements at 
positions -1516, -1069, -758 and -60 (Figure 24). The p2.0Aldhlal construct containing-
1963 to +27 of Aldhlal proximal promoter was used as template for the generation of 
three deletion constructs: p1.5Aldhlal (-1496 to +27), pl.OAldhlal (-1005 to +27) and 
pO.5Aldhlal (-480 to +27) with progressive loss of the AP-1-like elements. To identify 
the critical AP-1-responsive element required for transactivation of Aldh 1 a 1 gene by c-
Jun, HepG2 cells were co-transfected with the Aldhla1 5'-flank luciferase reporter 
constructs containing progressive deletions ofthe AP-l-like elements and a plasmid 
encoding c-Jun protein. The deletion of the AP-l-like element at positions -1516 had no 
significant effect on c-Jun-mediated transactivation of Aldhlal-luciferase activity (Figure 
25). However, the deletion of the putative AP-l sites at positions -1069 and -758 
significantly decreased activation of Aldhlal-luciferase activity by c-Jun. Thus, deletion 
analysis indicates that the region containing these two AP-l-like elements at positions -
758 (AP-l site B) and -1069 (AP-l site C) relative to Aldhlal transcription start site is 
critically important for c-Jun-dependent transactivation of Aldhlal transcriptional 
activity. 
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J..970 GGTACCAAAT GGGCAGGCAT GGTA ACTG TC TCCCAAG,-rr CC'TTTAGCTA CATGCATAAT 
C/EBP 
-1910 GC-rrTG"""'-G AAGAGCACAT TATTACATAA TTATCCAAGT AAATCCAATG AATGATGTGC 
-1850 CCATlCAGAG AATAAGGTGG TATGTCAAGT ATGTlGTGCA GCCTGTGT1T TTTTCc-rr CT 
MAF/AP-:l..R 
-1790 AGACATCAAA TGAACCAGTT "TTGAATCCAC AAACAACT~~:~"AG"rc.."TGCAA AACACAGCTG 
C/EBP 
-.1.730 TTTGGGAATT GGCCTGAGCA CCACTCTGTG TTATGTAACA GCTGTTGAGA AATrACACAT 
Sox " C/EBP -.1.670 TTA,ACTCAAA AAGTATCTGT GAAAGAGAAA ACAATICATT T.,...,...-y-rTCCAA AAAATAAGGG 
GA-Boxes 
-~6~O GAGTGGGAGA GAGACAGAgA G~GAGA§AGA GAGAGAGAGA GAGAGAGAGA GAGAGAGAGA 
NF E2/AP "- (0) 
-~550 ~8y,8,S:;Z8~8AG CAGGCTATTC CAGGATA~"ic"T SiAAXS:"" 6A-GA A AAAACAGTCA ATGTCATGGA 
AhR-Arnt 
-1490 TCTGGCTGGA TS;;TG~CTT~C CTecceT""'- TTACATATAC AATTCCATTA AAAATGAGCA 
-.1..430 TTCATATACC TGTTGTeTAT TGrTCATTTI AATTCATATA GAACACTTTC AAACAGTACT 
GATA 
-J..370 GATATGTCCC AGGAAGATGA AGATATTTCC CATCTGTTTC ATAAGAAAAG -rrrrCTATTC 
-.L3.LO TTCCCTGTTA GGATGCATAA AAG~AAC CATAATTTCC ATGTGTGTAA CTACTCACTG 
-1250 GAAGATCCCA AACTGAGTTG GACCCTATAT GGGGGATCAT ATTATCGATA TCAAGGAAGG 
AP-2 NF-KB 
-1190 TCTAGAAAAG AGGAATAACA TCTTGGGGTG CATTGCCTGA GGCGAA"'-'-C CAGCCTTATC 
FTF/REV-ERBA/FXRE MAF/AP-.1.(C:> 
-1.130 CTTCAAGGTC TGTGACCAAA GCTGTATTCC TCTCTGTATT TACAAATTGA GAA~i£".IC~_@"" 
-.1070 CAAGGCAAAA AGAGAAACAC ACTCCTCAGG TCCCTGTTCC TeeCCTAGCT AAGTGCAAAT 
-.1010 GCAGGGGAGG TGGCAATTTC ACTACAAAGA AGTTATCACT AATTCTTATA ACCAGAGCAT 
-950 CCTAAGAATG TTATCTTGTT ceTTCCATAT CTTGTGCTGG GGCTTCAACA CAGAGAAGCA 
-890 TTGTATTCAA AATGAAAATG CTACAGTTCA AATTTGTCCT TTCCAAGTTC CCAGATGAAA 
STATS 
-830 ACATTCAGAA "'-'-AAACTCT TAG GAGG TGA TA"'-'-ACATT CTTTCCTTCG ACACTGCTTA 
AP "- (B) AhR-Arnt 
-770 GAGTAATGAT ""I"CACAAGTGC ACGCACCTCC CCAATCAGAC ATTACTTTCG CTTTAAATGA 
MAF/AP-1R 
-7.1.0 GTTTTCACAG ATAACTTCGG TGTAATACTC TATGAGGGTC TAAGAGTGAC AAGGAACTCT 
NF-KB 
-650 GAAAAGTCCC ACATAG"TTTT CTGTTCCCAC CAAAAAGTAC AAAGACAATG CGAAGATTCT 
-590 GATATAACAT GAGTTTGGTG GAATTTTTTT TTTCTTTTAA GCTTGGGAGA TCGAGTGTAG 
-530 AAAAAGGGCA TCTC TCCC TA ACAGCACCCT GATCTGCTGG AATAAGGATG GGTTTGCTGG 
COUP 
-470 TAGCCATGTT AGGCAGATTT GTGGTTCTCT GCTCCGTATC TCCTCGTGAG AA~8!;z8!;;.is;jIC 
-4.10 TCTTTAGACT CCTCTTCATT TCAATGCCTI TGTTCCGGAG TCTGTTAGAG AAGAAAAAGT 
MAF/AP-:LR 
-350 TACAGTAGCA TAACAAAGCA GGAAAAGGGA ATGGAAAAAA AAAATAATAA CTGGCTTCCA 
-290 GTGTCTGGAG CAGCTGCACA CACACCCTTA GCACAGGTTT GGCTTGGTAA ATTAATTCAT 
TATA 
-230 C~TAG TGAGCAGTCT CCAGATAGAA CTTCAGGGCT GAGGTGCAGG TTCCTTAAGG 
-.1..70 ATTTACATGT AAAGGCAAAG GCTTTCAGCC CTAGGTGTTA CAAGTGAGTG GTGCCCTTCA 
CCAAT Oct-.1 
-~.10 TGCCCTGCCC TGAGTCTGCC CATCCAATCA TATCCCGATA TGCAAATGAC ~AGTGCA 
GAiA MAF/AP-.1(A)-
-50 TGCAGATAAA AAGGAGCAAG GGCTCTTTCA GAACCAATTT GCTGAGCCTG TCACCTGTGT 
E2F 
+.1.0 TCCAGGAGCC AAACCAAGAT CT 
Figure 24. The nucleotide sequence of mouse Aldhlal promoter depicting potential AP-
1, Nrfl (ARE) and NF-KB binding sites as well as other putative transcription factor (TF) 
binding sites. The sequence shown is -1963 to +27 bp of mouse Aldhl al promoter. The 
underlined nucleotides represent putative TF binding sites identified by Genomatrix 
Matlnspector Professional consensus sequence identification software. Arrow indicates 
the transcription start site (+ 1). 
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Figure 25 . Deletion analysis to identify the AP-l-like responsive element in the proximal 
promoter Aldhlal gene. HepG2 cells were transiently co-transfected with 250 ng of-
4673/+27Aldhlal , -1963/+27Aldhlal, -14961+27Aldhlal , -10051+27Aldhlal or-
4801+27Aldhlalluciferase construct and either pcDNA3.1 vector control or c-Jun (40 
ng) expression plasmid. Luciferase activity was normalized to p-galactosidase activity 
and corrected for activities in cells co-transfected with empty plasmids. Data are means ± 
SD from at least three independent experiments. * Significant induction compared to 
vector transfected cells (p< 0.05; 2 tailed t test). 
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Characterization of AP-l-like elements responsible for c-Jun-mediated 
transactivation of Aldhlal promoter activity by mutagenesis analysis 
To investigate the importance of the AP-1-like elements at -1069 and -758 in the 
activation of Aldh1a1-luciferase by c-Jun, these putative AP-1 elements were mutated by 
site directed mutagenesis. The functional consequences of the mutations were examined 
by transient transfection of the WT and mutant Aldh1a1-luciferase reporter constructs 
into HepG2 cells. The mutation of the proximal putative AP-1 element at position -758 
(p1.5Aldh1a1MutB) resulted in ::::c50% reduction in c-Jun-mediated activation of Aldh1a1 
promoter activity compared to the pl.5Aldh1a1 WT (WT) constructs (Figure 26). 
However, mutation of the distal AP-I sequence at position -1069 (p1.5Aldh1aIMutC) 
modestly decreased Aldh1a1-luciferase activity compared to the WT plasmid. Double 
mutation of the putative AP-1 elements at sites Band C in the promoter of Aldhla1 gene 
attenuated c-Jun responsiveness. These results indicate that both AP-1-like elements at 
sites Band C may be essential for c-Jun dependent transactivation of Aldh1a1 gene with 
the AP-1 at site B playing a pivotal role. 
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Figure 26. Mutagenesis of the putative AP-1-like elements located at -1069 bp (C site) 
and -758 bp (B site) on Aldh1a1 promoter activity. HepG2 cells were transiently co-
transfected with 250 ng ofp1.5Aldh1a1 WT (-1496/+27 Aldh1a1), p1.5Aldh1a1MutB, 
p1.5Aldh1a1MutC or p1.5Aldh1a1MutB/C luciferase constructs and either pcDNA3.l or 
c-Jun (40 ng) expression plasmids. Luciferase activity was normalized to p-galactosidase 
activity and corrected for activities in cells co-transfected with empty plasmids. Data are 
means ± SD from at least three independent experiments. * Significant difference 
compared to c-Jun and p1.5AldhWT co-transfected cells (p< 0.05; 2 tailed t test). 
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EMSA and super shift analysis to assess binding of AP-l nuclear proteins to AP-l-
like elements in the proximal promoter of Aldhlal gene 
We next wanted to establish whether AP-l proteins bind to these putative AP-l-
like elements at sites Band C by EMSA. The nuclear extract isolated from HepG2 cells 
transfected with plasmid encoding c-Jun (Figure 27) was incubated with biotin-labeled 
double-stranded probes containing AP-l-like elements Band C. We observed formation 
ofa DNA-protein complex when labeled probe spanning AP-l-like element B was 
incubated with nuclear extract but not with site C (Figures 28, 29 and 30). The specificity 
of nuclear proteins binding to the AP-l-like element B was examined by competition 
with cold unlabeled WT probe and unlabeled mutant p~obe containing mutations at the 
AP-l-like element at site B. The nuclear proteins present in HepG2 cells overexpressing 
c-Jun were allowed to form complexes with unlabeled WT (25- to 100-fold) or mutant 
probe (lOO-fold) prior to the incubation with biotin-labeled probes spanning AP-l-like 
element at site B. The results demonstrate that 100-fold excess concentration of unlabeled 
WT probe completely competed with the biotin-labeled probe containing site B for AP-l 
binding proteins (Figure 28). Thus, excess unlabeled specific WT probe completely 
inhibited the formation of complexes with the biotin-labeled probe containing AP-l 
element at site B. However, pre-incubation with unlabeled mutant probe only slightly 
competed with the biotin-labeled AP-IB site for protein binding (Figure 29). We then 
examined whether an increase in the concentration of nuclear extracts might result in 








Figure 27. Western blots indicating over-expression of c-Jun in the nuclear extracts of 
HepG2 cells. Nuclear extracts were prepared from HepG2 cells transfected with either 
pcDNA3.1 (vector control; 2 flg/well) or pcDNA3.1-c-Jun (c-Jun expression plasmid; 2 
flg/well) for 48 h using NE-PER nuclear and cytoplasmic extraction reagents (Pierce, 
Rockford, IL) according to standard protocol. 48 h after transfection cell extracts were 
separated on SDS-PAGE gel and transferred onto nitrocellulose membranes. The 
membranes were probed with antibodies against c-Jun (1: 1 000; sc-45) and GAPDH 




1 2 3 4 5 6 7 8 9 10 
Bound DNA ~ 
Free Probe ~ 
c-Jun (5 ~g) + + + + + + + + 
AP-18 Cold(25X) - + -
AP-18 Cold(50X) + 
AP-1B Cold(100X) - + 
AP-1C Cold(25X) + -
AP-1C Cold(50X) - + -
AP-1C Cold(100X) - + 
Figure 28. EMSA analysis indicates the formation of nuclear protein complex with the 
AP-l-like element at site B (-758) but not with the AP-1-like element at site C (-1069). 
Biotin-labeled double stranded probes were incubated with 5 Ilg of nuclear extracts from 
HepG2 transfected with c-Jun expression plasmids for 20 min. In the competition 
experiments, 25-1 OO-fold excess of unlabeled double stranded probes was included in the 
binding reactions. The protein-DNA complexes were resolved by electrophoresis on 6% 
precast DNA retardation gel and the binding reactions were then electrophoretically 
transferred onto a nylon membrane. The immobilized biotin-labeled DNA was then 
detected using the Chemiluminescent Nucleic acid detection kit. The result shown in this 
figure was identical to that of three other independent experiments. 
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1 2 3 4 5 6 7 8 
Bound DNA ~ 
Free Probe ~ 
c-Jun (5 I-lg) + + + +. + + 
AP-1B Probe + 
AP-1B mut + 
AP-1C Probe 
+ 
AP-1C mut + 
Figure 29. The nuclear protein complex with the AP-l-like site at B (-758) was competed 
by excess unlabeled wild type probe but not probe containing mutation in the AP-l-like 
element. The specificity of binding to the AP-l site at B was further confirmed with 100-
fold excess of unlabeled double-stranded probe with mutations at the AP-l-like site at B. 
EMSA was performed with nuclear extracts from HepG2 cells over-expressing c-Jun as 
in Figure 28. The result shown in this figure was essentially identical to that of three 
other independent experiments. 
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However, EMSA result shown in Figure 30 indicate the absence of nuclear protein 
complex at the AP-l-like element at site C even when incubated with high concentration 
of nuclear extracts (10 Ilg) from c-Jun overexpressing HepG2 cells. These results indicate 
that the nuclear proteins do not form complexes with the AP-l-like element at site C. 
To identify the composition of the nuclear proteins that form complexes with the 
AP-l-like element at site B, super shift assays were performed by incubation of protein-
DNA complex with antibodies against c-Jun, c-fos or Nrf2 at 4°C for 30 min (Figure 31). 
Incubation of nuclear protein-DNA complexes with antibodies against c-Jun but not c-fos 
or Nrf2 blocked the formation of the nuclear protein-DNA complex. The absence of 
nuclear protein complex with AP-l site B instead of a super shift might be as a result of 
the 6% polyacrylamide gel used in our experiment. The antibody-nuclear protein-DNA 
complex may be too large to get into the gel. Future experiments will examine whether 
this problem can be resolved by using lower % gels, such as 4-5% gel with a longer run 
time. Moreover, the absence of nucleoprotein complex at site B might also be due to c-
Jun antibody binding to the DNA-binding domain ofthe c-Jun, thereby blocking the 
interaction between c-Jun and DNA. 
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Figure 30. EMSA analysis indicates no protein binding to the AP-1 site C (-1069) at 
higher concentrations of nuclear extracts. The experiment was performed essentially as in 
Figure 28 . However, biotin-labeled double stranded probes were incubated with 10 f.lg of 
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Figure 31. Super shift analysis confirms that a protein in the nuclear extract that binds to 
the AP-1 site B is c-Jun and not c-fos or Nrf2. EMSAs were performed by incubating 
nuclear extracts from HepG2 cells transfected with c-Jun encoding plasmids with biotin 
labeled probe containing AP-1 B site of the mouse Aldh1 a1 promoter. In super shift 
experiments, the nuclear extracts were incubated with rabbit polyclonal c-Jun, c-fos and 
Nrf2 antibodies for 30 min at 4°C prior to incubation with the labeled probe. The figure is 
a representative ofthree other independent experiments. 
120 
ChIP experiment to assess in vivo binding of nuclear proteins to putative AP-l sites 
in the proximal promoter of Aldhlal gene 
To investigate the functional importance of the AP-1-like sequences at sites Band 
C in the proximal promoter of Aldh1a1 gene, ChIP experiment was used to assess 
whether BHA promotes recruitment of c-Jun to these putative AP-1 binding sites at B and 
C. Using c-Jun or c-fos antibodies, the complexes containing cross-linked AP-1 proteins 
to the cognate AP-1 elements were pulled down from chromatin extracts prepared from 
the liver of control or BHA-treated mice. The DNA fragments were then analyzed by 
qRT-PCR with primers spanning the AP-1-like elements at B or C in the proximal 
promoter of Aldhl al gene. As shown in Figure 32, liver extracts from BHA-treated mice 
showed;:::; 10-fold increase recruitment of c-Jun to AP-1-like element at site B compared 
to IgG control. The recruitment of c-fos to the AP-1 element at site Bin BHA-treated 
mice though higher than in control mice was comparable to that of IgG control. These 
results confirm that BHA promotes enhanced binding of c-Jun to the AP-1 B site in the 
proximal promoter of Aldh1a1, which is associated with increased transcription. The 
recruitment of c-Jun to AP-1-like element at site C was similar to that of site B. However, 
this result differs from our EMSA experiment, demonstrating the absence of nuclear 
protein complexes with the AP-1-like sequence at site C. This disparity might be due to 
the close proximity of the AP-1-like elements at B and C, which are only 300 bp. The 
sonication method employed for DNA shearing in the ChIP experiment generated DNA 
fragments of;:::;500 bp. Thus, inefficient shearing of the DNA could produce a single 
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Figure 32. ChIP analysis to examine in vivo binding of c-Jun and c-fos to the AP-1 at 
sites Band C. Chromatin were prepared from the liver of control or BHA-treated 
mice. The complexes containing cross-linked DNA binding proteins to their cognate 
cis-element were pulled down with antibodies against IgG, c-Jun or c-fos conjugated 
to Dynabeads protein A/G. The purified DNA was analyzed by real-time PCR with 
primers spanning AP-1 sites B in the proximal promoter of Aldh1a1 gene. 
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DISCUSSION 
Due to the potential metabolism, electrophile detoxification and anti-apoptotic 
role of Aldhlal in mouse liver, an understanding of the molecular mechanism underlying 
Aldhlal regulation is of utmost importance, and could be of therapeutic importance in 
prevention of oxidative stress-induced pathologies. Aldhlal gene expression is 
modulated by electrophiles, such as acrolein and BRA, which are associated with 
enhanced expression of Aldhl al gene and transcriptional activation of c-JunJ AP-l. 
Transient transfection studies in RepG2 demonstrate that Aldhlal gene is activated by c-
Jun homodimers, but not by c-Jun/c-fos heterodimers. The transcription factors, Nrf2 and 
NF -KB were not involved in electrophile-induced transcription of Aldhl al gene. Previous 
studies indicate that the up-regulation of cytoprotective genes by electrophiles are 
mediated by enhanced recruitment of redox-sensitive transcription factors to the cis-
responsive element in the promoter of these genes. The up-regulation of CYP2J2 gene 
transcription by BRA is dependent on the binding of c-Jun and Nrf2 to an atypical AP-l-
like element in the proximal promoter ofCYP2J2 (Lee and Murray, 2010). The induction 
of rat glutathione synthetase gene expression by tBRQ is mediated by a regulatory 
element composed of two adjacent AP-l-like binding sites and is transactivated by the 
AP-l complex (Yang et aI., 2002). In addition, JunD up-regulates the expression of the 
human ferritin gene by oxidative stress via an ARE enhancer containing two AP-l motifs 
located at -4.5 kb upstream region of the human ferritin R gene (Tsuji, 2005). 
The deletion of the region between -1496 to -480 bp ofthe 5 'flank of Aldhlal 
gene relative to the transcription start site completely abolished transactivation by c-Jun. 
Analysis of this region by Genomatrix software indicates the presence of two AP-l-like 
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elements at positions -1069 (site C) and -758 (site B). The sequence of the AP-1-like 
elements at position -758 (ATGATTCA) and -1069 (GCTCAGTCA) contains a single 
nucleotide mismatch with the AP-1 consensus TGAG/CTCA found in the human 
collagenase gene. The difference in the AP-1 motifs between Aldh1a1 and human 
collagenase gene could explain the differential regulation of these genes by AP-1 
complexes. While the collagenase gene is regulated by c-Jun/c-fos heterodimer, Aldh1a1 
gene expression is mediated by c-Jun homodimer. The mutation of the AP-1 sequence at 
position -758 significantly impaired c-Jun-mediated transactivation of Aldh1a1 reporter 
activity. However, the activation of Aldh1a1 activity was modestly affected by 
mutagenesis of the AP-1-like sequence at positions -1069, while mutation of both AP-1 
sites completely abolished c-Jun-dependent transactivation. Thus, transient transfection 
studies indicate that both AP-1-like elements are important for c-Jun-mediated activation 
of Aldh1a1 reporter activity with the AP-1-like motif at position -758 playing a more 
critical role. 
EMSA and super shift analysis demonstrate the presence of c-Jun, but not c-fos or 
Nrf2 in the nuclear protein complex bound to the AP-1 like sequence at -758, suggesting 
the importance of AP-1 sequence at -758 in c-Jun-mediated activation of Aldh1a1 gene. 
However, the AP-1 element at -1069 did not form protein complexes even when 
incubated with high concentrations of nuclear extracts from HepG2 cells transfected with 
c-Jun encoding plasmid. This observation is in contrast to the transient transfection 
studies that showed mutation of site -1069 modestly decreased the activity of Aldh 1 a1 
promoter by c-Jun. The functional importance of the AP-1 sequence at -758 and -1069 in 
electrophile-mediated activation of Aldh1a1 gene was tested by ChIP experiment. The 
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binding of c-Jun to both AP-l elements at -758 and -1069 in the promoter of Aldhl al 
gene was strongly increased by treatment of mice with BHA. The enhanced recruitment 
of c-Jun to the AP-l element at -1069 by BHA is not consistent with the EMSA and 
transient transfection studies. However, due to the proximity of the two AP-l sites, which 
are less than 500 bp apart, it may be difficult to obtain DNA fragments with the separate 
AP-l elements by sonication. 
In summary, we describe an AP-l sequence at positions -758 that plays a critical 
role in Aldhl al gene expression by electrophiles. The deletion and mutagenesis of this 
AP-l-like sequence significantly abrogate activation of Aldhlal reporter activity by c-
Jun. The formation of nuclear protein complex with the AP-llike sequence -758 
containing c-Jun was detected by EMSA. BHA promotes binding of c-Jun to the AP-I 
responsive sequence at -758 within the Aldhlal proximal promoter that regulates gene 
expression. Transient transfection experiments also demonstrate that the AP-l like 




DISCUSSION AND CONCLUSIONS 
Aldehydes generated by the process of lipid peroxidation are implicated in the 
pathogenesis of several oxidative stress-associated pathologies, such as steatohepatitis, 
liver fibrosis, atherosclerosis, myocardial ischemia-reperfusion injury, cancer and 
cataractogenesis. Humans have elaborate systems to metabolize these toxic electrophiles 
and prevent oxidative damage, including the aldehyde dehydrogenases superfamily of 
enzymes. To date, the relative contribution of the different Aldh isozymes in cellular 
detoxification of lipid aldehydes especially in mouse liver is highly controversia1. 
Moreover, all previous characterization studies were done using rat cytosol with limited 
or no studies in mice. Previous studies with human and rat ALDHs demonstrate that 
ALDH3A1 but not ALDH1A1 provides protection against lipid derived aldehydes 
(Townsend et a1., 2001). However, recent studies with Aldh1a1-1- mice showed that 
ALDH1A1 has the potential to protect against these toxic species (Choudhary et a1., 
2005;Lassen et al., 2007). In chapter II, we presented ample evidence that Aldh1a1 plays 
a major role in cellular defense against oxidative damage induced by reactive lipid 
aldehydes in mouse liver. Aldh1a1 exhibits far higher affinity and catalytic efficiencies 
for lipid aldehydes and OS-conjugates compared to Aldh2 or Aldh3a1. The endogenous 
Aldh1a1 gene was highly expressed in mouse liver and liver-derived cell lines compared 
to Aldh2 and Aldh3al. The knockdown of Aldh1a1 expression by siRNA caused 
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Hepa-Iclc7 cells to be more sensitive to acrolein-induced cell death and resulted in 
increased accumulation of acrolein-protein adducts and caspase 3 activation. Moreover, 
previous studies demonstrate high levels of Aldhl al gene expression in the liver and lens, 
two organs noted for generation of ROS and cytotoxic lipid aldehydes, suggest the 
importance of Aldhl al in cellular protection against oxidative stress-induced damage. 
These results indicate that mechanisms to induce the expression of Aldhl al gene in 
mouse liver may be a useful strategy to prevent inflammatory diseases, such as the 
progression of hepatic steatosis to steatohepatitis. 
Microarray analysis of gene expression profiling in mouse liver by electrophiles 
such as BHA or acrolein demonstrates the specific up-regulation of several antioxidant 
and electrophile detoxification genes, including Aldhlal. QRT-PCR analysis confirmed 
the activation of Aldhlal and other electrophile detoxification genes such as Nqo-l, Ho-
I and Gstm I in mice liver by acrolein or BHA. These results are consistent with previous 
studies that indicate that Aldhl al gene expression is induced by a variety of microsomal 
enzyme inducers such as phenobarbital (PB) and BHA (Alnouti and Klaassen, 2008). 
Consistent with the mRNA expression, the cytosolic Aldhlal activity was significantly 
induced in mice liver treated with BHA or acrolein but not by SFN. 
The signaling pathway involved in electrophile-mediated activation of Aldhl al 
gene in mouse liver is unknown. One mechanism underlying electrophile-mediated 
induction of Aldhlal gene expression can include electrophilic adduction to signaling 
proteins involved in Aldhlal gene regulation. Electrophiles binding to keapl promote 
Nrf2 nuclear localization and transactivation ofNrf2-responsive genes. However, while 
BHA-induced expression ofNqol, Ho-l and Gstml genes in WT mice were significantly 
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reduced in Nrf2-I- mice, Aldhlal gene was still responsive to BHA in Nrf2-I- mice liver 
indicating that BHA-mediated activation of Aldhlal gene is independent ofNrf2. This 
result is consistent with previous studies using Keap-l knockdown (keap l-kd) mice with 
constitutively active Nrf2 (Reisman et aI., 2009). The mRNA expression ofNqol and 
Gstml genes were significantly increased in keapl-kd mice compared to WT control, 
suggesting that the inducible expression of these genes is Nrf2 dependent. However, 
Aldhlal mRNA expression in keapl-kd mice liver was comparable to that ofWT mice, 
confirming that electrophile-induced expression of Aldhlal gene is regulated by Nrf2-
independent mechanism. Even though the 5' flanking sequence of Aldhlal gene contains 
numerous Nrf2-like binding sites (ARE), Nrf2 failed to stimulate the activity of Aldhlal-
luciferase reporter, which further supports our hypothesis that electrophile-induced 
expression of Aldhlal gene is independent ofNrf2. 
We hypothesized that electrophile-induced transcription of Aldhlal gene is 
mediated by activation of AP-l gene. Previous studies demonstrate that the phenolic 
electrophilic compounds and acrolein induce the expression of cytoprotective genes by 
stimulating the expression and activity of AP-l proteins. The activation of c-Junl AP-l by 
oxidative stress during acute hepatitis served a hepatoprotective function by 
transcriptional up-regulation of Nos 2 gene (Hasselblatt et aI., 2007). JunD was recently 
shown to regulate the human ferritin H gene expression involved in antioxidant defense 
and protection against oxidative stress-mediated cytotoxicity (Tsuji, 2005). We showed 
that the c-jun and c-fos mRNA expression were significantly increased by BHA or 
acrolein in the livers ofWT mice and Hepalc1c7, which correlate with enhanced 
Aldhlal mRNA expression. Furthermore, over-expression of c-Jun, JunD or JunB 
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induced endogenous Aldhlal protein expression in mouse liver-derived cell lines. The 
low basal expression of Aldhlal gene expression in Nrf2-I- mice could possibly be 
attributed to reduced expression of c-Jun and c-fos gene in these mice. The 
transactivation potential of c-Jun is enhanced by JNK mediated phosphorylation. BHA 
and acrolein augments the protein levels and activity of c-Jun compared to control. 
Moreover, the phosphorylation of c-Jun by acrolein correlates with the activation of its 
upstream kinase, JNK. These results established that electrophile-induced transcription of 
Aldhlal gene is mediated by enhanced expression and activity of AP-l genes. Transient 
transfection analysis with c-Jun dominant negative proteins (TAM67) further confirmed 
that activation of Aldhlal-Iuciferase reporter activity by acrolein is dependent on c-
JuniAP-l. 
Lipid aldehydes contribute to the up-regulation of electrophile detoxifying genes 
by modulating the activity of protein kinases, such as JNK, p38 and ERK (Wu et aI., 
2006;Zhang and Forman, 2008). Experiments using specific inhibitors of JNK, ERK or 
MEKI revealed that the treatment of HepG2 with JNK (SP600l25) or ERKIMEKI 
(PD98059) inhibitors block acrolein or c-Jun-mediated transactivation of Aldhlal 
promoter activity. However, the phosphatase inhibitor (okadaic acid) significantly 
increased Aldhlal promoter activity but had no effect on c-Jun-induced Aldhlal 
luciferase activity. These results suggest that MAPK, such as JNK is essential for 
transactivation of Aldhl al gene in HepG2 cells. 
The AP-l proteins regulate gene expression as either homodimers of jun or 
heterodimers with fos family. Transient transfection studies indicate that all the jun 
family proteins (c-Jun, Jun D and Jun B) activate Aldhlal-Iuciferase reporter activity. 
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We also noticed that while Fral and Fral had no effect on c-Jun-mediated transactivation 
of Aldhlal-luciferase activity, over-expression of c-Fos inhibited activation of Aldhlal 
reporter activity by c-Jun. Abrogation of c-Jun-dependent gene activation by c-Fos was 
previously reported by Marden et aI., who demonstrated that whereas c-Jun homodimers 
strongly activated CYP2J2 expression, heterodimers formed between c-Fos and c-Jun 
were inactive (Marden et aI., 2003). Thus, mouse Aldhl al and human CYP2J2 genes 
show similar pattern of regulation by AP-l with the predominant AP-l complex that 
causes enhanced Aldhlal promoter luciferase activity being c-Jun homodimer and not c-
Jun/c-Fos heterodimer. 
Previous studies demonstrate that Nrf2 acts as a binding partner for c-Jun in 
transcriptional activation of cytoprotective gene. For example, the activation of CYP2J2 
gene expression by BHA dependent on functional interaction between c-Jun and Nrf2 
(Lee and Murray, 2010). However, Nrf2 had no effect on c-Jun-mediated transactivation 
of Aldhlal-Iuciferase activity. Electrophiles, such as acrolein and HNE have been 
reported to enhance the expression of cytoprotective genes by activation of nuclear factor 
KB (NF-KB) transcription factor. TNFa is a pro-inflammatory cytokines stimulated by 
cytotoxic aldehydes and a known activator of the NF-KB signaling pathway. While TNFa 
treatments did not activate Aldhlal-luciferase activity, it inhibited c-Jun-mediated 
activation of Aldhlal-luciferase activity, suggesting that NF-KB activation abrogates c-
Jun-induced activation of Aldhlal activity. This is consistent with in vivo results in 
mouse liver which demonstrate that activators ofNF-KB signaling pathway such as high 
fat diet causes significant reduction in Aldhl al gene expression. 
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The mechanism by which AP-1 proteins modulate Aldh1a1 gene expression by 
electrophiles is still unknown. Previous studies demonstrate that the up-regulation of 
CYP2J2 gene transcription by BHA was dependent on the binding of c-Jun and Nrf2 to 
an atypical AP-l-like element in the proximal promoter ofCYP2J2 (Lee and Murray, 
2010). Analysis of the 5' -flanking sequence of Aldh 1 a 1 gene indicates the presence of 
four AP-1-like elements. The promoter deletion and mutagenesis studies indicate that two 
AP-1-like elements between -1496 to -480 bp of the 5'-flank of Aldh1a1 gene relative to 
the transcription start site are important for c-Jun-mediated activation of Aldh1a1 reporter 
activity with the AP-1-like motif at position -758 playing a more critical role. 
EMSA and super shift analysis demonstrate the presence of c-Jun, but not c-fos or 
Nrf2 in the nuclear protein complex bound to the AP-1 like sequence at -758, suggesting 
the importance of AP-1 sequence at -758 in c-Jun-mediated activation of Aldh1a1 gene. 
The AP-1 element at -1069 apparently did not form protein complexes with extracts from 
HepG2. This observation contrasts our mutagenesis studies which demonstrate that the -
1069 site modestly affect c-Jun-mediated transactivation of Aldh1 a1 promoter. The in 
vivo binding of c-Jun to both AP-1 sequences at -758 and -1069 was strongly increased 
by treatment of mice with BHA detected by ChIP experiment. However, the enhanced 
recruitment of c-Jun to the -1069 site by BHA might be due to close proximity «500 bp) 
between this site and the -758 site, it may be difficult to obtain DNA fragments with the 
separate AP-1 elements by sonication. Future ChIP experiment where the chromatin is 
fragmented by enzymatic digestion using micrococcal nuclease will allow one to examine 
whether BHA promotes binding of c-Jun to both AP-1 sites. 
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In conclusion, we showed that Aldhlal has both electrophile detoxification and 
antiapoptotic roles in mouse liver and liver-derived cell lines. We also have provided 
evidence that Aldhlal gene can be induced by electrophiles such as acrolein and BHA 
and that increased expression of Aldhlal gene by electrophiles was dependent on c-
JuniAP-l and not Nrf2 or NF-KB. Aldhlal gene expression was modulated by c-Jun 
homodimer and not c-Jun/c-fos heterodimer. The MAPK especially JNK also plays a 
crucial role in electrophile mediated activation of Aldhlal gene. The deletion and 
mutagenesis of two AP-l-like sequences at positions -758 and -1069 significantly 
abrogate activation of Aldhlal reporter activity by c-Jun. The formation of nuclear 
protein complex with the AP-llike sequence -758 containing c-Jun was detected by 
EMSA. BHA promotes binding of c-Jun to the AP-l responsive sequence at -758 within 
the Aldhlal proximal promoter that regulates gene expression. Due to the lipid aldehyde 
detoxification and anti-apoptotic role of Aldhlal in mice liver, an understanding of the 
mechanism to activate Aldhlal gene expression might provide a useful rationale for 
therapeutic protection and amelioration of oxidative stress-induced pathologies. The 
proposed model for the activation of Aldhlal transcription by electrophiles is illustrated 
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Figure 33. Proposed schematic model for the activation of Aldhlal gene by electrophiles. 
Electrophiles such as BHA and acrolein are known to induce oxidative stress in cells by 
redox cycling and depletion of cellular reduced GSH, respectively. In response to 
oxidative and electrophilic stress, stress-activated protein kinase such as JNK 
phosphorylates c-JunI AP-l and enhances its trans activating potential. There is enhanced 
recruitment of c-Jun homodimer to AP-l-like element in the proximal promoter of 
Aldhlal gene resulting in transcriptional activation of Aldhlal gene. Increased 
expression of Aldhlal leads to enhanced metabolism and detoxification of acrolein and 
HNE, thereby inhibiting the progression of fatty liver to steatohepatitis (NASH). 
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FUTURE STUDIES. 
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of pathologies ranging 
from simple triglyceride accumulation in hepatocytes (simple steatosis) to steatosis with 
inflammation (steatohepatitis, NASH), fibrosis, cirrhosis and hepatocellular carcinoma 
(Browning and Horton, 2004). Hepatic steatosis is benign and reversible. However, 
formation of NASH may progress to fibrosis and other end-stage liver diseases. The 
prevalence ofNAFLD in the general population is estimated to be between 14-24% with 
::::;30 million Americans affected with the disease. Cirrhosis ofthe liver accounts for 14% 
of liver transplants in the US. The "two hit model" was proposed to explain the etiology 
ofNAFLD (Day and James, 1998). The "first hit" is attributed to insulin resistance, 
which leads to simple steatosis. The "second hit" is due to oxidative stress, which might 
be a consequence of increased production ofROS in the liver, relative to antioxidants, 
generated from activation of alternative pathways for fatty acid oxidation such as the 
peroxisomal ~ oxidation and microsomal ro oxidation catalyzed primarily by acyl-CoA 
oxidase and cytochrome P450 4A, respectively. ROS are relatively short-lived and exert 
local effects. However, they initiate lipid peroxidation in cells by attacking PUF A, which 
results in formation of aldehyde products such as acrolein, HNE and MDA (Esterbauer et 
aI., 1991). These aldehydes have longer half-lives than ROS and can diffuse to distant 
sites of their production, thereby amplifying the effects of oxidative ROS. It is proposed 
that the deleterious effect of ROS is mediated by these aldehydes (Esterbauer et aI., 
1991;Esterbauer, 1993). 
Reactive aldehydes are implicated in the initiation and perpetuation of 
inflammation in NASH. The accumulation of reactive aldehydes in the liver can promote 
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the influx of inflammatory cells by stimulating the production of the proinflammatory 
cytokines, TNFu, thereby amplifying inflammatory response (Browning and Horton, 
2004;Esterbauer et ai., 1991). In addition, reactive aldehydes are also known to activate 
hepatic stellate cells leading to collagen deposition (Browning and Horton, 2004). Thus, 
lipid aldehydes can promote progression from steatosis to NASH by directly inducing 
hepatocyte death and necrosis, inflammation and liver fibrosis. We showed that Aldh1al 
is a major enzyme in mouse liver involved in oxidative metabolism and detoxification of 
lipid aldehydes. Thus, we hypothesize that activation of Aldhla1 gene expression in the 
liver is a therapeutic strategy to prevent progression to NASH. Future experiment should 
examine whether Aldh1a1-1- mice are more susceptible to NASH than WT mice on long 
term high fat diet (HFD), a standard nutritional method for stimulating NAFLD and 
NASH in rodents (Kim et aI., 2004). Male C57BLl6 (WT) mice and Aldh1al-l - mice on 
C57BLl6 background could be placed on low fat diet (LFD) or HFD for 12 weeks. 
Subsequently, the liver can be examined for lipid accumulations using Hand E staining. 
Markers of oxidative stress can be examined, such as total, reduced (GSH) and oxidized 
(GSSG) glutathione, and aldehyde accumulations in the liver. Finally, the levels of pro-
inflammatory cytokines, such as TNF u, IL-1 ~ and Cox2 can be compared in both 
genotypes. Aldh1a1 gene expression is induced in mice liver by phenobarbital (PB) 
(Alnouti and Klaassen, 2008). Future studies could also assess whether activation of 
Aldhla1 gene expression in the liver by PB can prevent NASH. C57BLl6 mice can be 
administered either saline or 100 mg/kg PB (i.p) in saline daily for 7 days. The markers 
of oxidative stress and aldehyde accumulation, pro-inflammatory cytokines and lipid 
accumulations can be assessed in control and treated group of mice. 
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APPENDIX 
LIST OF ABBREVIA nONS 
4-HNE: 4-hydroxy-2-nonenal 
Acrolein: propen-2 al 
AP-1: Activator protein 1 
Aldh: aldehyde dehydrogenases 
LPO: Lipid peroxidation 
MDA: malondialdehyde 
WT: wild type 
ORF: open reading frame 
CYP: Cytochrome P450 
ROS: reactive oxygen species 
MTT: 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
AKR: aldoketoreductase 
Nrf2: Nuclear factor-E2 related factor 2 
ARE: Antioxidant response element 
BHA: butylated hydroxy anisole 
tBHQ: tert-butylhydroquinone 





GST: Glutathione-S transferase 
ADH: Alcohol dehydrogenase 
GS-HNE: glutathione conjugate of 4-HNE 
Keap-1: Ketch-like ECH-associated protein 1 
NAD(P)+: Nicotine adenine dinucleotide phosphate, oxidized form 
NF-KB: nuclear factor kappa B 
PCR: Polymerase chain reaction 
QRT-PCR: Quantitative real time PCR 
RXR: retinoid X receptor 
RAR: retinoic acid receptor 
TPA: 12-0-tetradecanoyl-phorbol-13 acetate 
TRE: TP A response element 
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SUMMARY OF Ph.D DISSERTATION RESEARCH 
Reactive lipid aldehydes are implicated in the pathogenesis of various oxidative 
stress-mediated diseases, including the transition from hepatic steatosis to non-alcoholic 
steatohepatitis (NASH). The role of Aldehyde dehydrogenase (Aldh) isozymes in 
detoxification of lipid aldehydes, such as acrolein and HNE in mice liver is highly 
controversial. The first part of my thesis was to define which hepatic Aldh isoforms plays 
a major role in detoxification of lipid-derived aldehydes in mice liver by enzyme kinetics 
and in vitro knockdown experiment. Kinetic studies revealed that Aldhlal exhibits 
higher affinity for acrolein and HNE compared to Aldh2 and Aldh3al. We also 
demonstrated that knockdown of Aldhlal expression by siRNA caused lipid-derived 
cells to be more sensitive to acrolein-induced cell death, and resulted in increased 
accumulation of acrolein-protein adducts and activation of caspase 3. These results 
indicate that Aldhlal plays a major role in cellular defense against oxidative damage 
induced by reactive lipid aldehydes in mouse liver. We also noted that hepatic Aldhlal 
mRNA levels were significantly increased (;::: 3-fold) in acrolein-fed mice compared to 
control. In addition, hepatic cytosolic ALDH activity was induced by acrolein when 1 
mM NAD+ was used as cofactor, suggesting an Aldhlal-protective mechanism against 
acrolein toxicity in mice liver. Thus, mechanisms to induce Aldhlal gene expression 
may provide a useful rationale for therapeutic protection against oxidative stress-induced 
pathologies. 
The second part of my thesis was to decipher the mechanisms of electrophile-
induced transcription of Aldhlal. We analyzed the mRNA levels of hepatic Aldhlal in 
C57BL6 (WT) and Nrf2-I- mice exposed to butylated hydroxyanisole (BHA) by qRT-
PCR. In vivo, BHA is demethylated to tert-butylhydroquinone (tBHQ), which is known 
to undergo redox cycling to tert-butylquinone (tBQ) generating ROS. BHA exposure 
resulted in ~2-fold increase in mRNA levels of Aldhlal in WT and Nrf2-I- mice 
compared to control of the same genotype, while the induction of Nrf2 target genes, such 
as Nqo-l, Ho-l and Gstml upon BHA administration was significantly reduced in Nrf2-I-
mice. The mRNA and protein levels of the AP-l genes (c-Jun and c-fos) were 
significantly induced by BHA treatment in WT mice. Transient transfection experiments 
were conducted in HepG2 cells with Aldhlal 5'-flanking luciferase reporter vectors. 
While co-transfection with Nrf2 expression plasmid had no effect, over-expression of c-
Jun resulted in ;:::4-fold induction in Aldhlal transcriptional activity. We proposed that 
electrophile-induced transcription of hepatic Aldhl al is mediated by c-Jun/ AP-l. Over-
expression of a dominant negative c-Jun (TAM67) protein in HepG2, treatment with 50 
~M JNK (SP600125) or MEKI (PD98059) inhibitors significantly abrogate the 
electrophile-mediated transcription of Aldhlal. We further showed that c-Jun induces 
Aldhlal promoter activity as a homodimer and not as c-Jun/c-Fos heterodimer. Deletion 
and mutagenesis studies established that two AP-l sites at position -758 and -1069 
relative to Aldhlal transcription start site mediate c-Jun-induced transcription of 
Aldhlal. We further confirmed that electrophiles promote the binding of c-Jun to the 
proximal AP-l site by electrophoretic mobility shift assay (EMSA) and ChIP assay. 
Taken together, these data suggest that Aldhlal may be a novel therapeutic target for 
preventing the transition from fatty liver to NASH. 
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